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Abstract
Tuberculosis (TB) is an infectious disease that is considered to be the biggest killer of
mankind in the history of infectious diseases. It is responsible for more than 1 billion deaths
in the last 200 years. Nowadays, there are still more than 10 million new TB cases every year
and it causes more than 1.5 million deaths annually, according to World Health Organization
estimates. Nigeria, with a persistent incidence of about 219 cases / 105 inhabitants for the
year 2019, is among the 8 countries that accounted for two-thirds of the new TB cases in
2018. The control of the disease in this country is coordinated by the National Tuberculosis
and Leprosy Control Program (NTBLCP). Despite efforts, that are mainly focused in the
provision of free DOTS (Directly Observed Treatment, short-course) to persons with active
TB that goes to the hospital, the estimated prevalence is around 330/105 population, which is
approximately the same as the estimated TB prevalence in 1990 (323/100,000).
Epidemiological models can be used for a more precise diagnosis of TB situation in
certain territories, as well as to help on the design and evaluation of control actions. In this
project, two modeling approaches have been used to these ends. First, a top-down approach
at the country level (Nigeria) by means of the design, testing and fitting of several SEIR-type
models, aimed to provide a global picture of the situation and to quantify some of the most
relevant parameters. Second, a bottom-up approach to a smaller area (Gombe state, in the
north-east of the country) by means of the design, testing and fitting of an agent-based
model, aimed to unravel a particular context and to help on the design and quantification of
control actions. In addition, fieldwork was also carried out in order to look for the particular
socio-economic factors that are responsible for the epidemiological situation of TB spread;
the statistical analysis of the data obtained is the third approach of this project.
Several SEIR-type models were built in an attempt to progressively characterize and
understand TB dynamics in a different context, these models were fitted to both some
selected High burden and low Burden countries around the world and, in particular, to the
epidemiological situation in Nigeria. The splitting of the infectious (sick) population in
two subpopulations, those that are diagnosed (and treated) and those that are not, confirmed
a dramatic low notification rate that varies from 16 to 20% during the analyzed years
(2000-2010). This factor revealed to be the bottleneck for the control of the disease in this
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country. Model’s predictions showed no relevant effects of control actions without a previous
increase in the notification rate. Fieldwork was designed in coordination with NTBLCP local
authorities with the aim of analyzing socio-economic factors that condition such notification
rate in Gombe state. It consisted of an initial gathering of data from NTBLCP Gombe
state branch, Gombe State Hospitals Management Board, and various hospitals in Gombe
state, followed by a set of 52 in-depth interviews with TB patients from different health
centers. Obtained data and interviews’ outcomes were statistically analyzed using inferential
statistics and Anova analysis of mean, with the help of machine learning techniques. Results
were devastating: none of the patients interviewed had any knowledge of TB symptoms
and 90% had no knowledge of TB transmission mechanisms after talking to the health
workers. Mean patients’ delay was 9.6 weeks with a standard deviation of 4.8; only 10% of
interviewed patients went to the doctor within the first month of feeling sick, 30% within 1-2
months, 20% within 2-3 months, and 40% after feeling sick for more than 3 months. The
epidemiological information obtained from the top-down approach and the results derived
from the fieldwork were used for adapting an agent-based model (ABM) of TB spreading
in the context of Gombe state. The resulting ABM was successfully fitted to the evolution
of estimated prevalence and diagnosed cases from 2007 to 2016. Then, it was used to test
different interventions aimed to increase the notification rate, decrease the diagnosis delay,
and increase the population’s awareness regarding TB transmissible. The multi-approach
methodology used in this project revealed to be a robust way of tackling a real problem. It
was capable of (1) providing a global and detailed picture of TB situation in a certain area,
(2) relating model’s parameters and outcomes with a real socioeconomic context, and (3)
generating a useful tool for helping on the design and evaluation of TB control actions.
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Resumen
La tuberculosis (TB) es la enfermedad infecciosa que más muertes ha causado en la
historia de las enfermedades infecciosas, conociéndose como the big killer. Es responsable
de más de mil millones de muertes en los últimos 200 años. Hoy en día, todavía hay más
de 10 millones de casos nuevos de TB cada año y causa más de 1.5 millones de muertes
anuales, según las estimaciones de la Organización Mundial de la Salud (OMS). Nigeria, con
una incidencia persistente de aproximadamente 219 casos / 105 habitantes para el año 2019,
se encuentra entre los 8 países que representaron conjuntamente dos tercios de los nuevos
casos de tuberculosis en 2018. El control de la enfermedad en este país está coordinado
por el Programa Nacional de Control de Tuberculosis y Lepra (NTBLCP). A pesar de los
esfuerzos, que se centran principalmente en la provisión de DOTS gratuitos (tratamiento
observado directamente, curso corto) a personas con TB activa que acuden al hospital, la
prevalencia estimada es de alrededor de 330 / 105 habitantes, que es aproximadamente igual
a la prevalencia estimada de TB en 1990 (323 / 100,000).
Los modelos epidemiológicos se pueden utilizar para un diagnóstico más preciso de
la situación de TB en ciertos territorios, así como para ayudar en el diseño y evaluación
de acciones de control. En este proyecto, se han utilizado dos enfoques de modelización
para estos fines. Primero, un enfoque de arriba hacia abajo (top-down) a nivel de país
(Nigeria) mediante el diseño, prueba y ajuste de varios modelos tipo SEIR, con el objetivo
de proporcionar una imagen global de la situación y cuantificar algunos de los parámetros
más relevantes. En segundo lugar, un enfoque de abajo a arriba (bottom-up) en una área más
pequeña (estado de Gombe, en el noreste del país) mediante el diseño, prueba y ajuste de un
modelo basado en agentes, con el objetivo de desentrañar un contexto particular y ayudar en
el diseño y cuantificación de las acciones de control. Además, también se realizó un trabajo
de campo para investigar los factores socioeconómicos particulares que son responsables de
la situación epidemiológica de la propagación de la tuberculosis. El análisis estadístico de
los datos obtenidos es el tercer enfoque de este proyecto.
Se construyeron varios modelos de tipo SEIR en un intento de caracterizar y comprender
progresivamente la dinámica de la TB en diferentes contextos. Estos modelos se ajustaron
a algunos países seleccionados de alta carga y baja carga en todo el mundo, y en particular
a la situación epidemiológica en Nigeria. La división de la población infecciosa (enferma)
en dos subpoblaciones, la de personas que se diagnostican (y se tratan) y la de las que no,
confirman una tasa de notificación baja dramática que varía entre el 16 y el 20 % durante los
años analizados (2000-2010). Este factor reveló ser el cuello de botella para el control de la
enfermedad en este país. Las predicciones del modelo no mostraron efectos relevantes de las
acciones de control sin un aumento previo en la tasa de notificación.
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El trabajo de campo se diseñó en coordinación con las autoridades locales de NTBLCP
con el objetivo de analizar los factores socioeconómicos que condicionan dicha tasa de
notificación en el estado de Gombe. Consistió en una recopilación inicial de datos de la
sucursal del estado de NTBLCP Gombe, la Junta de Administración de Hospitales del
Estado de Gombe y varios hospitales en el estado de Gombe, seguida de un conjunto
de 52 entrevistas en profundidad con pacientes con tuberculosis de diferentes centros de
salud. Los datos obtenidos y los resultados de las entrevistas se analizaron estadísticamente
utilizando estadísticas inferenciales y análisis de medias de Anova, con la ayuda de técnicas
de aprendizaje automático. Los resultados fueron devastadores: ninguno de los pacientes
entrevistados conocía los síntomas de la tuberculosis y el 90 % no conocía los mecanismos de
transmisión de la tuberculosis después de hablar con el personal sanitario. El retraso medio
de los pacientes en acudir al centro médico fue de 9.6 semanas con una desviación estándar
de 4.8; solo el 10 % de los pacientes entrevistados acudió al médico dentro del primer mes
de sentirse enfermo, el 30 % dentro de 1-2 meses, el 20 % dentro de 2-3 meses y el 40 %
después de sentirse enfermo durante más de 3 meses.
La información epidemiológica obtenida del enfoque bottom-up y los resultados derivados
del trabajo de campo se utilizaron para adaptar un modelo basado en agentes (ABM) de
propagación de TB en el contexto del estado de Gombe. El ABM resultante se ajustó
con éxito a la evolución de la prevalencia estimada y los casos diagnosticados de 2007 a
2016. Luego, se usó para probar diferentes intervenciones destinadas a aumentar la tasa de
notificación, disminuir el retraso del diagnóstico y aumentar la conciencia de la población
sobre la TB transmisible.
La metodología de enfoque múltiple utilizada en este proyecto reveló ser una forma
sólida de abordar un problema real. Fue capaz de (1) proporcionar una imagen global y
detallada de la situación de la TB en un área determinada, (2) relacionar los parámetros y
resultados del modelo con un contexto socioeconómico real, y (3) generar una herramienta
útil para ayudar en el diseño y la evaluación de acciones de control de TB.
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Resum
La tuberculosi (TB) és la malaltia infecciosa que ha causat més morts a la història
de la humanitat. És responsable de més de mil milions de morts en els darrers 200 anys.
Actualment, encara hi ha més de 10 milions de nous casos de tuberculosi cada any i provoca
més d’1.5 milions de morts anuals, segons les estimacions de l’Organització Mundial de la
Salut. Nigèria, amb una incidència persistent d’uns 219 casos / 105 habitants durant l’any
2019, es troba entre els 8 països que van representar dos terços dels nous casos de tuberculosi
el 2018. El control de la malaltia d’aquest país està coordinat pel Programa Nacional
de Control de la Tuberculosi i la Lepra (NTBLCP). Malgrat els esforços, que es centren
principalment en la prestació de DOTS gratuïts (Tractament observat directament, de curta
durada) a persones amb tuberculosi activa que van a l’hospital, la prevalença estimada és d’uns
330 per cada 100,000 habitants, que és aproximadament la mateixa prevalença de tuberculosi
que s’estimava l’any 1990 (323 / 100,000). Es poden utilitzar models epidemiològics per a
un diagnòstic més precís de la situació de tuberculosi en determinats territoris, així com per
ajudar en el disseny i avaluació de les accions de control de l’epidèmia.
Inicialment es van desenvolupar diversos models de tipus SEIR per intentar caracteritzar
i comprendre progressivament la dinàmica de la tuberculosi en contextos diferents, aquests
models s’adaptaven tant a països del món seleccionats amb una alta incidència com a països
amb baixa incidència. Aquesta ha estat la primera aproximació per poder estudiar la situació
de la tuberculosi a Nigèria, què és l’objectiu del treball.
En aquest projecte, s’han utilitzat dues estratègies de modelització per fer-ho. En primer
lloc, una estratègia top-down a nivell de país (Nigèria) mitjançant el disseny, proves i
adequació de diversos models de tipus SEIR, amb l’objectiu de proporcionar una imatge
global de la situació i quantificar alguns dels paràmetres més rellevants. En segon lloc, una
estratègia bottom-up estudiant una àrea més petita, l’Estat de Gombe, al nord-est del país,
mitjançant el disseny, la prova i l’adequació d’un model basat en agents (ABM). El model
ABM té per finalitat entendre en detall la situat particular de l’Estat de Gombe i ajudar en
el disseny i quantificació de possibles accions de control. A més, també es va realitzar un
treball de camp per buscar els factors socioeconòmics particulars responsables de la situació
epidemiològica de la tuberculosi; l’anàlisi estadística de les dades obtingudes és la tercera
estratègia de treball d’aquest projecte.
La divisió de la població infecciosa (malalta) en dues subpoblacions, les que són diagnos-
ticades (i tractades) i les que no ho són, van confirmar una taxa de notificació dramàticament
baixa que varia del 16 al 20 % durant els anys analitzats (2000-2010). Aquest factor es va
revelar com el coll d’ampolla per al control de la malaltia en aquest país. Les prediccions del
model no mostraven efectes rellevants de les accions de control sense un augment previ de la
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taxa de notificació. El treball de camp es va dissenyar en coordinació amb les autoritats locals
NTBLCP amb l’objectiu d’analitzar els factors socioeconòmics que condicionen aquesta
taxa de notificació a l’estat de Gombe. Va consistir en una recollida inicial de dades de la
sucursal estatal NTBLCP a Gombe, la Junta de Gestió d’Hospitals de l’Estat de Gombe i
diversos hospitals de l’Estat de Gombe, seguida d’un conjunt de 52 entrevistes en profunditat
amb pacients amb TB de diferents centres de salut. Les dades obtingudes i els resultats
de les entrevistes es van analitzar estadísticament mitjançant estadístiques inferencials i
Anova de mitjana, amb l’ajut de tècniques d’aprenentatge automàtic. Els resultats van ser
devastadors: cap dels pacients entrevistats no coneixia els símptomes de la tuberculosi i el
90 % no coneixia els mecanismes de transmissió de la tuberculosi després de parlar amb
el personal sanitari. El retard mitjà dels pacients va ser de 9,6 setmanes amb una desviació
estàndard de 4,8; només el 10 % dels pacients entrevistats van acudir al metge durant el
primer mes de sentir-se malalt, el 30 % entre els 1-2 mesos, el 20 % entre els 2-3 mesos i el
40 % després de sentir-se malalt durant més de 3 mesos.
La informació epidemiològica obtinguda amb l’estratègia top-down i els resultats derivats
del treball de camp es van utilitzar per adaptar un model basat en agents (ABM) de propagació
de la TB en el context de l’Estat de Gombe. L’ABM resultant es va ajustar amb èxit a
l’evolució de la prevalença estimada i els casos diagnosticats del 2007 al 2016. A continuació,
es va utilitzar per provar diferents intervencions destinades a augmentar la taxa de notificació,
disminuir el retard de diagnòstic i augmentar la consciència de la població respecte a la
tuberculosi transmissible. La metodologia utilitzant diferents estratègies utilitzada en aquest
projecte s’ha mostrat com una forma robusta d’afrontar el problema real. Ha fet possible (1)
proporcionar una imatge global i detallada de la situació de la tuberculosi en un determinat
àmbit, (2) relacionar els paràmetres i els resultats del model amb un context socioeconòmic
real i (3) generar una eina útil per ajudar en el disseny i l’avaluació d’accions de control de la
tuberculosi.
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Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb). It
usually affects lungs, where it can cause typical TB lesions that can be detected through X-ray
during diagnosis, but it can also affect other organs in the body [18]. TB has co-evolved with
humans since paleolithic era [21], and it is considered the biggest killer of mankind in history
of infectious diseases. It is the responsible for more than 1 billion deaths in the last 200
years [14]. Despite the fact that TB can be cured by a regimen of drugs, it still causes more
than 1.5 million death annually, which represents more than HIV and diabetes combined. Its
estimated global spread in 2017 is shown in Figure 1.1
The bacillus is transmitted by the inhalation of infected aerosols generated by active
TB (ATB) patients [78], as shown in Figure 1.2. The inhalation of the bacilli will usually
lead to the trigger of an immune response that can have one of the three different clinical
outcomes: (1) complete clearance of the pathogen, (2) latent tuberculosis infection (LTBI) or
(3) progression to primary active disease [19, 15].
Infected aerosols must be deposited on the pulmonary alveoli to be able to generate
infection, as seen in Figure 1.3. In fact, this is one of keys of the success of Mycobacterium
tuberculosis: its ability to grow inside the alveolar macrophages (AM) [19].
Some certain protective factors in the lungs can prevent the infective capacity of the Mtb.
The quality of the aerosol is the first factor, as not all infected patient are able to generate
sufficient quantity [18]. The second factor is the quality of the alveolar surfactant, which can
also destroy the lipophilic wall of the Mtb just as may be destroyed by the AM when it is
phagocytised [18]. Nevertheless, it is difficult to evaluate the infectiousness of the aerosol
because it is not clear to what extent these factors can affect it. What is clear is that there
must be close contact between the patient with active TB and susceptible persons before
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Fig. 1.1 Global view of estimated TB incidence per 100,000 inhabitants, in 2017
[98]
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Fig. 1.2 TB transmission circle in the population
[78]
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Fig. 1.3 Infectious cycle of M. tuberculosis. 1. Bacillus entry into the pulmonary alveolus
through a drop of aerosol. 2. Phagocytosis by an Alveolar Macrophage (AM) and subsequent
multiplication inside. 3. Destruction of the AM, local dissemination of M.tuberculosis,
phagocytosis by other AMs and generation of a local inflammatory response dominated by
monocytes (3 a) or polymorphonuclear cells (PMN) (3 b), thanks to which the bacilli can
be drained into the regional lymph node, where Th1 or Th17 lymphocytes proliferate it. 4.
Lymphocytes are attracted by the inflammatory response of the lesions and activate infected
MAs or attract more PMN, depending on whether the immune response opts for a Th1 (4
a) or Th17 (4 b) response, respectively. In the first case there is a control of the bacillary
population and there is a drainage of numb bacilli through the foamy macrophages (5 a), until
it is controlled by encapsulating the lesion (6). In the second, the lesions are growing no more
thanks to the entry of PMN and the extracellular bacillary growth in the NET, generating new
peripheral lesions. In this case, the bacillary concentration is much higher, and hence the
drainage is much more important, either through the alveolar fluid or at the systemic level by
granuloma neovascularization (5 b). At the pulmonary level, the alveolar fluid bacilli (7) tend
to be drained into the gastrointestinal tract (8), although they can be part of new aerosols,
generating new lesions (1) [20].
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new infection occurs [18]. It must be taken into account that, ability of each individual to
develop ATB depend on many factors, including the bacillary load (which also depend on
the intensity of contact with the case), i.e., more than six hours a day for a period which
depends on the diagnosis delay time (60 to 90 days in countries with good healthcare system)
[18, 84].
LTBI occurs when the host’s immune response manages the initial containment of the
Mtb by developing and encapsulating granulomas as seen in Figure 1.3. More often than
not, the bacilli remain physically contained and immunologically constrained by these
encapsulated granulomas throughout the lifetime of the hosts [77, 37]. During this process,
an endogenous reinfection can produce new infection spotlights that will presumably undergo
the same control dynamics [19]. However, even years after infection, especially in the case
of immunocompromised hosts (like HIV patients), the control process can fail and the host
can develop an ATB. On average, about 10% of the LTBI people develop an ATB during
their life [87]. A latent-infected host can be re-infected several times, thereby increasing the
load of Mtb in its body and hence increasing the chance of progressing to ATB. According
to the World Health Organization (WHO), there was an estimated number of 2 to 3 billion
people with LTBI in 2015 [70], thus at risk of developing an active disease.
Tuberculosis is still a major global health concern and one of the leading causes of death
[16]. As reported by WHO, there were an estimated 10.7 million new ATB cases and 1.7
million TB-related deaths worldwide in 2017 [102]. Even though most TB cases occur in
resource-limited countries, it is still a threat to higher-resource countries. This is due to the
nature of the disease’s strong interaction with HIV dynamics and also the recently world-wide
emergence of drug-resistant TB. The main manifestation and the only infectious form of TB
is the pulmonary form, hence worthy of study. Tuberculosis has killed more than any other
infectious disease in the world, it was estimated that it took more than 1,000,000,000 lives
over the cause of 200 years [76]. It is a very silent disease that has eluded mankind for a very
long time. It affects people of all social status.
1.2 Epidemiology of tuberculosis
1.2.1 Basic concepts
The word epidemiology is an amalgamation of Greek word epi meaning on or upon, demos
meaning people and logos meaning study. Put together, epidemiology implies study of what
befalls a population of people [49]. Many definitions have been proposed by various scholars,
but the following definition capture the general underline purpose.
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Epidemiology is the study of the distribution and determinants of health-related states
or events in specified populations, and the application of this study to the control of health
problems [17]. Epidemiological information is used to plan and evaluate strategies to prevent
illness and as a guide to the management of patients in whom disease has already developed.
Epidemiology of a disease is an integral part of understanding pattern and behavior of the
disease. Like in every discipline, some of the most common variables used in epidemiological
studies includes the following.
Prevalence, sometimes referred to as prevalence rate, is the proportion of persons in a
population who have a particular disease or attribute at a specified point in time or over a
specified period of time [22]. Prevalence differs from incidence in that prevalence includes
all cases, both new and preexisting, in the population at the specified time, whereas incidence
is limited to new cases only [22]. Sometimes we used what is called a point prevalence.
Point prevalence refers to the prevalence measured at a particular point in time. It is the
proportion of persons with a particular disease or attribute on a particular date. Incidence is
the most common terminology in defining epidemiology of a disease [22].
Incidence refers to the occurrence of new cases of disease or injury in a population over a
specified period of time. Although some epidemiologists use incidence to mean the number
of new cases in a community, others use incidence to mean the number of new cases per unit
of population. It is usually link to an attack rate [22].
An attack rate is the proportion of the population that develops illness during an outbreak,
An alternative and more accurate phrase for attack rate is incidence proportion. to account
for number of persons that died from a given out-brake, we normally talk about case fertility
rate. A case-fatality rate is the proportion of persons with the disease who die from it [22].
1.2.2 Tuberculosis in the world
Latest on tuberculosis
Worldwide, TB is one of the top 10 causes of death and the leading cause from a single
infectious agent (above HIV/AIDS) [102]. Millions of people continue to fall sick with
TB each year. In 2017, TB caused an estimated 1.7 million deaths (range, 1.2–1.4 million)
among HIV-negative people and there were an additional 300,000 deaths from TB (range,
266,000–335,000) [70] among HIV-positive people. Globally, the best estimate is that 10.0
million people (range, 9.0–11.1 million) developed TB disease in 2017: 5.8 million men, 3.2
million women and 1.0 million children [102]. There were cases in all countries and age
groups, but overall 90% were adults (aged >=15 years), 9% were people living with HIV
(72% in Africa) and two thirds were in eight countries: India (27%), China (9%), Indonesia
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(8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) and South Africa
(3%) [70]. These and 22 other countries in WHO’s list of 30 high TB burden countries
accounted for 87% of the world’s cases. Only 6% of global cases were in the WHO European
Region (3%) and WHO Region of the Americas (3%) [68].
Fig. 1.4 Global view of TB incidence for countries with at least 100,000 cases
[98]
The severity of national epidemics varies widely among countries. In 2017, there were
fewer than 10 new cases per 100,000 population in most high-income countries, 150–400
in most of the 30 high TB burden countries, and above 500 in a few countries including
Mozambique, the Philippines and South Africa [102]. Drug-resistant TB continues to be a
public health crisis. The best estimate is that, worldwide in 2017, 558,000 people (range,
483,000–639,000) developed TB that was resistant to rifampicin (RR-TB), the most effective
first line drug, and of these, 82% had multidrug-resistant TB (MDR-TB) [68]. Three countries
accounted for almost half of the world’s cases of MDR/RR-TB: India (24%), China (13%)
and the Russian Federation (10%) [68]. Globally, 3.5% of new TB cases and 18% of
previously treated cases had MDR/RR-TB. The highest proportions (>50% in previously
treated cases) are in countries of the former Soviet Union. Among cases of MDR-TB in 2017,
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8.5% (95% confidence interval, 6.2–11%) were estimated to have extensively drug-resistant
TB (XDR-TB). About 1.7 billion people, 23% of the world’s population, are estimated to
have a latent TB infection, and are thus at risk of developing active TB disease during their
lifetime 1.4. The Sustainable Development Goals (SDG) and End TB Strategy targets set
for 2030 cannot be met without intensified research and development [7]. Technological
breakthroughs are needed, so that the annual decline in the global TB incidence rate can be
accelerated to an average of 17% per year by 2025. Priorities include a vaccine to lower
the risk of infection, a vaccine or new drug treatment to cut the risk of TB disease in the
1.7 billion people already latently infected, rapid diagnostics for use at the point of care and
simpler, shorter drug regimens for treating TB disease
High burden countries
Here we present 30 countries with their corresponding estimated TB burden per 100000
population in 2017 that are regarded as high TB burden countries 1.1.
1.2.3 Tuberculosis in Nigeria
Nigeria had an estimated population of more than 200 million in 2019, with approximately
more than 54% living in poverty [61]. The country is divided into 36 states plus the Federal
Capital Territory (FCT). States are subdivided into 774 local government areas (LGAs) and
geographically clustered into six geopolitical zones. The health system is structured along
primary, secondary and tertiary levels roughly corresponding to the LGA, state and federal
levels. Overcrowding and period in contact with patients are key factors of TB infection.
Paradoxically, TB is often seen as a XIX century disease, mainly associated with the poor
living conditions in crowded cities. Today, TB is reaching the highest number of cases
in absolute numbers in the history [70] precisely because of the massive urbanization of
populations. This fact is especially painful in Nigeria, a country that is undergoing rapid
urbanization with a rapidly growing population. At the current growth rate of about 2.8%
to 3.5% a year, it is estimated that Nigeria’s urban population will double in the next two
decades [8]. As a consequence, TB is endemic in Nigeria.
Despite current global control efforts to reduce TB, Nigeria’s incidence is refusing to
show any significant decline [70]. On March 14th, 2017, a wide circulated paper announced
that Nigeria is rank 4th in TB infection worldwide [80]. This was followed by the press
released by the national TB programme coordinator. The statistics show that over 80% of TB
cases in Nigeria are still undetected while the disease claims millions of lives over the years
in the country [5, 70].
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Table 1.1 TB high burden countries as listed by WHO, together with absolute (x 103) and
relative (per 105 inhabitants) incidences in 2018 [99]. In bold, absolute incidences above
400,000 cases; in italic, relative incidences greater than 500/105 inhabitants.
Countries Absolute Relative Countries Absolute Relative
incidence incidence incidence incidence
(x103) /105 (x103) /105
Angola 109 355 Russian 79 64
Federation
Bangladesh 357 221 South Africa 301 520
Brazil 95 45 Thailand 106 153
China 866 61 Tanzania 142 253
Democratic People 131 513 Viet Nam 174 182
Rep. of Korea
Democratic 270 321 Cambodia 49 302
Rep. of Congo
Ethiopia 165 151 Central 25 540
Africa Rep.
India 2,690 199 Congo 20 375
Indonesia 845 316 Lesotho 13 611
Kenya 150 292 Liberia 15 308
Mozambique 162 551 Namibia 13 524
Myanmar 181 338 Papua 37 432
New Guinea
Nigeria 429 219 Sierra Leone 23 298
Pakistan 562 265 Zambia 60 346
Philippines 591 554 Zimbabwe 30 210
It is reasonable to say that, in spite of effort being made by all stakeholders battling TB
in Nigeria, the epidemic is still very persistent. The current estimate of TB prevalence in
Nigeria by WHO is around 330/100,000 population, which is approximately the same as
the estimated TB prevalence in 1990 (323/100,000). The same situation is observed in the
number of deaths due to the disease (70/100,000 to 65/100,000). The reason for this steady
state of the TB epidemic in the country is still unclear. Many associate it with poverty and the
consistent growth in population due to a very high fertility rate of the women in the country
(the population grew from 95,62 million people in 1990 to 206,20 in 2018), others presume
that there is a need for a better strategy in order to fight the disease towards a significant
decline in the near future [27].
Nigeria is a setting where several health-care options (medical pluralism) including
orthodox medicine (public, private, or drugstores), traditional medicine, spiritual healers
etc., operate freely [27]; the public health facilities within which the TB control programme
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operates is "distanced" from the people and are often not the first choice during health seeking
decisions. In fact, high TB prevalence in Nigeria has a lot to do with policies of the TB
control program. Several studies have shown that TB prevalence has a lot to do with policies
made in TB control [45, 50, 55, 28]. Nigeria adopted the passive case finding approach as
recommended by WHO, based on a study conducted in India [57, 13]. successful TB control
only happens when social and cultural factors are taken into consideration [83]. TB is a major
public health problem in Nigeria and it was declared a national emergency in 2006 [73].
Following the Abuja Declaration in 2001, Directly Observed Therapy Short course (DOTS)
activities have been scaled up across Nigeria. In spite of the documented effectiveness of
DOTS in the Nigerian context Nigeria has one of largest burden of TB cases in the world [44].
Despite expressions of political will to control TB and a clearly articulated national TB policy,
neither the set target for CDR nor cure rates has been achieved nationally. TB continues to
account for high rates of morbidity and mortality within Nigeria in spite of reports of 99%
geographic coverage using the DOTS strategy by 2008 [73, 66]. This situation has been
further compounded by the high HIV prevalence of 4.1% in Nigeria. Nigeria accounts for
about 10% of the total global burden of HIV with estimates of 3.4 million people living with
HIV by the end of 2011 [73, 64].
1.3 Global fight against TB
1.3.1 Sustainable Development Goals (SDGs)
The Sustainable Development Goals (SDGs) were born at the United Nations Conference
on Sustainable Development in Rio de Janeiro in 2012. In order to meet up with the urgent
universal needs that include both political, economic and environmental, some universal
goals were introduced during the conference. The Millennium Development Goals (MDGs),
which started a global effort in 2000 to tackle the indignity of poverty, were replaced by the
SDGs that year.
The MDGs lasted for 15 years where it drove progress in several important areas, such as
reducing extreme poverty, access to water and sanitation, reduction in child mortality and
maternal health among others. Some of the global movement that were kicked started by the
MDGs includes but are not limited to free primary education, inspired countries to invest in
the future generations, very huge stride in combating HIV/AIDS and other treatable diseases
such as malaria and tuberculosis.
The SDGs were born out of commitment to finish what was stated and to tackle even
more pressing challenges facing our world today. A total of 17 interconnected goals were set
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1.5. The goals were interconnected in such a way that success in one will affect success in the
rest. Annihilating climate change threat will impacts how to manage our natural resources
extensively, achieving gender equality, better health, eradicating poverty will poster and
facilitate peace and inclusive society, reduce inequality and integrated economies. The SDGs
could be seen as the greatest chance to improve the future generation. The uniqueness of the
SDGs includes the reaffirmation of the international commitment to end poverty, permanently,
everywhere, making sure no one is left behind. Most import, involved in making or building
a more sustainable, safer, more prosperous planet for all humanity.
The SDGs came into effect in January 2016, and they will continue to guide United
Nations Development Programme (UNDP) policy and funding until 2030. As the lead United
Nations (UN) development agency, UNDP is uniquely placed to help implement the Goals
through their work in some 170 countries and territories.
Each of the aforementioned goals carries sub goals and sub categories. In particular, the
goals within the 3rd objective (Ensure healthy lives and promote well-being for all at all
ages) is a mandate that WHO describe as:
1. By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live
births.
2. By 2030, end preventable deaths of newborns and children under 5 years of age, with
all countries aiming to reduce neonatal mortality to as low as 12 per 1000 live births
and under-5 mortality to at least as low as 25 per 1,000 live births.
3. By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical
diseases and combat hepatitis, water-borne diseases and other communicable diseases.
4. By 2030, reduce by one third premature mortality from non-communicable diseases
through prevention, treatment and promote mental health and well-being.
5. Strengthen the prevention and treatment of substance abuse, including narcotic drug
abuse and harmful use of alcohol.
6. By 2020, halve the number of global deaths and injuries from road traffic accidents.
7. By 2030, ensure universal access to sexual and reproductive health-care services,
including for family planning, information and education, and the integration of
reproductive health into national strategies and programmes
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Fig. 1.5 Sustainable Development Goals as they came into effect in January of 2016
[98]
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8. Achieve universal health coverage, including financial risk protection, access to quality
essential health-care services and access to safe, effective, quality and affordable
essential medicines and vaccines for all.
9. By 2030, substantially reduce the number of deaths and illnesses from hazardous
chemicals and air, water and soil pollution and contamination.
Our vested interest in this research work is related to 3.3, which is related to ending TB
epidemics.
1.3.2 WHO End TB Strategy 2035
The movement of the United Nations from the 2015 Millennium Development Goals to the
sustainable Development Goals puts WHO at a point of inflexion.
To complement the transition from the MGDs to SDGs, the world community has
launched a dramatic accelerated fight against TB and thus most affected by it: the poorest,
most vulnerable, socially marginalized and inequitably reserved. TB has been a threat to
health security, a challenge hitch to the human development, a whip on the human population.
The World Health Organization’s new and holistic strategy approved by the World Health
Assembly of 194 Member States in 2014 places patients and communities at the heart of the
response. Some of the progress made include but not limited to
1. 43 million lives saved between 2000 and 2014 through effective TB diagnosis and
treatment
2. 47% decline in TB mortality rate and 42% decline in TB prevalence rate since 1990
3. HIV-related TB deaths down by 32% in the last decade
4. Fragile progress in MDR-TB Treatment for MDRTB has increased with almost all
cases detected in 2014 started treatment
And some of the major challenges includes but not limited to
1. US$ 1.4 billion funding gap per year for implementation of existing TB interventions.
An additional gap of US$ 1.3 billion exists for research
2. 3.6 million people with TB are missed by health systems every year and therefore may
not get adequate care they need
3. TB/HIV response needs acceleration Anti-retroviral treatment, treatment of latent TB
infection and other key interventions still need further scale-up
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4. MDR-TB remains a public health crisis Only one in four MDR-TB cases detected and
one in two cases cured
End TB Vision
The vision to end TB aim at everyone with TB should have access to the innovative tools and
services they need for rapid diagnosis, treatment and care. This is a matter of social justice,
fundamental to the goal of universal health coverage. Considering the growing prevalence of
drug-resistant tuberculosis, ensuring high quality and complete care will also benefit global
health security.
End TB Strategy and Targets
The End TB strategy aims to end the global TB epidemics, with targets to reduce TB deaths
by 95% and to cut new cases by 90% between 2015 and 2035 (shown in Fig 1.1), and to
ensure that no family is burdened with catastrophic expenses due to TB. It sets interim
milestones for 2020, 2025, and 2030. There are 3 main pillars for the End TB Strategy,
namely
1. Integrated, patient centred care and prevention
2. Bold policies and supportive systems
3. Intensified research and innovation
The targets for the set strategy are
1. Reduction in number of TB deaths by 35% in 2020, 75% in 2025, 90% in 2030, 95%
in 2035 compared with 2015
2. Reduction in TB incidence rate by 20% in 2020, 50% in 2025, 80% in 2030, 90% in
2035 compared with 2015
3. TB family facing catastrophic cost incidence rate by 0% in 2020, 0% in 2025, 0% in
2030, 0% in 2035 compared with 2015.
The May 2014 resolution calls on governments to adapt and implement strategy with
high-level commitment and financing. It reinforces a focus within the strategy on serving
populations highly vulnerable to infection and poor health care access, such as migrants. It
also highlight the need to engage partners within the health sector and beyond, such as in
the fields of social protection, labour, immigration and justice. The WHO was requested
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by the resolution Secretariat to help Member States adapt and operationalize the strategy,
monitor implementation and evaluate milestone progress towards the 2035 targets, noting the
importance of tackling the problem of multidrug-resistant TB and promoting collaboration
across international borders.
In order to reinforce Pillar 3, the WHO in 2018 publish a Guidelines for country-level
TB modelling. The document aims to provide concrete, pragmatic guidance for how TB
modelling and related technical assistance is undertaken to support country decision-making
of which we based our research on [69].
Fig. 1.6 Desired decline in global TB incidence rates to reach the 2035 targets [69]
1.3.3 The National TB and Leprosy Control Programme in Nigeria
The control of the disease in Nigeria is coordinated by the National Tuberculosis and Leprosy
Control Program (NTBLCP), in line with the End TB Partnership initiatives whose ultimate
target is to eliminate TB as a public health problem by the year 2050 (meaning reaching less
than 1 case per million population) [27].
NTBLCP of Nigeria was officially launched in 1991 with a mandate to coordinate
TB and Leprosy Control activities in the Nigeria and reduce the burden of both diseases.
The NTBLCP is structured along the three tiers of government i.e. Federal, State and
Local Government Areas. Its activities are supported by development partners. Prominent
among these are WHO, Global Fund to fight AIDS, TB and Malaria (GFATM), International
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Union Against Tuberculosis and Lung Diseases (IUATLD) and United States Agency for
International Development (USAID). There is a National TB training centre in Zaria which is
responsible for development of human resource, training guidelines and operational research
relating to TB [73]. The basic strategy of NTBLCP remains the provision of free DOTS to
all persons with ATB. NTBLCP efforts have yielded results as to contained TB burden by
doubling of smear positive case detection rate (CDR) from 16.3% to to 31.1% over the years
[73]. However, these indicators of NTBLCP good performance appear to be overshadowed
by the exponential increase in total number of new cases of TB in the country.
1.4 Models in epidemiology
Even with long history of epidemiology and all, the study of diseases using mathematical
techniques begins about 350 years ago. The work of John Graunt (1620-1674), is some
what unanimously regarded as the first statistical study of infectious disease. His book of
1663 of Natural and political observations describes the Bill of Mortality which was directly
related with methods of public health statistics. After a century or so, a mathematician called
Daniel Bernoulli used method of mathematical analysis to analyzes mortality from smallpox.
The work was published in 1766 and was considered the first epidemiological model [49].
The author argued that inoculation with live virus obtained from a mild case of smallpox
would reduce the death rate and thereby increase the population, even if the inoculation
itself might occasionally be fatal. A contemporary reformulation of Bernoulli’s approach in
terms of differential equations is given in [49]. Between 1873 to 1894, P.D. En’ko developed
a transmission model based on some specific assumptions without resorting to previously
developed theory. He compared synthetic epidemics, the number of which are calculated
using the model actual outbreaks of measles and scarlet fever in two boarding school in St.
Petersburg [9]. In 1902, Ronald Ross received the Nobel Prize in Physiology or Medicine
for his work on the life cycle of the malaria parasite, he explained the complete life cycle
in human with the inclusion of mosquito as a vector and the Plasmodium parasite. The
work was extended by Macdonald, the formulated mosquito-born transmission is somtimes
referred to as the Ross-Macdonald model [30].
Threshold theorem was developed by Kermark and McKendrick between 1927 and 1939.
It state that introduction of infectious individual in a susceptible population could cause an
epidemic only if the density of the susceptible exceed a certain critical value or threshold.
The description of a system using mathematical tools, techniques or language is termed
as mathematical models. The process of developing the model is termed as modelling.
Generally, modelling approaches are considered of two types, the top-down approach and
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the bottom-up approach. An example of the top-down approach is a compartmental model,
while Agent Based Models are good example of the bottom-up approach.
Models could be classified in multiple ways: linear or nonlinear, static or dynamic,
discrete or continuous, deterministic or stochastic, among others. Furthermore, a wide variety
of modelling methodologies exist, ranging from decision analytic models to compartment
models, network models, Agent-Based models, and many other types and hybrids along the
spectrum of possibilities. Nevertheless, the principle of parsimony specifies that a model
should not be more complex than needed [35].
Modelling process includes several steps and phases. Figure 1.7 shows a possible
modelling process diagram including one of the most critical point, the formulation of the
question to be answered. This will determine the kind of model and approach to be used,
as well as the final modelling cycle that will follow. In general, models may be used for (1)
understanding purposes, (2) predictive purposes and/or (3) controlling purposes.
Fig. 1.7 Modeling diagram
[49]
Usually, modeling process (described in Fig. 1.7) involves the use of schematic diagram,
which requires translation of a biological scenario into a mathematical problem. The modeling
process typically begins with a clear description of the process based on the scientific
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understanding of the system. The translation into mathematical equations should be made
with the specific goal or biological question in mind. Then, the verbal description of the
system is encoded in mathematical equations. The model should incorporate only those
features that are relevant to the specific goal or biological question in mind. Once the model
is formulated, it can be investigated with a number of mathematical tools. Finally, the results
must be interpreted in the light of the biological scenario considered and potentially seek the
answer of the biological question that was set forth at the beginning. At the very least we
must address these questions: What did we learn about the real world from the model? Is our
model’s message supported by the information about the system? [49]. Our interest in this
research lies with the compartmental models and the Agent Based models. Thus, we briefly
describe each of the aforementioned models.
1.4.1 Compartmental models
In compartmental models, individuals in the population are divided into groups (or compart-
ments) and the model tracks the infection process for these individuals collectively. This kind
of model can be deterministic or stochastic. The compartmental models are used to study
different scenarios in disease transmission in order to understand its dynamics and assess
the effects of control strategies. We begin by introducing some of the most classical com-
partmental models used in epidemiology and which system of ordinary differential equation
is used to described the dynamics in each compartment. This type of model is inspired by
the work of Kermack and McKendrick [39], where the author proposed for the first time in
1927 the simplest compartmental models involving susceptible population, infectious and the
recovered individuals (SIR models).
SI model
SI model is considered the simplest of all the compartmental models, where S represents the
susceptible sub-population and I stands for the infectious collective. The schematic diagram
of the model is given in Figure 1.8.
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Fig. 1.8 SI model flow diagram (S: susceptible; I: infectious; β : infection rate)
where β I is referred to as force of infection or the incidence rate, i.e., the rate at which
the susceptible population becomes infected per unit of time.
This model is a simple mathematical model that can describe the behavior of some
epidemics efficiently. Figure 1.9 shows the graphical solution of the SI model, where all the
susceptible population becomes sick after a period of time t.
Fig. 1.9 SI model dynamics (S: susceptible; I: infectious)
SIR model
One of the most extended ways of introducing an epidemic model is through the work of
Kermack and McKendrick, which is one of the first epidemiological models, introduced in
1927 [38].
In this classic way of modeling, the spread of the disease in a population is considered
by splitting the population into 3 non-intersecting compartments, namely the healthy but
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are vulnerable to contract the disease which are called Susceptible and denoted by S, the
ones that have already contracted the disease and are infectious sick denoted by I, and finally
the ones that have recovered and can not contract the disease again called the Recovered or
Removed, denoted by R.
The number of individuals in each of these classes changes with time, that is, S(t), I(t),
and R(t) are functions of time t. The total population size N is the sum of the sizes of these
three classes:
N(t) = S(t)+ I(t)+R(t) [9] (1.3)
In order to simplify reality, the model considers 2 assumptions: (1) the sick individuals
are infectious, and (2) the total population size is constant. Equations 1.4 to 1.6 describe the
SIR model schematic diagram in Figure 1.10.










Equations 1.4 to 1.6 were derived by considering how the classes change over time. As
susceptible individual enters into contact with an infectious individual, that individual could
become infected with a certain probability and migrate to the sick class at per capita rate β .
The susceptible decrease in a unit of time by all individual that becomes sick at that time.
Individuals leaving the sick compartment by recovering goes to the removed compartment at
constant per capita probability per unit of time α , called the recovery rate.
Figure 1.11 shows a simple solution of the SIR model. If we let λ (t) = β I, then the
number of individuals who become infected per unit of time is equal to λ (t). The function
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Fig. 1.11 SIR model dynamics (S: susceptible; I: infectious sick; R: recovered or removed)
λ (t) is called the force of infection. The coefficient β is the constant of proportionality called
the transmission rate constant. The number of infectious individuals in the population, I(t), is
called the prevalence of the disease. For the model to be well defined , we equipped equation
1.4 to 1.6 with S(0), I(0), and R(0) as initial conditions, also as a word of cautious, we
need to be careful with the units of the of the quantities involved when forming a model.
Independent of the initial conditions.
limS(t) = S∞ (1.7)
This is because S(t) is monotone non increasing and bounded from below by 0. The
recovered individual has a monotone non-decreasing behavior and bounded from above by
N(t). Therefore:
limR(t) = R∞ (1.8)
On the other hand, the sick population may have monotone non increasing behavior, or
may increase to some threshold and then decrease to zero as in Figure 1.11. Therefore, from




> 1. The limit S∞ and R∞ of S(t) and R(t) can easily be evaluated and the quantity
S∞ is called the final size of the epidemics. For the epidemics to dies out, if
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lim I(t) = I∞ (1.9)



















Equation 1.12 shows that I(t) is integrable on [0 ∞) and hence the lim I(t) = I∞ = 0
Another important property of epidemics that can be estimated from the SIR model is the
maximum number of sick reached in the epidemic. This signifies the severity of the epidemic,
estimating it will allow us to know when a number of infections in a population will begin to
decline given a newly occurring infectious disease.
SIS model
The assumption for permanent immunity after recovery is not realistic for some types of
disease such as influenza. If we assume a simple scenario where recovered individual
becomes susceptible immediately, then we come up with another simple model called the
SIS model as shown in Figure 1.12. The model is described by equation 1.13 to 1.14 and
Figure 1.13 gives a typical graphical solution of the model.
Fig. 1.12 SIS model diagram (S: susceptible; I: infectious)
dS
dt
= −βSI +αI, (1.13)
dI
dt
= βSI −αI (1.14)
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Fig. 1.13 SI model dynamics (S: susceptible; I: infectious)
SEIR model
Other types of diseases like tuberculosis require a latent period of incubation, thus the SIR
model was extended by including an additional class called the exposed (E) class. Individuals
that are infected but not yet infectious are assigned to this class. We take
1
α
to be the mean
time spent in the exposed compartment. The flow chart of the model is given in Figure 1.14.
Fig. 1.14 SEIR model diagram (S: susceptible; E: exposed; I: infectious; R: recovered or
removed)
Transmission events happen via contact of S and E with constant rate (β ). The SEIR
model can be expressed mathematically through equation 1.15 to 1.18
24 Introduction


















Here N also describes the total host population size and R0 which is a threshold frequency





A typical solution of the model is given by 1.15.
Fig. 1.15 SEIR model dynamics (S: susceptible; E: exposed; I: infectious; R: recovered or
removed)
In some special cases, when the infectious cycle requires it, exposed class can include
infectious individuals without clinical symptoms. Then, the infection equations must be
modified to account for this possibility. In fact, the models described in this Section are the
simplest ones, and are usually taken as the starting point to develop more complex models
that account for the specificity of the studied disease.
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1.4.2 Agent Based Models (ABMs)
Historically, the complexity of scientific models was often limited by mathematical tractabil-
ity: when differential calculus was the only approach we had for modeling, we had to keep
models simple enough to “solve” mathematically and so, unfortunately, we were often limited
to modeling quite simple problems. With current computer capabilities, the limitation of
mathematical tractability is removed, so we can start addressing problems that require models
that are less simplified and include more characteristics and heterogeneity of the real systems.
Agent Based Models (ABMs) are less simplified in one specific and important way: they rep-
resent a system’s individual components and their behaviors. Instead of describing a system
only with variables representing the state of the whole system, we model its individual agents.
ABMs are thus models where individuals or agents are described as unique and autonomous
entities that usually interact with each other and their environment locally. A unique behavior
of each agent is usually described by a simple set rules, and the interaction between the
respective agents usually influence their behaviours. Modelling the agent individually allows
for the observation of the full effect of system as a whole through the diversity that existed
between the respective agent [48].
Agents can be organisms, humans, businesses, institutions, and any other entity that
pursues a certain goal. Being unique implies that agents are usually different one from each
other in such characteristics as size, location or resource reserves and history, among others.
Interacting locally means that agents usually do not interact with all other agents but only
with their neighbors-in geographic space or in some other kind of “space” such as a network.
Being autonomous implies that agents act independently of each other and pursue their own
objectives. They adjust their behavior to the current states of themselves, of other agents,
and of their environment. Using ABMs allows us address problems that concern emergence:
system dynamics that arise from how the system’s individual components interact with and
respond to each other and their environment. Hence, with ABMs we can study questions of
how a system’s behavior arises from, and is linked to, the characteristics and behaviors of its
individual components [81].
1.4.3 Models in tuberculosis
Several mathematical models have been used to estimate long-term dynamics of TB to help
to assess the development of strategies of TB control. The literature on compartment models
to describe complex systems is extensive [40, 24, 11]. Most of the models found in literature
are of SEIR type. Many authors use rigorous mathematical methods to show relationship and
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important properties from the model [74], while few uses data from agencies such as WHO,
local and national TB agencies to validate their studies.
Many different studies have been able to draw important conclusions on TB dynamics by
means of models and other methods [60, 56, 89, 58, 75, 31, 51, 41, 10, 46, 47]. Okuonghae
and Ikhimwin [62], for example, developed a model which classified the population by their
TB awareness level, a key factor which could affect the case detection rate. The model
highlighted the importance of the backward bifurcation phenomena when latently infected
individuals are exogenously re-infected. Another factor which could contribute to better
adjust TB models is the HIV dynamics, especially in the sub-Sahara African region [42].
HIV patients have a higher risk to become infected and also to progress to active disease once
infected than non-HIV infected people. According to WHO [71], nearly all HIV-positive
people with active TB will die.
By means of mathematical models, Wallis [91] was able to identify individuals with an
innate resistance to Mtb. He concluded that understanding the mechanisms of resistance may
lead to therapeutic strategies to counter immune evasion by Mtb. Moreover, models were also
used by Wallis [91] to assess the affinity of LTBI reactivation when patients are administered
drugs with TNF blockers. He was able to determine the specific TNF drugs that are more
efficient at reactivating the LTBI and thus predict the risk of relapse in persons undergoing
treatment. Similarly, another research project by Moualeu-Ngangue et al. [53] worked
with a model simulating the global TB dynamics. The study showed that TB spreading
crucially depends on the basic reproduction number (number of new cases one case generates
during its sick period, which is estimated to be between 10-15 [88, 91]). The research
was done in Cameroon where the role of TB diagnosis, treatment, TB awareness level and
traditional medicine on the dynamics of TB were assessed.Song et al.[85] investigated the
epidemiological time scales of TB and they evaluated the risk of infection from both close
contacts (clusters) and casual contacts (random). They concluded that the risk of infection
depends on the source of infection as well as on different environmental characteristics.
Lastly, Guzzeta et al [34] presented three different ways to model TB dynamics: (1)
an ODE model with no age structure and constant population size, (2) an age-structured,
stochastic version of the ODE model and (3) a socio-demographic Agent-Based Model
(ABM). The models were fitted to epidemiological data from Arkansas, USA. The author
compared the three different models and concluded that different modeling techniques have
their advantages and drawbacks and they should be chosen carefully. For example, an ODE
model is best suited to describe the evolution of prevalence, incidence, and mortality. On
the other hand, an ABM, which gives insight on the individual dynamics, would be best to
estimate the fraction of reactivated cases or to fit age-specific incidence of active TB.
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Although there are many studies into TB epidemic, cause, spread and suggestive measures
for therapy and control, none of the aforementioned studies uses mathematical model to
evaluate the actual epidemic of TB in Nigeria using data obtained from the local TB control
program in the community. This thesis proposes a mathematical model that will be used to
evaluate TB burden in this country. We aim to point out effective strategies that could be
used to effectively reduce TB burden and death due to TB in Nigeria.
1.5 Aim, approach and outline of the thesis
The aim of this thesis is to increase our understanding of TB epidemiology in high burden
contexts and propose improvements on its control strategies, with the final objective of
contribution in reducing TB epidemic in these settings.
In order to make progress to this end, we propose the combination of different approaches
that provide a global perspective of TB in these countries. We try to take into consideration the
main biological factors that govern TB spread together with social,economical, cultural and
political determinants. Although biological factors can be more or less common everywhere,
the other factors may vary greatly from one country to another and even in some countries,
from region to region. Therefore, we propose to progressively get closer to a real territory to
finally analyse social patterns that can affect the spread of the disease, cultural behaviours that
may facilitate the misdiagnosis or the political regulations that determine the health facilities
structures, operations and limitations, among others. In that sense, this thesis will start by
studying different country-level dynamics and will continue by analysing the situation of
Nigeria as a whole to finally focus on Gombe state. The methodological approaches to be used
in this process will also vary and be adapted to the scales and factors consecutively tackled.
The final picture will arise from a combination of compartmental top-down models, statistical
models and agent-based models together with field work carried out in a collaboration with
the NTBLCP Gombe state.
1.5.1 Specific objectives
The specific objectives to reach the main goal are detailed below. They have been grouped
into research, methodological and public health objectives.
Research objectives
R1 To understand the main features of TB dynamics in low burden countries and high
burden countries.
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R2 To determine the cause of high incidence and its persistence in Nigeria.
R3 To analyse the behavioural and socio-economic factors resulted to TB persistence in
Nigeria using Gombe as a case study.
R4 To propose interventions to improve TB control in Gombe (Nigeria).
Methodological objectives
M1 To develop several compartmental models with increasing complexity adapted to study
different context and address specific questions.
M2 To adapt a general Agent-Based Model for the study of the specific situation in Gombe
Public health objective
PH To look for possible in near future, real and feasible interventions to improve TB
control in Gombe (Nigeria)
1.5.2 Outline
The thesis consists of the following chapters. In chapter 1 we have briefly introduced the
main epidemiological features of tuberculosis disease and its present status around the world.
We also have shown the importance of mathematical models in epidemiology by introducing
a number of research work around this field for a very long period of time. In chapter
2, we developed a number of complex SEIR models, starting with the simple approach
and then continued to introduced new features of the disease in to the subsequent models
until all features (population as a limiting factor of the susceptible population, diagnosis
delay time, reinfection process etc) of the disease were explored. We test the proposed
models in two different context, the low burden and high burden context. Data from over 30
different countries are used to validate the proposed models. We also establish the stability
analysis of the model using second generation matrix method. In chapter 3, we use one
of the compartmental models from chapter 2 with a slight modification to assess the TB
situation in Nigeria. Notification of patient, number of latent infected individual, death
due to TB and diagnosis delay time among others are investigated. The model is validated
using demographic data from Nigeria. Control strategies such as efficacy of treatment over
increased in notification are tested, major problems behind the persistent high prevalence of
TB in Nigeria are investigated and identified. The research included in this Chapter has been
1.5 Aim, approach and outline of the thesis 29
published in Complexity (WILEY HINDAWI), the journal has Impact Factor of 2.59 and
Rank as Q1 under Mathematics and Interdisciplinary Applications by JCR in 2018.
In chapter 4, we collect data of TB cases from NTBLCP in Gombe state, which is one
of the states in the north eastern region of Nigeria. We also describe and show the results
of a field work where TB patient were interviewed. This is an effort to identify some of
the major challenges that lead to a very low notification of TB cases in Nigeria, which is
identified in chapter 3 as the major challenge that facilitates the persistence of TB prevalence
in Nigeria. Factors affecting behavioral and socioeconomic aspect of TB in Gombe state
are identified from the analysis of the data set collected. We carry out statistical analysis of
the aforementioned data sets, and establish relationships between various factors affecting
TB control in the state. Some of the result from this Chapter was present at 5th BSC Severo
Ochao Doctoral Symposium.
In chapter 5, we use results from chapter 4 to build an Agent Based Model for TB
dynamics in Gombe. The inferential statistical analysis of the data set in chapter 4 with the
help of machine learning tools allow for an estimation of the parameters used in building the
simulator. We carry out virtual experiments and test 3 types of intervention strategies that
can be adopted in order to reduce TB prevalence in Gombe state and Nigeria at large. The
result from this Chapter was presented in the International TB Conference in Barcelona, and
also at the Annual Departmental Physics Research meeting.
Finally, the sixth chapter consist of a general as well as specific conclusion about the
research, with remarks concerning future work.

Chapter 2
Understanding tuberculosis dynamics in
different contexts by a sequential
increase in complexity of SEIR models
2.1 Introduction
In this chapter, mathematical models of increasing complexity are used to study the effect of
susceptible population relative size and the role of the infected population on TB dynamics.
Starting from a classical SEI model, two additional compartment are proposed. First, the
sick class is split into infectious and non-infectious. Second, the infected population is
divided according to the number of years since the initial infection. Virtual experiments
are performed to evaluate if the increase in complexity (i) contributes to model accuracy in
predicting TB dynamics, and (ii) provides better information about TB. The effect of different
actions related to the epidemiological control is assessed by using 20 different countries data
of high and low burden settings. Splitting the sick class helps to quantitatively estimate the
effects on diagnosis time delay and allows obtaining the percentage of people who abandon
treatment soon after diagnosis. Dividing the infected class enables studying the effect of the
whole set of latent TB infection population, elucidating the effect of migration flows, and
analyzing particular situations such as the reinfection effect.
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2.2 Models description
TB epidemiology presents several characteristics that greatly contribute to its underlying
complex dynamics. Compartmental models facilitate obtaining a good approximation to the
problem. In the case of TB, they allow us to
1. Describe and understand the factors which determine the epidemiological behaviour of
the disease in a certain context
2. Facilitate the communication of these factors to actors which are not specialist in
mathematical modelling
3. Evaluate several control actions and their effects
A simple SEIR model may correctly describe the global tendency of TB in a certain con-
text and evaluate the main epidemiological parameters like the force of infection. However,
this kind of model does not allow to understand the mechanisms that are responsible for
such tendency, which may differ drastically from one context to another. Therefore, several
compartmental models with different degrees of complexity have been developed (Fig 2.1).
On the one hand, simplest models are easier to parameterize, given a certain prevalence
data set, and thus appropriate to assess global indicators. On the other hand, more complex
models are capable of answering more complex questions regarding the causes for the global
tendency and the possible solutions to reverse a bad trend.
2.2.1 Models formulation
The four basic models that have been built and tested are, from the simplest to the most
complex, the mathematical analysis of the model is given in Appendix 1:
• The classic SEI model, with 3 compartments (susceptible, S; exposed or latently
infected, E; and sick and infectious, I). This model allows to estimate global parameters
like the force of infection or the size of LTBI population, among others.
• SEI2 model, with 4 compartments (susceptible S; exposed or latently infected E; sick
and infectious I1; and sick but not infectious I2). This model allows to answer questions
related with the diagnosis delay.
• SE8IR model, with 11 compartments (susceptible S; exposed in their i-st year of
infection, Ei, i = 1..7; exposed with more than seven years since infection E>7; sick
and infectious, I; and recovered, R). The recovered class do not play a relevant
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epidemiological role, but it is considered separately for allowing the identification
of the population that has overcome an infectious cycle. This model is appropriate
to answer questions related with the characteristics of the exposed class and their
consequences on the TB dynamics.
• SE8I2R model, with 12 compartments (S; E1 to E7; E>7; I1; I2 and R).
Additionally, an extended model with the same compartments as SE8I has also been
developed including a reinfection variable, SE8I-reinf, for the specific case of a context where
reinfection is relevant. All of the basic features of the models are depicted in Fig 2.1 and
briefly explained below. Finally, all models are simulated in both LBC and HBC countries.
A simplification for LBC is also tested in some cases (SEI-low, SEI2-low, SE8IR-low and
SE8I2R-low), considering susceptible population as a non limiting factor, as detailed below.
Fig. 2.1 Overview of the several proposed compartment models with different levels of
complexity. The main compartments are susceptible (S), exposed or latently infected (E),
sick (I) and recovered (R). Sub-compartments of more complex models differentiate between
infectious (I1) and non-infectious (I2), and account for time since infection. Finally, reinfec-
tion of exposed individuals is explicitly considered in one of the cases, thus allowing the flow
Ei>1 to E1.
SEI model
Fig 2.2 shows the structure and flows of the classical SEI model for TB dynamics. The new
recruits inflow into the susceptible population box (S) at a rate Π, equivalent to the birth rate;
this population either die at a rate µ1 or get infected and move to the exposed compartment
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(E) at a rate Λ, where Λ =
αI
N
is the force of infection, α is the contact rate and N is the total
population. Since α indicates the number of people infected by every TB-sick, it is possible
to assess the impact of this parameter on the disease dynamics.
Fig. 2.2 The SEI model with S standing for susceptible, E, the exposed, and I the infectious.
Following a given probability which is generally understood, 10% of the latent infection
individuals in E may develop an active disease and move to the sick class (I) within a period
of 7 years, the probability function rate is given as a2. They can also recover and return to S
at a rate a3, or die at a rate µ2. The sick population spend a given time in the I compartment
until they recover and go back to S at a rate a4, or die at a rate µ3. The dynamics of this
model are driven by equations 2.1 to 2.3. The summary and description of the parameters is
given in Table 2.1.
dS
dt
= Π+a3E +a4I − (Λ+µ1)S, (2.1)
dE
dt
= ΛS− (a3 +a2 +µ2)E, (2.2)
dI
dt
= a2E − (a4 +µ3)I. (2.3)
SEI-low model
The model SEI is also considered in a setting where the susceptible population is approxi-
mated to be the general population (this is the case of low burden countries), that is N ≈ S.
In this setting, the equations for the model are also 2.1 to 2.3 but assuming that force of
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Table 2.1 Summary and description of parameters in SEI and SEI2 models
SEI Interpretation SEI2 Interpretation
Π Recruitment rate Π Recruitment rate
Λ TB force of infection Λ TB force of infection
a2 Probabilty rate from E to I class a2 Probability rate fro E to I1 class
a3 Progression rate from E to S class a3 Progression rate E to S class
a4 Progression rate I to S class a4 Progression rate I2 to S class
µ1 Death rate in S class µ1 Death rate in S class
µ2 Death rate in E class µ2 Death rate in E class
µ3 Death rate I class µ3 Death rate in I1class
a5 Progression rate I1 to I2 class
a6 Relapse rate I2 to I1 class







= Π+a3E +a4I −Λ∗−µ1S, (2.4)
dE
dt
= Λ∗− (a3 +a2 +µ2)E, (2.5)
dI
dt
= a2E − (a4 +µ3)I. (2.6)
SEI2 models
Fig 2.3 shows the flowchart of the SEI2 model. In this new version of the model, the sick
class is split into two sub-populations, I1 and I2, where only the individuals in I1 can infect
the susceptible population. I2 corresponds non infectious. Two new transitions appear. First,
the time delay parameter a5 between I1 and I2. Second, relapse probability for individual in
I2 abandon treatment halfway at a given rate a6. This model can be described by equations
2.7 to 2.10. The description of parameters can be found in Table 2.1.
dS
dt
= Π+a3E +a4I2 − (Λ+µ1)S, (2.7)
dE
dt
= ΛS− (a3 +a2 +µ2)E, (2.8)
dI1
dt
= a2E − (a5 +µ3)I1 +a6I2, (2.9)
dI2
dt
= a5I1 − (µ4 +a6 +a4)I2. (2.10)
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Fig. 2.3 The SEI2 model, with two sick compartments I1 and I2 in addition to the susceptible
(S) and the exposed (E) compartment.
SEI2-low model
Similarly, the SEI2-low considers a non-limiting susceptible population (N ≈ S) for the case






= Π+a3E +a4I2 −Λ∗−µ1S, (2.11)
dE
dt
= Λ∗− (a3 +a2 +µ2)E, (2.12)
dI1
dt
= a2E − (a5 +µ3)I1 +a6I2, (2.13)
dI2
dt
= a5I1 − (µ4 +a6 +a4)I2. (2.14)
SE8IR model
As stated by WHO, an integral part of the population suffers from latent TB [70], [71], [53],
[102]. We consider the probability of developing active TB in the range of 10−13% in the
first seven years of infection and 5−6% the first two years [100] of infection. Therefore, the
time since infection distribution among exposed people is very important in understanding
TB dynamics. The SE8IR model (Fig 2.4) is an extended version of the SEI model with
exposed compartment divided into 8 sub-compartment. We also introduced a an additional
compartment for recovered individuals R.
The individuals will move through these eight compartments depending on the time since
they became infected. Each infected will spend 12 month in each Ei box with probability
1
NEi
.pi for developing active disease. The total probability for developing active disease of
a box Ei at a time t is approximated to be pi(t). The flow of individual from Ei to Ei+1 at
time t is given as
i
NEi





.k1) = k1 Compartment
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Fig. 2.4 The SE8IR model. In addition to the susceptible class (S) and the sick-infectious (I),
the exposed population (E) is divided into eight sub-populations according to the time since
infection with a specific probability of developing an active infection, and the recovered class
(R).
E>7 comprises all the people that have been infected for more than 7 years. The chance
to develop an active disease decreases with time [26, 15, 77], therefore the probability of
developing active disease in the different compartments (Ei) satisfies the relation pi+1 ≤ pi
(pi = ai2 +bi+ c, 1 ≤ i ≤ 8, a = 0.001035,b =−0.0152,c = 0.06).
The death rate is assigned to each of the Eis compartment as ν1. A fraction of individuals
in E>7 may return to the susceptible population at a rate k3. The sick population can either
move into the recovered compartment at a rate k2 or die at a rate µi. Equations 2.15 to 2.25
describe the dynamics of the SE8I model and Table B.2 describes the parameters. The model
opens the possibility to study effect of migration especially in the LBC and also to evaluate
the transitory behavior caused by evolution of the Ei distribution.
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dS
dt
= Π− (Λ+µs)S, (2.15)
dE1
dt
= Λ(S+R)− (ν1 + p1 + k1)E1, (2.16)
dE2
dt
= k1E1 − (ν1 + p2 + k1)E2, (2.17)
dE3
dt
= k1E2 − (ν1 + p3 + k1)E3, (2.18)
dE4
dt
= k1E3 − (ν1 + p4 + k1)E4, (2.19)
dE5
dt
= k1E4 − (ν1 + p5 + k1)E5, (2.20)
dE6
dt
= k1E5 − (ν1 + p6 + k1)E6, (2.21)
dE7
dt
= k1E6 − (ν1 + p7 + k1)E7, (2.22)
dE>7
dt







(piEi)+ p8E>7 − (µi + k2)I (2.24)
dR
dt
= k3E>7 + k2I − (µr +Λ)R. (2.25)
SE8IR-low model
Again, a simplification for LBC is considered (N ≈ S), taking Λ∗ = αI
S
as force of infection
in equations 2.26 to 2.36.
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Table 2.2 Summary of parameters in SEI8R and SE8I2R models
SE8IR Interpretation SE8I2R Interpretation
Π Recruitment rate in S class Π Recruitment rate in S class
Λ TB force of infection Λ TB force of infection
νi Death rate in Ei class νi Death rate in Ei class
pi Probability function pi Probability function
(pi = ai2 +bi+ c) from Ei to I (pi = ai2 +bi+ c) from Ei to I1
k1 Progression rate k1 Progression rate
from Ei to Ei+1class from Ei to Ei+1 class
k3 Progression rate k3 Progression rate
from E>7 to R class from E>7 to R
k2 Progression rate k4 Progression rate from
from I to R class I2 to R class
µi Death rate in I class µi Death rate in I1 class
µs Death rate in S class µs Death rate in S class
µr Death rate in R class µr Death rate in R class
k2 Progression rate from I1 to
I2 class I1 to I2 class






= Λ∗− (ν1 + p1 + k1)E1, (2.27)
dE2
dt
= k1E1 − (ν1 + p2 + k1)E2, (2.28)
dE3
dt
= k1E2 − (ν1 + p3 + k1)E3, (2.29)
dE4
dt
= k1E3 − (ν1 + p4 + k1)E4, (2.30)
dE5
dt
= k1E4 − (ν1 + p5 + k1)E5, (2.31)
dE6
dt
= k1E5 − (ν1 + p6 + k1)E6, (2.32)
dE7
dt
= k1E6 − (ν1 + p7 + k1)E7, (2.33)
dE>7
dt







(piEi)+ p8E>7 − (µi + k2)I (2.35)
dR
dt
= k3E>7 + k2I −µrR. (2.36)
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SE8IR-reinf model
The possibility of reinfection has been included in an extended version of the SE8IR model,
and it is shown in Fig 2.5. Such force of reinfection is introduced as Λ1. The rest of the flows
and rates are equivalent to those explained for the SE8IR model. Equations 2.37 to 2.46 show
the dynamics of this model.
Fig. 2.5 The SE8IR-reinf model, where the feature of reinfection is integrated into the SE8IR
model.
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dS
dt







Ei +E>7)− (ν1 + p1 + k)E1, (2.38)
dE2
dt
= k1E1 − (ν1 + p2 + k1)E2 −Λ1E2, (2.39)
dE3
dt
= k1E2 − (ν1 + p3 + k1)E3 −Λ1E3, (2.40)
dE4
dt
= k1E3 − (ν1 + p4 + k1)E4 −Λ1E4, (2.41)
dE5
dt
= k1E4 − (ν1 + p5 + k1)E5 −Λ1E5, (2.42)
dE6
dt
= k1E5 − (ν1 + p6 + k1)E6 −Λ1E6, (2.43)
dE7
dt
= k1E6 − (ν1 + p7 + k1)E7 −Λ1E7, (2.44)
dE>7
dt







(piEi)+ p8E>7 − (µi + k2)I (2.46)
dR
dt
= k3E>7 + k1I − (µr +Λ)R. (2.47)
SE8I2R model
The SE8I2R model (Fig 2.6) inherits the complexity introduced in SEI2 as well as in SE8IR.
Therefore, the exposed population is divided into eight sub-populations according to the time
since first infection and in addition, the sick population is divided into two sub-populations:
the individuals who have not yet been diagnosed and are spreading the disease (I1) and
the diagnosed, under treatment and isolated individuals who stopped spreading the disease
although they are still in the sick phase (I2). The flows and rates are analogous to those
explained above for SEI2 and SE8IR models and are formulated in equations 2.48 to 2.59.
Table B.2 describes the parameters of the model.
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dS
dt
= Π− (Λ+µs)S, (2.48)
dE1
dt
= Λ(S+R)− (ν1 + p1 + k1)E1, (2.49)
dE2
dt
= k1E1 − (ν1 + p2 + k1)E2, (2.50)
dE3
dt
= k1E2 − (ν1 + p3 + k1)E3, (2.51)
dE4
dt
= k1E3 − (ν1 + p4 + k1)E4, (2.52)
dE5
dt
= k1E4 − (ν1 + p5 + k1)E5, (2.53)
dE6
dt
= k1E5 − (ν1 + p6 + k1)E6, (2.54)
dE7
dt
= k1E6 − (ν1 + p7 + k1)E7, (2.55)
dE>7
dt







(piEi)+ p8E>7 +gI2 − (µi + k2)I1 (2.57)
dI2
dt
= k2I1 − (g+µi)I2. (2.58)
dR
dt
= k3E>7 + k4I2 − (µr +Λ)R. (2.59)
SE8I2R-low model




as force of infection.
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Fig. 2.6 The SE8I2R model. The difference in feature with the previous model is that the






= Λ∗− (ν1 + p1 + k1)E1, (2.61)
dE2
dt
= k1E1 − (ν1 + p2 + k1)E2, (2.62)
dE3
dt
= k1E2 − (ν1 + p3 + k1)E3, (2.63)
dE4
dt
= k1E3 − (ν1 + p4 + k1)E4, (2.64)
dE5
dt
= k1E4 − (ν1 + p5 + k1)E5, (2.65)
dE6
dt
= k1E5 − (ν1 + p6 + k1)E6, (2.66)
dE7
dt
= k1E6 − (ν1 + p7 + k1)E7, (2.67)
dE>7
dt







(piEi)+ p8E>7 +gI2 − (µi + k2)I (2.69)
dI2
dt
= k2I − (g+µi)I2, (2.70)
dR
dt
= k3E>7 + k4I2 −µrR. (2.71)
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2.2.2 Parameter estimation
Overall, before running the simulations, the parameters of the different models are established
and analyzed. The differentials are solved in order to establish some correlation between
the models. To estimate the different parameters, the fittings are carried out sequentially.
Starting with the simplest model (SEI), simulations are fitted to the epidemiological data of a
specific country. Subsequently, using the parameter estimates for the simplest model, the
SE2I parameters are fitted. This process is repeated for SE8IR, SE8I2R and SE8IR-reinf.
The need to fit a gradually increasing number of parameters in the more complex models is
partially eased by using information from the previous simpler models fitted. This step-by-
step procedure ensures consistency between the fittings of the different models. Moreover, it
drastically simplifies the fitting of the most complex models. This methodology allows us
to understand the role played by each parameter and deduce that simple models may not be
enough to understand some specific behaviours.
2.3 Results
TB epidemiological data from 20 countries is analyzed and validate the models from Section
2.2. The selected countries are categorized into 10 LBC and 10 HBC according to their
average TB prevalence (more details in Supplementary material). In this section, a description
of how these models are fitted to 10 LBC and 10 HBC is given. We begin by exploring
(i) the possibility of using the susceptible non-limiting simplification for LBC countries
(i.e., the -low version of the different models), and the consequences of using this kind of
simplification for HBC, (ii) why simple models are not enough in the study of complex
dynamics of TB, and how the increase in models’ complexity can reveal some important
behavior TB dynamics. Furthermore, the role of the latent infected population and the role
played by time since infection in the population on the disease’s dynamics in a population
are shown. Finally, the effect of reinfection, especially in a HBC, is investigated.
2.3.1 Setting the best models for HBC and LBC: Susceptible popula-
tion as a limiting factor
A fundamental question regarding the role of population in TB dynamics is to what extent the
population size affects the dynamics of TB for every epidemic situation(LBC and HBC). To
address this subject matter, various virtual experiments are performed in the two settings with
the two sets of models presented in section 2.2. We are interested in observing the epidemic
trend when using the model with Λ and the model with Λ∗ as their force of infection (i.e.,
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taking susceptible population as a limiting factor or assuming that S = N). Firstly, based on
the average prevalence as either low burden or high burden, the countries are classified. The
detail of the countries fitted can be found in the Supplementary material. Finally, simulations
with the two sets of models and fitting of these countries are conducted.
Comparison of models performance between low and high incidence burden setting
To illustrate our findings, two countries are taken: Spain as an example of LBC and Nigeria
as an example of HBC. Fig 2.7 (A) shows the prevalence dynamics of model with Λ (SE8IR
model) and model with Λ∗ (SE8IR-low model) as their force of infection versus time in
Spain, while Fig 2.7 (B) shows the prevalence dynamics vs time in Nigeria. It is important to
note the Y axis in this figure to see the steady state achieved in Nigeria still corresponds to a
high incidence. In the case of LBC, all the proposed models perform very well with a very
high R2 value, even after a long period of time. For instance, in the case of Spain, R2 remains
over 0.968 for all models. R2 for the rest of countries can be consulted in the supplementary
materials. In the case of HBC, however, the SE8IR-low model conducts poorly as time
elapses. Another point of note is that the SE8IR-low model tends to underestimate the
incidence of the disease in HBC. Therefore, as expected, the simplification S = N could only
be valid in the case of LBC.
Fig. 2.7 The effect of susceptible population size on the dynamics of TB demonstrated in
both low and high burden countries. (A): Result of the model simulation with susceptible
population size as a limiting factor (SE8IR model) and without this limiting factor (SE8IR-
low model) in an LBC (Spain). (B): Result of the simulation of the model with susceptible
population size as a limiting factor (SE8IR model) and the model without this limiting factor
(SE8IR-low model) in an HBC (Nigeria).
46 Understanding TB dynamics with SEIR models
2.3.2 Models complexity and parameter derivation, using Argentina
as a case study
Given the complex nature of TB, a sequence of parameter relations starting from the simplest
model SEI to the most complex model SE8IR-reinf is carried out. For each country under
study, the SEI model is fitted to the epidemiological data. Subsequently, the SEI2 is fitted
to the same data by finding the relationship between the parameters of SEI and SEI2. In a
similar way, more complex models are fitted to the epidemiological data, and the parameters
of SE8IR, SE8I2R, SE8IR-reinf are also inferred successively. This step-by-step strategy
makes it easier to predict and make good estimates of the parameters involved in the more
complex models. Furthermore, it allows us to obtain a very good fitting for the countries
studied. In the Supplementary material, tables report the best fitting parameter sets for all the
models without and with the S = N simplification (-low) have been added.
In order to discuss this process, a specific country setting is used and the kind of questions
that can be answered by each of the models is also presented. Let us present Argentina, a
LBC, to explain how the fitting is carried out. The importance of the models’ complexity to
understand TB dynamics is elucidated. First, Argentina’s setting with the SEI-low model
is analyzed. Second, the diagnosis delay in the model with SEI2-low is included. Third,
the role of the latent infected individuals with the SE8IR-low model is explored. Finally,
the SE8I2R-low model to combine both the diagnosis delay and the time since infection
variables in the population.
Fig 2.8 presents the simulation results for Argentina with different models of various
complexity levels and compares it with the epidemiological data during 20 years. In this
case, the -low versions of the models are used because the simplification is feasible for an
LBC setting. The experiment starts by fitting the prevalence of Argentina to the SEI-low
model and solving the model numerically using Matlab software package ODE-45, the R0
was analytically computed and the results are in the supplementary materials. The contact
rate of the sick individuals in the I compartment for Argentina is then estimated using a
formula derived from the R0. The solution vector of the sick class I is plotted as a function
of time and the parameters of the model are then adjusted until the models are perfectly fitted
to the prevalence of Argentina.
The SEI-low model provides a general understanding of the TB dynamics in the country
without the need to increase complexity. For example, the disease-free equilibrium (DFE)
and the conditions under which an equilibrium exists may be identified for the sick class
to approach the DFE, the supremum of the effective force of infection Λ must be found
such that R0 < 1. This force of infection for each sick individual strictly depends on the
contact rate, which is estimated to be 1.01 per month (12.12 new infected persons per year).
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Fig. 2.8 Comparison of -low models’ fittings for epidemiological data in Argentina. Results
of the models simulations with different complexity levels without the population size as a
limiting factor for Argentina. Models’ parameters are sequentially optimized computationally
to fit the simulation results. The models’ results are contrasted with epidemiological data of
Argentina (blue stars).
Among those infected, only 10-13% are expected to develop active disease. Therefore, each
sick individual will produce less than one sick person in a period of six months, which can
be considered the threshold of infecting new people by a sick individual before complete
recovery.
Consecutively, epidemiological data from Argentina is fitted to the SEI2-low model,
which includes an extra compartment taking into account the diagnosis delay time as seen
in Fig 2.3. Introducing a diagnosis delay time (a5) allows the model to assess the effect of
an early treatment abandonment (probability of moving from receiving treatment I2 back to
infectious I1). In Argentina, the diagnosis time delay is fixed at 2 months with a contact rate
of 6.1/month, which reduces the number of newly infected TB cases. It is estimated that each
case generates 12.2 new infected individuals before they are diagnosed. After dividing the
sick I compartment from SEI-low model into a non-infectious I1 and an infectious I2 state in
the SEI2-low model, the contact rate parameter must be increased to fit the epidemiological
data from Argentina, since the time window to infect new individuals is now smaller. This
model simulates more accurately the reality of TB dynamics, especially in countries where
there is a good TB control (LBC), and facilitates to estimate the number of new infections
generated by a non-diagnosed infectious TB sick. From the average 12.2 new infected
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cases generated during the first 2 months throughout which the sick individuals remain
non-diagnosed, 5% are expected to become sick within the first 2 years since infection and
another 5-6% within the next 7 years since infection. Lastly, the different diagnosis delay
times tested are (a5 = 60-days; a5 = 45-days; and a5 = 30-days), while all other parameters
are kept constant (including contact rate). The results are shown in Fig 2.9. It appears that
reducing the diagnosis delay time would lead to a better control of the disease. Implementing
policies to reduce the diagnosis time delay would imply faster eradication of the disease.









































SEI2 with 60 days delay
SEI2 with 45 days delay
SEI2 with 30 days delay
Fig. 2.9 Analysis of TB dynamics in Argentina with SEI2 model showing the effect of
diagnosis time delay. The SEI2 model is simulated in the population of Argentina with
different diagnosis time delay parameter (60, 45 and 30 days) and compared with the
epidemiological data from Argentina while keeping all other parameters constant including
the contact rate.
Some of the most intriguing questions in the study of TB are (i) how to determine
the population percentage that are latently infected as they show no clinical symptoms,
and (ii) what role does time since infection plays in developing active TB. The SE8IR-
low is purposely designed to address these problems. Thus, a new way to give an actual
approximation of the LTBI in a population is given here. A more detailed analysis of how the
infected population can affect the dynamic of tuberculosis is also given in the next subsection.
In Fig 2.8 we present the result of SE8IR-low (blue curve) simulation in the population of
Argentina. The LTBI population (E) from the SEI model is split into eight boxes, in an effort
to distinguish between the time since infection in this population. The reason behind it is
that developing active TB has a lot to do with how long an individual is infected [60, 79, 91].
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The initial population of each box is created using the contact rate estimated from R0 for
Argentina, and the probability of developing active TB is set. The result of the simulation
shows that about 20 to 28% of the Argentina’s population were infected with latent TB during
the simulation time span. Fig 2.10 shows our results. Note that about 25% of the LTBI were








































































Fig. 2.10 Distribution of exposed population in Argentina according to the SE8IR model.
A: Frequency distribution of time since infection among LTBI population using data from
Argentina in 1993. B: Frequency distribution of time since infection among LTBI population
using data from Argentina in 2012.
With SE8I2R-low model, the diagnosis time delay is combined with the time since
infection. The fitting is carried out similarly to the case of SEI8R-low model and the result
from this experiment is presented in Fig 2.8 (green curve). In this case, the contact rate for
the SE8I2R-low is slightly larger than that of the SE8IR-low. This is partly due to the fact
that the sick population I1 has a smaller window of time to infect the general population,
Hence, both the contact rate and the time spent in the sick box have a great impact on the
nature and behaviour of TB dynamics. These virtual experiments show that the diagnosis
time delay in Argentina is two months and the early abandonment rate for people receiving
treatment is found to be 0.2%.
2.3.3 Analysis of the latent infected population, using Niger as a case
study
Fig 2.11 shows the role played by the latent infected population in the case of TB dynamics
in Niger Republic. The initial population of the latent infected population is estimated to
be 33.6% of the population, using the contact rate (α) obtained by calculating the Ro. The
latent infected population is segregated based on the time period since their first infection.
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The initial distribution of the LTBI population among Ei compartments and other parameters
are adjusted until the model is fitted to the epidemiological data in Niger. The distribution of
the latent infected population that fit the data best with an R2 value of 0.99987 is given in Fig
2.11 (A), in blue. This distribution shows that at least 75.1% of the latent infected population
were infected less than 7 years ago, with E1 and E2 accumulating more than 28.29%. 24.9%
have been infected for more than 7 years.
In order to explore the effect of the LTBI population structure in terms of time since infection,
the initial total amount of exposed individuals is redistributed in different ways among Ei
compartments, as seen in Fig 2.11 (A). This redistribution is carried out by taking some
members of E>7 compartment and redistributing them uniformly into (E1) and (E2) (green
distribution). The result is shown in Fig 2.11 (B) (green curve). A second redistribution
is explored by relocating some Ei individuals into the E>7 compartment. The result of
increasing the population with more than 7 years of infection to about 70% of the latent
infected population is also shown in Fig 2.11 (A) (red distribution), and it is presented in Fig
2.11 (B) (red curve).
Even though the total initial LTBI population (i.e., ∑7i=1 Ei +E>7) and all other parameters
involved are kept constant, there is clear evidence that the time since infection has a strong
impact on the dynamics of TB, and it cannot be neglected when designing control strategies.



























































































Fig. 2.11 SE8IR model showing the effect of LTBI population to the dynamics of TB in
the population of Niger. A: Different initial distributions of the LTBI population used for
the simulations. B: Results of the simulations with different initial distributions of a latent
infected population, while keeping the total LTBI population constant. Blue: original data
and fitted model. Green: relative increase in recent infections (population from E>7 is
redistributed into E1 and E2). Red: relative increase in old infections (population from Ei is
redistributed into E>7).
2.3 Results 51
Another interesting question that these virtual experiments can address is the impact
of migration from HBC on the dynamics of TB. To have an insight into this phenomenon,
a similar experiment is carried out where 30,000 infected individuals are introduced with
different times since infection. The result of this experiment is presented in Fig 2.12. In
the first experiment, the individuals introduced are assumed to be in their eighth (or more)
year of infection (box E>7). This leads to an increase in the dynamics of the disease as it
can be seen in the figure. In the second situation, entering individuals are assumed to be in
their fourth, fifth and sixth-year of infection. The same number of individuals introduced
in the first experiment is reintroduced into these compartments uniformly and the result is
presented in Fig 2.12. Finally, the last simulation introduces all the incoming individuals
into the first, second and third-year box. It can be concluded that immigration is also one of
the factors which needs to be investigated and taken into consideration when designing TB
control strategies in a given community. Despite not showing clinical symptoms, those that
have a latent TB infection might still affect the TB dynamics in a community.
























































SE8IR with immigrants in E
>7
Fig. 2.12 SE8IR model showing the effect of LTBI immigrant population to the dynamics
of TB in the population of Niger. The same number of individuals is repeatedly introduced
into the latent infected population. In each simulation, the individuals are considered to have
different times since infection. Green curve: individuals are uniformly introduced into the
first, second and third-year since infection box. Red curve: individuals are introduced into
the fourth, fifth, and sixth-year box. Black curve: all the individuals are introduced into the
E>7 box
.
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2.3.4 Analysis of reinfection using Laos Republic as a case study
In this section we study a context with a very high prevalence, the Laos Republic, where
reinfection is relevant. The global procedure of a gradual increase in the models complexity
is also followed. By studying such a HBC case, we observed that the higher up the ladder of
complexity, the more abrupt the changes are in the behaviour of the models.
The fitting of the models was carried out with the above-mentioned methodology. Let
us concentrate on the results of the SE8IR model when fitted to the epidemiological data.
The initial exposed population is set as plotted in Fig 2.13 (B) , with an initial prevalence of
1500 per 100,000 inhabitants and a period of 69 months for infecting while remaining sick.
The fitted contact rate (α) is 0.219. The result of this experiment is given in Fig 2.13 (C)
(red dotted curve). Even though the model is correctly fitted to the epidemiological data, the
obtained parameters do not seem reliable. Analyzing this situation, it can be observed that
both the contact rate and the initial distribution of the exposed class are too small compared
to the average prevalence. Moreover, the infection period of the sick class (6 years) appears
to be too long as well. In fact, the average lifespan of sick people without treatment is
significantly shorter than 6 years. Any attempt to either increase the contact rate, change the
initial conditions of the exposed class or decrease the sick period results in an abrupt decrease
on the prevalence, which turns out to be smaller than the epidemiological data. Therefore,


















































































Fig. 2.13 SE8IR-reinf model showing the effect of reinfection to the dynamics of TB in
the population of Laos. (A) Initial distribution of the LTBI population used to simulate
SE8IR-reinf model in Laos. (B) Distribution of the LTBI population used to simulate SE8IR
model in Laos. (C) The red curve shows SE8IR-reinf model fitted to the epidemiological data
from Laos showing the effect of reinfection with realistic parameter values. The green curve
shows SE8IR model fitted to epidemiological data from Laos with unrealistic parameters.
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A possible modification of the model that could make sense in such context is the
introduction of the reinfection process (SE8IR-reinf). The exposed or infected classes are
assigned a force of reinfection given as Λ1 = 5∗ (Λ) and using the initial distribution of the
infected class shown in Fig 2.13 (A) with about 45% of the total population. The model’s
fitting to the data, with an initial prevalence of 1500, provides an average contact rate of
1.263/month and a period of 18 months for infecting while remaining sick, with all other
parameters set similarly to the SE8IR model. These values appear closer to reality. The model
is fitted with a R2 of 0.999 and the R0 is found to be 2.0028. The result of this experiment is
given in Fig 2.13 (C). This experiment demonstrates how important the reinfection of the
exposed class is, especially in countries with a higher prevalence. Furthermore, the initial
conditions of the exposed class are also very important in understanding TB dynamics. In the
case of HBC, not only does the initial distribution of the exposed class determine the shape
of the curve, it also paves a way to the period of time for the sick class to stay active. Other
modifications of the model could be tested, as for instance the inclusion of the long-term
non-diagnosed class. Nevertheless, the simple consideration of a reinfection process has
drastically changed the results. This is a sign of the importance of this process in HBC
contexts.
2.4 Discussion
The peculiar behavior of Mycobacterium tuberculosis in human lungs is the cause of quite
particular epidemiological dynamics compared to other infectious diseases. In this context,
mathematical models help us raising questions which enable the understanding and analysis
of control methods and the subsequent corrections of health interventions. In this research, we
present a set of mathematical models of increasing complexity that allow studying different
types of situations.
Departing from classical models (SEI) which are able to evaluate the number of infected
people per each sick, new important additions are proposed. First, sick compartment (I)
is split into two compartments: the infectious sick and the non-infectious sick who follow
a pharmacological treatment. This division helps quantitatively evaluating the effects on
diagnosis time delay, not only in terms of the number of people infected by every sick but
also in the number of people infected by each unit of time. We study the case of Argentina
to illustrate this issue. Furthermore, the splitting allows obtaining the percentage of people
abandoning the treatment soon after diagnosis. Second, the set of infected people (E) is
divided into eight compartments depending on the number of years since the initial infection.
The probability of becoming sick is considered to present a parabolic decreasing behavior. In
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this context, we present the case study of Niger. On one hand, this approach allows studying
the epidemiological effect of the whole set of LTBI and elucidate the effect of migration
flows. On the other hand, dividing LTBI enables the analysis of particular situations such as
the reinfection effect, as in the case of Laos Republic.
The proposed methodology with models of increasing complexity provides a progres-
sively ease in the parameterization process of models. In this sense, simpler models are
convenient to attain a first approximation of those that are more complex. With this process,
it is possible to obtain information on diverse epidemiological characteristics, from the
infection speed to the distribution of people according to the time since infected. Moreover,
this methodology allows carrying virtual experiments to evaluate the effects of different
actions related to the epidemiological control, as shown by using 20 different countries data
sets of high and low burden settings.
The proposed mathematical methodology of this work could be extended to study al-
ternative situations. For instance, it would be feasible to assess the effect of having a low
percentage of diagnosis by introducing another compartment with sick who do not receive
treatment. Another example could be to examine the effect of drug-resistant strains by sub-
dividing the compartment in drug-sensitive and drug-resistant. In this way, the mathematical
strategy is able to accurately respond to every situation of a city or country.
Despite mathematical equations proposed in this research are not easily understandable
by non-mathematical experts, the model dynamics with flows and compartments is simple
enough to facilitate its comprehension by non-specialists. Therefore, models streamline the
dialog among specialists in modelling and epidemiologists without mathematical training so
virtual experiments can be carried out to help to gauge the effectiveness of control strategies.
Chapter 3
Modelling tuberculosis dynamics in
Nigeria for the analysis of its
country-level situation
3.1 Introduction
In this chapter, we employ the use of a mathematical compartmental model to evaluate TB
burden in Nigeria. We use data obtained from NTBLCP and and WHO to validate the model.
We point out effective strategies that could be use to effectively reduce TB burden and death
due to TB in this country at different levels. We investigate the latently infected population,
and try to pinpoint the major reason for TB persistence in the population of Nigeria. Our goal
is to develop a close enough to reality mathematical model of TB epidemics that can allow
us to investigate effects of demographics and notification of TB epidemics in a population of
Nigeria, as well as to estimate the actual burden of the disease including death toll and case
fertility ratio in some of the regions in the country.
3.1.1 Facts and hypotheses
All newborn into the model susceptible class is uninfected and free from HIV. For the purpose
of this research, we assume a constant birth rate Π and TB/HIV co-infection is not explicitly
modeled. These assumptions are simplifications that are not relevant for the current purpose,
which is the identification of significant damage caused by poor case detection on TB control
program.
We propose to use the model in the exploration of different situations in Nigeria as a
virtual experiments platform. The situations evaluated have been selected to start working on
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four wide hypothesis, although the final confirmation of all of them would require further
research including on-field projects and incorporating experts form other involved disciplines.
The four starting hypothesis are the following:
1. TB prevalence still remains a major health challenge in Nigeria due to poor case
detection.
2. Increase in effective treatment may not necessarily cause a significant decrease in the
prevalence of TB in the country if active case finding is not implemented. In other
words, increasing the notification rate is necessary for decreasing TB transmission in
Nigeria.
3. The persistence and non-decreasing dynamics of TB in Nigeria are also related to a
large number of latently infected population.
4. Poor notification rate has resulted in a large number (hundreds of thousands) of deaths
of TB patients.
3.2 Model structure
Figure 3.1 represents the model diagram, which we briefly outline. Birth occurs at a constant
rate Π into the susceptible class S with the assumption that all newborn are susceptible to
Mtb. E1,E2, ...,E7,E>7 represent the non-infectious population infected with tuberculosis
without any clinical symptoms (LTBI) in their various years of infection; i.e., an individual
who was infected recently (less than one year ago) will be assigned to E1, while an individual
who was infected last year would be assigned to E2 population. The last LTBI compartment,
E>7, consists of all latently infected population with more than 7 years of infection. I1 and I2
represent the population that is sick, i.e., they have an active disease with clinical symptoms
and they can infect the general population; I3 is the sick population that was diagnosed and
are receiving effective chemoprophylaxis, thus unable to infect anyone. As shown in the
diagram, only people in the I2 compartment will be diagnosed and will move towards I3
compartment, while the I1 compartment accounts for the missed TB cases. Death rates in
the model depend on disease status; they are fixed into µS for susceptible population, ν1 for
exposed classes, and µI1,µI2 and µI3 for sick individuals of I1, I2 and I3, respectively. Based
on the disparate time scale of natural death versus death due to TB disease, we assume that
µS ≤ ν1 ≤ µI3 ≤ µI2 ≤ µI1
Transmission of Mtb occurs following adequate contact between the sick infectious
individuals (I1 and I2) and the susceptible population. We assume that the latent infected (Ei)
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Fig. 3.1 The model: a compartment model for TB transmission in Nigeria. The model shows
the dynamic flow of TB including susceptible population S; the latently infected population
are discerned based on the time since they were infected, therefore E1 stands for people being
latently infected for a period of one year; E2 stands for people infected for 2 years, etc.; E>7
stands for people that have been infected for more than 7 years; two types of non-diagnosed
sick population are considered, I1 and I2, and sick under treatment is shown as I3. Birth
occurs at constant rate Π. Transmission of Mtb depends on
α(θ I1 + I2)
N
and probability
leading to active TB is given as pi = ai2 + bi+ c , where i is the ith year of infection. k1
indicate succession from one infected compartment to the next. A fraction of the sick, β , will
be detected and notified; k2 is related to diagnosis time delay before starting treatment and γ
indicates a fraction of relapse for sick under treatment. Recovery rate is given as k3 while k4
represents the fraction of the infected population that gets rid of the disease spontaneously.
We account for all course of death, µs , νi , µI2 , µI3 , and death due to active TB, µI1 .
are not infectious and thus not capable of transmitting the bacteria. We use the incidence
expression
α(θ I1 + I2)
N
to indicate successful transmission of Mtb due to nonlinear contact
dynamics in large population [54] α is the transmission rate that represents possible interac-
tions that may occur among the susceptible population and the sick infectious population,
which is defined as the average contact per unit time. Infectivity of I1 is assumed to be lower
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(0 ≤ θ ≤ 1), as the undiagnosed long-term sick individuals probably reduce their activity due
to their poor health conditions.
Newly infected individuals progress directly to the infected class E1 and stay there for a
period of one year, where the probability of developing active disease is p1. If they do not
become sick, they progress to E2 (at a per capita rate k1) the subsequent year, where the
probability of developing the active disease is p2. The progression through the latent infected
compartment will continue yearly at a constant per capita rate k1. Finally, all latent infected
patients with more than seven years of infection will remain in the compartment E>7 for a
very long period of time, where the probability of becoming sick (p8) is very low and later
would be integrated back into the susceptible society at a constant per capita rate of k4.
The probability of developing an active disease decreases across the latent infected
compartment, pi, is assumed to be an autonomous decreasing quadratic function, given
as pi = ai2 + bi+ c, where i is the ith year of infection. The sum (∑ piEi) represents the
10-13% of the latently infected population that will become sick in seven years or more, and
p1E1 + p2E2 is about 5-6% of the latently infected population that will become sick in the
first two years of infection.
We define T as the fraction of the sick infectious population that were notified and are
receiving effective chemoprophylaxis, k2 as the rate of effective per capita notification and
k3 as the rate of per capita of successful therapy completion. We assume that starting a
treatment removes an individual from infectious class I2 and place them into T . We also
assume that individuals receiving chemoprophylaxis can abandon therapy, thus showing a
relapse at a per capita rate γ .
3.2.1 Model formulation
We used a system of non-linear differential equations to model the dynamics of individuals
within the population settings. Setting the N(t) = S(t)+E1(t)+E2(t)+E3(t)+E4(t)+
E5(t)+E6(t)+E7(t)+E>7(t)+ I1(t)+ I2(t)+T (t), and suppressing time dependence, t, for
each variable, N(t) represent the total population size at time t. The twelve model equations
are:
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dS
dt
= Π+ k4E>7 + k3T −
(









α(θ I1 + I2)
N
)
S− (ν1 + k1)E1 + p1E1, (3.2)
dE2
dt
= k1E1 − (ν1 + k1)E2 + p2E2, (3.3)
dE3
dt
= k1E2 − (ν1 + k1)E3 + p3E3, (3.4)
dE4
dt
= k1E3 − (ν1 + k1)E4 + p4E4, (3.5)
dE5
dt
= k1E4 − (ν1 + k1)E5 + p5E5, (3.6)
dE6
dt
= k1E5 − (ν1 + k1)E6 + p6E6, (3.7)
dE7
dt
= k1E6 − (ν1 + k1)E7 + p7E7, (3.8)
dE>7
dt
= k1E7 − (ν1 + k1)E>7 + p8E>7, (3.9)
dI1
dt
= ∑(1−β )(piEi)+(1−β )p8E>7 −µI1I1, i = 1,2,3...,7. (3.10)
dI2
dt
= ∑β (piEi)+β p8E>7 + γT − (µI2 + k2)I2, i = 1,2,3...,7. (3.11)
dT
dt
= k2I2 − (γ + k3 +µT )T. (3.12)
Equation 3.1 describe the rate of change of the susceptible population S. There is a gain
into this population through constant birth rate Π. A loss in this population occurs as a
result of infection with Mtb with transmission rate
α(θ I1 + I2)S
N
and constant death rate µs.
Equations 3.2 to 3.9 represent the rate of change of the latent infected population over time.
The rate of change of E1 increases as a result of Mtb infection that results in latent infection
at a rate
α(θ I1 + I2)S
N
, and decrease by developing active TB at rate p1E1, natural death ν1,
and movement to the second year of latent infection class at rate k1E1. E2(t),E3(t), ...,E>7(t)
, increase by successive movement of latent infected individual from one class to the next
and decrease by progressive movement to the next infected class, natural death ν1, and
developing active TB at the rate piEi in each ith latent infected class. A fraction (1−β )of
the Mtb infection which progress to active TB and were undetected decrease by death due
to TB and other causes at the rate µI1, and the detected fraction are increased by relapse
at a rate γT and decrease by diagnosis at a rate k2I2 and by death at a rate µI2. The rate of
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change of sick individuals under treatment are increased at a rate k2I2, and reduced at a rate
γT , recovery rate k3T , and natural death at the rate µT .
3.2.2 Model validation and calibration
In order to determine the effects of various parameters on the dynamics of TB in Nigeria,
equation 3.1 to 3.12 are integrated by a Range–Kutta method of order 4, using a Matlab
software (Ode45). We started by fitting our model to the 2000-2010 prevalence data on
Nigeria from the official WHO reports and Nigerian epidemiological fact sheets [59]. The
reason why this period was chosen is because of reliability of available data together with
the fact that all parameters can be approximately considered constant for that period, what
would not be applicable if the period was longer. We used the least squares curve fitting in
Matlab, by specifying the lower and upper bounds of specific parameters to be estimated.
The recruitment rate of susceptible was chosen and calculated such that population of the
country remains constant during the simulation. The treatment efficacy (1− γ) is considered
to be 80% with probability of relapse taking as 20%. The parameter values that gave the best
fit are given in Table 3.1, and were obtained with a R2 = 0.9992.
The initial conditions were chosen in accord with available data when possible (i.e., for
total population, estimates of global LTBI population, population in sick compartments and
the ratio I1/I2). The distribution of LTBI among time since infection compartments was also
fitted in this process. We finally obtained these initial conditions (considering a population of
100,000):
(S(0),E1(0),E2(0),E3(0),E4(0),E5(0),E6(0),E7(0),E>7(0), I1(0), I2(0),T (0)) (3.13)
= (58303,6100,5000,4438,4020,3550,3140,2860,12250,284,55,0)
This corresponds to an initial prevalence of 339 and a notification rate of 16%. Figure 3.2
show the epidemiological data together with the best fit of the model.
As a validation of the previous calibration, we took data from a wider period (1990-2015)
and confronted it with the model. Keeping all the parameters constant but with a small
change in the force of infection value, as well as in the initial conditions, the new R2 was
0.9706. Therefore, we assumed that the calibration for 2000-2010 period as the baseline for
our subsequent virtual experiments.
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Table 3.1 Summary description of parameters of the model fitted to Nigeria data
Parameter Parameter description Values (month−1) Source
Π Birth rate in S class Constant NA
µs Death rate in S 0.012 calibrated
µi1 Death rate in I1 0.146 calibrated
µi2 Death rate in I2 0.146 calibrated
µT Death rate in T 0.01 calibrated
ν1 Death rate in LTBI 0.0108 calibrated
α Contact rate of sick population 3.54 calibrated




pi Probability of devolping active TB ai2 +bi+ c derived
β Notification rate 0.16 [71]









γ Relapse rate 0.20 [71]
ν8 Death rate in E>7 0.008 calibrated




a Probability component for active TB 0.001035 calibrated
b Probability component for active TB -0.0152 calibrated
c Probability component for active TB 0.06 calibrated
(1− γ) Effective TB treatment rate 0.80 [71]
3.3 Results
We begin by fitting our model to the current prevalence data on Nigeria from the WHO reports
and epidemiological fact sheets [6]. We use the least squares curve fitting in Matlab, by
specifying the lower and upper bounds of specific parameters to be estimated. The parameter
values that produce the best fit are given in table 3.1. We begin by a plot showing the result
of the model as function of time calibrated against the current TB prevalence scenario in
Nigeria (Fig. 3.2).
Numerical simulations of the model allowed us to estimate some important parameters
associated with TB in Nigeria. In addition, we were able to observe and quantify the effect
of the infected population on the prevalence of TB in the country. It also allowed us to
make a distinct connection between the notification parameter and the death toll on the sick
population (infectious) population, the relationship between the death and the prevalence of
the disease in the country. To illustrate these effects, we divide this section into 3 subsections.
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Fig. 3.2 Model simulation calibrated against tuberculosis prevalence data in Nigeria:
The figure shows the tuberculosis prevalence curve of the model, calibrated with 2000-2010
data, compared with the data estimates from WHO in that period. The model prevalence
curve is obtained by solving equations (3.1) to (3.12), using the initial conditions in equation
(3.13) and parameter values in Table 3.1. The goodness-of-fit measure (R2) for simulation
trajectories was evaluated and found to be 0.9992.
Hypotheses 1 & 2 were used to explain the case detection and how effective treatment affects
TB dynamics in Nigeria; we made a prediction of TB new cases and provide an alternative
strategy for TB control. Hypothesis 3 was used to explain the relationship between LTBI and
the dynamics of TB prevalence. Finally, by means of hypothesis 4 we quantified the death
due to TB and estimate the death toll due to TB for the next decade in Nigeria, and we also
estimate lives that could be saved with the alternative strategy proposed.
3.3.1 Hypothesis 1 & 2: Case detection and effective treatment
The model was successfully fitted into WHO data of TB prevalence in Nigeria. Then,
we compared the fitted tendency with predictions regarding an increase in notification
parameter. The parameter values obtained after fitting the model into data of Nigeria are
briefly summarized and discussed in table 3.1. As shown in Fig. 3.2, the obtained Baseline
simulation represents the epidemic TB situation in Nigeria successfully. Values for many
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parameters were determined from vital statistics TB data from NTBLCP Gombe state, official
TB data from the World Health Organization (WHO) and other recent literature mentioned
in Table 3.1. When the values could not be estimated from data or literature, as in the case of
the parameters associated with the contact rate, they were obtained with the model’s fitting
into epidemiological data (R2 = 0.9992).
Recall, WHO estimates that about 30% of the world population is infected with LTBI
[104]. However, the model revealed that about 34-37%(depending on the choice of contact
rate for the sick population and some other parameters that where calibrated) of Nigeria’s
population is latently infected with TB. This population is distributed across the various
infected classes ranging from E1 to E>7, and the time since infection in this population was
also fitted.
We then used our model to investigate how the notification of new TB cases affects the
dynamics of TB in Nigeria. We tested the hypothesis that the non-improvement in notification
observed in the situation of Nigeria may partially explain why the prevalence of TB in this
country is very persistent and not declining as compared to others, showing an incidence
rate between 400 and 500/100,000 (more than 130 times the incidence rate in the USA)
[43, 45, 23]. The notification rate of TB in Nigeria is about 16% [71]. Therefore, initial
conditions for new TB cases were calculated by assigning 16% of new cases into I2 (i.e., the
compartment that gathers the sick population that goes to hospital and receive care at some
point), and 84% were assigned to I1 (i.e., the population that remain sick throughout their
life cycle until death).
Fig. 3.3 shows the fitting of the model into the prevalence of TB in Nigeria, namely
baseline, together with some simulations where an increase in the notification rate was
explored. The mean prevalence for the epidemiological data is 330.64 with a standard
deviation of 6.7, while the mean for the model is 330.39 with a standard deviation of 6.6 and
a R2 coefficient of 0.9992 (Table 3.2). The model is pretty consistent with the epidemiological
data. The mean resultant prevalence for each simulated notification rate is recorded in Table
3.2 as well. These results show a clear decrease in the prevalence of TB when the notification
of the new TB cases increases.
In the Baseline simulation, the model predicted 62,000 deaths due to TB in the year 1990,
72,000 deaths in the year 1995, and 118,000 in the year 2014. These results are within the
range of annual TB deaths estimated by WHO [71]. Fig. 3.4 shows the predicted decline
in prevalence after 10 years for each of the notification rates tested. In fact, a simply 10%
relative increase in case notification of people with active TB reduces the TB prevalence by
15% when compared with the current situation. Predicted TB deaths also would decline by
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Fig. 3.3 Hypothesis 1: Baseline simulation and effect of the notification rate Model fitted to
the prevalence of tuberculosis in Nigeria, the blue star represents the epidemiological data
of TB prevalence while the red line-circle represents the model simulation. The fitting was
done with 16% of the sick population being notified. The experiment was repeated with 20%
(yellow curve), 25% (green curve), 30% (black curve), 60% (magenta curve), and 85% (cyan
curve) notification respectively
more than 15% when compared with the Baseline simulation that fitted the epidemiological
data.
A new simulation series was designed in order to explore the effect of an improvement
of effective treatment, i.e., a decrease in γ . The results showed that a 10% improvement
of effective treatment among active TB individual produces a decline of only 5% in the
prevalence of TB and related deaths compared with the Baseline fitting, as shown in Fig. ??.
Given these results, the most effective intervention for reducing future TB cases and related
deaths in Nigeria as predicted by the model is active case finding.
3.3 Results 65
Table 3.2 Summary of the mean prevalence of data and model simulations, as well as R2 of
the fitting
Case detection rate Mean prevalence Standard deviation References
Epidemiological data 330.64 6.7 [71]
Model 16% Notification 330.40 6.8, R2 = 0.9992 Model
Model 20% Notification 311 NA Model
Model 25% Notification 288 NA Model
Model 30% Notification 266 NA Model
Model 60% Notification 156 NA Model
Model 85% Notification 105 NA Model
Fig. 3.4 Hypothesis 1: Evolution of tuberculosis prevalence in Nigeria after 10 years of
simulation with different notification rate. Each point on the curve shows the prevalence of
tuberculosis in Nigeria when simulated with corresponding notification value on the x-axis
for 10 years.
A final virtual experiment was designed in order to explore the effect of an improvement
of effective treatment in a context with a high case detection rate. In this simulation series,
the detection rate was fixed at 80% and different treatment success rates were explored. The
results showed that, in this case, the improvement in treatment effectiveness would provide
a significant decrease in TB prevalence (Figure 3.5(b)). With a notification rate of 80%,
the increase in effective treatment by 10% will lead to a decline in the prevalence of 23%
and associated deaths by almost 30%. In the case of a poor case detection rate, increase in
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(a) 16% case notification (b) 80% case notification
Fig. 3.5 Hypothesis 2: Effective treatment in the population with good surveillance and poor
surveillance. (a) The figure depicts a relative increase in effective treatment from 80%, 85%,
90% to 95% in a population with poor case detection, where the notification rate is only 16%.
(b)The figure shows a significant decrease in prevalence due increase in effective treatment
from 80%, 85%, 90% to 95%, in a population with a very good case detection, where the
notification rate is 80%.
10% of effective treatment is associated with only 5% decrease in prevalence and related
deaths. Therefore, an increase in the treatment effectiveness is only relevant if it is combined
with an active case finding or in a scenario where the notification rate is significantly high.
Nevertheless, with the growing problem multi-drug resistant TB, investment in treatment
becomes more relevant and needs to be maintained.
TB prediction in Nigeria
Looking at the current TB situation in Nigeria, one can wonder what the situation will be if
all parameters are left unchanged especially in terms of passive case finding. We envisioned
this scenario and with the help of the Baseline simulation results, the following results are
presented. Fig. 3.6(a) shows the predicted evolution of TB when the notification rate is
gradually increased, while Fig. 3.6(b) shows the effect of a sudden increase in this parameter.
The simulation starts with the Baseline that represents the current situation (16% notification,
red-dashed line). Keeping the notification at this rate without any changes may keep the
prevalence of TB in the country in between 350 to 320/100,000 even after 40 years from the
present day. This is precisely the present situation of TB in Nigeria, where there has not been
any significant changes or decline in TB prevalence for the past 25 years (323/100,000 in
1990 and 332/100,000 in 2015 [71]). Increasing the notification rate up to 20% in 10 years
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(a) (b)
Fig. 3.6 Hypothesis 1: Effective strategies in a gradual increase in TB notification in the case
of poor tuberculosis surveillance (a) Result of the prediction made by the model when the
notification of new tuberculosis cases is gradually increased. The red curve shows the poor
notification rate situation, which represents the present situation of tuberculosis in Nigeria
(the blue stars). The rest of the curves represent a change in case detection and increasing in
the notification of new cases by some percentages over a period of time. (b) Result of the
prediction made when the notification of new tuberculosis cases is suddenly increased. The
legend is valid for both plots
could keep the prevalence between 300 to 290/100,000 population. If no more effort is made
to increase the notification further, the prevalence would remain in this range even after a
period of 50 years. Increasing the notification further to 25% in another 10 years would
reduce the prevalence to between 290 and 260/100,000 population, and a further increase in
notification to 30% would bring down the prevalence to between 220 and 240/100,000. We
repeated the experiment with a sudden increase in the notification from 16% to 30% as seen
in 3.6(b) when the prevalence would remain in the range of 270/100,000 to 280/100,000.
For a successful and reasonable decline in TB cases in Nigeria to be achieved, case finding
needs to be active and increased from period of time to time. Although a 30% notification rate
is viable, a real TB prevalence decrease in Nigeria can only be achieved with a notification
rate around 80%. Both strategies presented in Fig. 3.6(a) and 3.6(b) produce the same results
at the long run in terms of TB prevalence decline. However, in terms of Public Health, a
progressive decreasing strategy would be more feasible due to the economic resources that
need to be allocated by Health authorities. In contrast, increasing the notification rate by a
large percentage could be very ambitious and resource demanding. At this junction, the most
important point is to be able to make interventions as soon as possible given the long time
required to actually see changes in TB prevalence.
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3.3.2 Hypothesis 3: Latent infected population
Although it is known that latently infected individuals are connected with the incidence of
TB, it is not completely clear how this connection can influence the dynamics of the disease
in a population. Our first hypothesis implied that poor case detection leads to higher number
of un-notified TB cases, which leads to a high number of latently infected individuals that are
at risk of developing active TB, thus results in a persistent high TB prevalence. Our model
was also used to as a virtual experimental device to test the effect of the latently infected
population in Nigeria, which can provide a significant information that can be very difficult
or impossible to guess otherwise. We are going show why the prevalence of TB in Nigeria is
substantially high and non-decreasing for a very long period of time.
(a) (b)
Fig. 3.7 Hypothesis 3: Changes in latent tuberculosis with respect to an increase in notifica-
tion rate or in effective treatment (a) Simulated dynamics of the latently infected population
with different notification levels, with all other parameters kept constant in the population of
Nigeria. The red curve shows the latently infected population that remained constant for more
than 20 years, thereby producing new sick constantly. With an increase in notification up to
30%, the pool of the LTBI starts decreasing (blue curve), and a further increase in notification
shows a much higher decrease in the pool of LTBI (black curve, 85% notification rate). (b)
Simulation of the latently infected population with improvement in effective treatment, with
all other parameters kept constant in the population of Nigeria. There is little or no change
in the number of the latently infected population before and after increasing the effective
treatment.
We explored the effect of increasing the notification rate or the treatment success on the
LTBI population (Fig. 3.7). Figure 3.7(a) shows the result of various simulations of the
latently infected population carried out with different notification parameters. The latently
infected population consistently declines with each increase in notification rate. This result
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Fig. 3.8 Hypothesis 3: Latent infected population after 10 years of simulation of the model
with different notification levels. Each point of the curve represents the corresponding
population of the latent infected compartments, when the model is simulated with the
corresponding notification rate on the x-axis.
explains why a population with a poor case detection program can fail to achieve a significant
progress in reducing new TB cases, because the latently infected population remains the same
for a very long period of time due to what is called the replacement principle, where each sick
TB patient produce at least one sick patient before death or progress to receive treatment (the
number of new cases that receive treatment is very few). This type of situation guaranteed
the consistent production of newer TB cases if active case finding is not implemented.
The increase in notification rate does not only affect the active TB new cases but also
the latently infected population. A 10% increase in notification was associated with a 38%
decline in latent infected TB, while a 10% increase in effective treatment showed only a 2.9%
decline in the latently infected population (Fig 3.7(b)).
3.3.3 Hypothesis 4: Poor notification and mortality in sick population
We finally tested the hypothesis that low notification rate has resulted in massive death in
the sick population. This phenomenon might be a mystery in Nigeria as not every death is
reported to the authorities. Only the deaths that occur in a notified case of TB are recorded as
a death due to this disease. As the notification rate of tuberculosis in Nigeria is just 16%, one
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can wonder how many deaths cases due to TB went unnoticed. As mentioned earlier, we
used the notification of 16% to fit the data to the model.
Fig. 3.9 Hypothesis 4: The figure shows the decrease in mortality due to TB in the sick
population for a period of 10 years with different notification levels. The red curve represents
the current mortality due to tuberculosis in Nigeria (baseline), and the rest of the curves
shows what the situation would look like if the notification were to be different.
Fig. 3.9 shows the estimated TB-related mortality per hundred thousand populations in
the population of Nigeria obtained from the model. The present-day mortality rate in Nigeria
is shown by the red curve, which shows that mortality due to TB in Nigeria is between 70 to
65 individual per 100,000 populations. This result is very consistent with the report from
WHO [71]. The model shows that an increase in the notification by 10% would lead to the
decrease in mortality by 20%. Actually, we see from the Fig.3.9 that, if the notification is
increased from 16% to 25%, the mortality declines to less than 60/100,000 individuals, which
implies hundreds of thousands of lives that would be saved. In order to better understand
these dynamics, we estimated the mortality rate in Nigeria after 10 years of simulation with
the model by using different notification parameters, starting from the current situation in
Nigeria (notification rate of 16%). The result of this experiment is shown in Fig. 3.10.
The expected cumulative number of death due to TB with the 16% notification after 10
years of simulation is 4,748,971. An increase in notification into a rate of 20% could have to
save up to 292,244 lives within this period. If the notification rate was increased into 25%,
up to 584,489 lives could be saved within this period.
Although the estimated TB prevalence in Nigeria from 1990 to the year 2016 remains
the same, the estimated number of new cases increases annually. These are attributed to the
increase in the population of the country, but at the same time, it shows a massive increase in
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Fig. 3.10 Hypothesis 4: The result of 10-year simulation of the model using different
notification rates. Each point on the curve represents the mortality in the sick population after
the model is simulated for 10 years with the corresponding notification rate on the x-axis.
the number of deaths due to TB in the population as estimated by the model. The estimated
new TB cases rise from 310,000 in 1990 to more than 600,000 in 2015, and the estimated
number of TB-related deaths by the model rises from 62,000 in 1990 to more than 120,000
in 2015. If the population of Nigeria continues to grow at the rate of 3.2% annually [90],
and the case finding remains passive at 16% notification, then TB-related deaths will reach
up to 3,456,640 in the year 2030, this is twice more than the current number of deaths
due to TB in the world reported by WHO in 2017 [101]. Depending on availability of
funds, political willingness to implement active case finding in Nigeria, and the strategy
implemented, millions of lives could be saved from 2018 to 2030. Globally, the model
predicted a total death amount of 11,872,530 individuals from 2017 to 2030. An increase in
case detection by 15% within this period could save up to 2,557,160 lives and would reduce
the incidence by more than 30%.
3.4 Discussion
Epidemiological data from Nigeria shows that TB situation in this country is very persistent
in time, in spite of the efforts made by all stakeholders battling the disease. While TB
prevalence in Nigeria in 1990 was 323/100,000 population, today is around the same number
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(330/100,000) according to WHO. The same situation is observed in the number of deaths
due to the disease (70/100,000 today compared to 65/100,000 in 1990). The reason for this
steady state of the TB epidemic in the country is still unclear. Many associate it with poverty
and population growth. Nigeria recently overtook India as the world’s poverty capital [97]
with about 87 million people in abject poverty [97]. Its unprecedented demographic growth
(from 95,62 million people in 1990 to 206,20 in 2018) is mainly due to a very high fertility
rate (5.526 according to the World Bank in 2016). Others presume that there is a need for a
better strategy in order to fight the disease towards a significant decline in the near future
[27].
Nigeria is a particular setting where several health-care options (medical pluralism)
including orthodox medicine (public, private, or drugstores), traditional medicine, spiritual
healers, and so forth operate freely [27]. The public health facilities where the TB control
programme operates is distanced from citizenship. More often than not, these health facilities
are not the first choice during health seeking decisions. Unlike the theory of Dim and Dim
[27] and Zwerling et al. [105], we believe that high TB prevalence in Nigeria has a lot to
do with policies of its TB control program, as stated in other studies [45, 50, 55, 28]. Today,
Nigeria is ranked as number 3 in the world in terms of TB burden [6] just behind China and
India. The country has adopted the passive case finding as recommended by WHO [59],
based on a study conducted in India [57, 13]. Nevertheless, the Indian context has completely
different demographic, cultural and literacy settings from Nigeria. However, successful TB
control only happens when social and cultural factors are taken into consideration [83]. It is
therefore imperative to revise and consider the means of extending the NTBLCP strategy.
In this study, we applied epidemic models to real populations to draw conclusions about
one of the leading health challenges in Nigeria. We numerically showed that an increase
in the diagnosis rate together with a treatment’s success of TB patients is an essential step
towards the TB control in Nigeria. In order to increase notification rate of TB in Nigeria
using the current passive case detection strategy, the people at the community level should be
empowered with adequate knowledge of the growing burden of the disease and accessible
potentials for a cure. Alternatively, active case-finding strategies could be explored and
implemented, although the existence of many remote communities in some Nigerian areas
would dramatically make difficult this task. In any case, the analysis reveals that, with current
strategies, it will be impossible to actualize the aims of End TB strategy, with targets to
reduce TB deaths by 95% and to cut new TB cases by 90% between 2015 and 2035 [93].
Even with a high increase in the notification, and without considering HIV/TB co-
infection and the problem of multi-drug resistant strains (MDR), mortality from TB in
Nigeria will still be dramatic for the next few decades to come. Two main facts will
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contribute to this increase in mortality. First, Nigeria population growth of more than 3.2%
annually [? 90]. Second, the resulting deaths due to TB which are expected to drastically
increase by 2030 unless effective TB control is implemented in the country. The results
we obtained in our study confirm this situation. This issue poses a great threat not only to
Nigeria but also to the entire world TB program and to the ambitious End TB Partnership
[93] by 2030.
The increase of TB diagnosis by applying active case finding along with specific actions
to guarantee TB treatment’s adherence and success could be used to achieve the goals set by
WHO in Nigeria by reducing TB mortality significantly, TB prevalence and LTBI population.
Perhaps the time has come for a critical reexamination of the costs, risks, and benefits of
active case finding in this country. Indeed, the strategies evaluated in this paper would require
substantial resources and an extraordinary mobilization of international attention, since the
greater part of TB control programme funding comes from external sources [59]. We have
not attempted to estimate the cost difference of the control strategies proposed. Initiating
and sustaining such a large-scale effort of active case finding would be very challenging.
However, the first step needs to include both a realistic assessment of implementing these
ambitious initiatives and the identification of an optimal way to implement them. For that,
the socioeconomic context of the different Nigerian territories and the social inequalities
within and between them should be taken into account, so that they can be transformed into
feasible policy recommendations. Furthermore, the success could not be guaranteed without
both realistic evaluation of the costs of pursuing active case-finding and the treatment of new
diagnosed TB sick.
Our results exploring different scenarios show the high relevance of increasing the
notification rate in contrast to the modest effects of an improvement of treatment efficacy
only. Nevertheless, the treatment efficacy would probably reveal as crucial if we included the
problem of MDR, which would be addressed in further studies. Despite contemplating the
absence of MDR as a limitation of the model, our conclusions cannot be questioned, since the
main problem is still the pool of non-diagnosed TB sick. Future studies could also include
the study of the reinfection effect in the model. This new setting would allow a detailed study
of the LTBI population and its distribution between old and recent infections.Nonetheless,
the reinfection effect would not change the main dynamics given by the current model and
the recommendations arisen from it.
To sum up, the model shows that WHO targets stated by The End TB Strategy [93]
would not be achieved with the current public management of TB in Nigeria. In fact, its
forecasted situation for 2030 suggests being far away from ending the TB epidemics as aimed
in the United Nations Sustainable Development Goals under Goal 3. The high percentage of
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undiagnosed TB sick in this country is a huge obstacle for the target incidence’s disease. It is
essential to increase the number of diagnosed and successfully treated, thus requiring not
only a significant economic effort but also a boost in social work in the community. This
result is not only valid for Nigeria, but also for such countries where non-diagnosis is a
serious problem. In all cases, a significant TB incidence’s decrease can only be achieved
by both increasing the notification rate to 80%-90% range and providing an appropriate
management of diagnosed patients. With both measures, new infections can be prevented
and the treatment’s success can be guaranteed. This situation is the bottleneck that needs
to be overcome in addition to the incorporation, improvement and/or strengthening of other
essential TB control measures such as Directly Observed Treatment or contact tracing, among
others.
Chapter 4
Analyzing socioeconomic factors that
facilitate low notification rate in Nigeria.
Case study: Gombe State
4.1 Introduction
This section is aimed at analyzing, interpreting and discussing the data obtained from the
National TB control program center (NTBLCP) in Gombe state for better perspectives
on demographic characteristics on TB dynamics. It also comprises the analysis of data
obtained through in-depth interviews of 52 TB patients in Gombe state for better perspectives
on socioeconomic characteristics, such as TB status and awareness, knowledge of the
participants in TB control. The analysis is aimed at identifying and understanding the most
important indicators that facilitate TB spread in the society of Gombe. It is particularly meant
to shade more light on the ‘whys’ of the TB spatiotemporal pattern in the study area.
All the analyses have been performed using either MatLab, R, Minitab and/or Excel
spreadsheet. In particular, these softwares allow to migrate Excel files to MatLab, Minitab or
R, and thus to treat data as vectors or matrices, making really easy doing computations with
them and finding relations or particular correlations.
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4.2 Material and methods
4.2.1 Review of relevant literature and databases
The pre-field activities began with a review of relevant journals and monographs, unpublished
dissertations, WHO fact sheets and other related documents in both hard and soft formats.
Other outstanding sources include records from the relevant government agencies, principally
the NTBLCP Gombe state branch, the Gombe State Hospitals Management Board and
various hospitals in Gombe state. The data that were obtained in this section comprise of
data of TB cases obtained from NTBLCP Gombe State between the year 2007 to 2016. It
consists of 14,559 cases. The relevant information available from the data related to this study
includes age, gender, origin, year of diagnosing and districts of the cases, among others.
4.2.2 Non-documentary data collection
Non-documentary data were simultaneously gathered in order to achieve objectives set in
this chapter. Data on demographic, socio-economic, environmental and behavioral factors
responsible for TB spread were gathered using In-depth Interviews (IDI) with patients on
TB treatment, the healthcare personnel handling the TB patients, and the general population,
as well as that on the level of awareness, knowledge and perception of the people on TB.
In-depth interview of 52 patient was conducted between the 1st September 2018 to 30th
October 2018. Some of the useful information includes age, gender, origin and risk factors,
the year of diagnosis, delay time before going to the hospital, the time delay before diagnosis
at the hospital, education level, income, job description, marital status, previous contact with
a known TB patient, and the district where the patient live. The table containing detail of the
interview questions is given in Appendix B.
4.2.3 Methods and instruments of data analysis
These methods form part of the post-field activities, and it comprised the entire procedures for
the analysis of the data gathered during the field activities while the instruments comprised
the principal techniques and tools employed in achieving the methods. We marrying up
part of documentary data with the non-documentary data gathered from the field, and then
analyzed it simultaneously. The data gathered were coded, categorized, analyzed iteratively
and discussed. We employed the use of inferential statistics and Anova analysis of mean,
with the help of machine learning techniques to make reasonable predictions and estimation
of some of the parameters involved in the model. Time delay at the hospital and before going
to the hospital was soughed and analyzed using Matlab and python software.
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4.2.4 Socio-demographic data of Gombe state
Gombe state is one of the 36 states in the Federal Republic of Nigeria. It was created on
1st October, 1996 out of the former Bauchi State, with headquarters in Gombe city as seen
in Figure 4.1. It is located in the northeastern part of Nigeria, The boundaries of the state
roughly correspond to those of the Tangale-Waja Chiefdom and Gombe Emirate. The state
share common borders with the states of Borno, Yobe, Taraba, Adamawa and Bauchi. The
Gombe state has an area covering 20,265Km2 and has an estimated population of 3,256,962
people on 2016 [92].
As transmission of TB has a social aspect that can not be overlooked and requires the
understanding of population distribution, it becomes imperative to mention some aspect
related distribution and population size of Gombe state. The current population of Gombe
state was estimated to be 3,400,066. The estimation was carried out with the help of
information from National Bureau of Statistics (NBS), starting from 2006 with a population
of 2,365,000 (by the NBS 2006 censures), at annual growth of 3.2% using logistic population
growth. Figure 4.2 shows the population growth from 2006 to 2017 and Figure 4.3 shows the
current gender and age group distribution of the state.
Gombe state has one Federal Medical Center, a state University Teaching Hospital and
22 secondary health facilities (General Hospitals). There are also a total of 508 primary
health care centers ranging from Health post to Health Clinic and Comprehensive Health
centers. Majority of the citizens (72.2%) live below $1/day [92]. The potentials of the state
are limited by an infant mortality rate of 20.7/1000 live births, maternal mortality rate of
1002/100,000 live births, an estimated HIV prevalence of 3.9%, and under 5 mortality rate
of 104/1000 (2008 estimates); the principal causes of morbidity and mortality are malaria,
tuberculosis, pneumonia, vaccine preventable diseases, snake bite, road traffic accidents, and
Acquired Immune Deficiency Syndrome (AIDS)[92].
4.3 Results
In this section, we present and discuss result from various analyses conducted on different
set of data collected with the vision of identifying the main reason for a low notification in
Nigeria.
4.3.1 Results from the analysis of TB data from NTBLCP
The analysis of data from NTBLCP disclosed that males are more vulnerable to TB than
females, and that the age group of 25-45 is the most affected group with 48% of TB cases.
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Fig. 4.1 The map of Gombe state, showing tertiary as well as secondary hospital in all the
districts of the state
This is to say, the TB situation with regards to gender and age group agreed with the assertion
of the most of literature, that the most active and productive age group is more vulnerable
to TB. Moreover, males being more active and more productive are more vulnerable than
their females’ counterpart in the state as shown in Figures 4.4. The United States Embassy in
Nigeria (2012) had specifically asserted that, the age groups commonly affected were the
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Fig. 4.2 Gombe State population: Estimated population of Gombe state from 2006 to 2017
most productive age groups, with the 25–34 age groups accounting for 33.6% of the smear
positive cases registered in Nigeria. However, 61.5% and 38.5% prevalence were found
in males and female patients respectively, with age group 31-40 years having the highest
prevalence of 28.8% [65].
In summary, the age groups most commonly affected by TB in Gombe state are also
the most productive age groups, with the 25–34 age group accounting for 26.7% and 35-44
age group account for 21.3% of all TB cases registered from 2007 to 2016 in Gombe state.
Another close look at the data reveal that the age group 25-44 contributed 48% of all TB
cases from 2007 to 2016, and male in this age group contributed 63% of the cases. In other
words, with some level of confidence, we can say that male in the age group of 25-44, are
probably an important source or agent of TB spread in Gombe state.
Although TB cases appeared to be highest in the age group of 25-44, TB incidence/100,000
is also very high in the age group of 45-65+. Figure 4.5 shows the trend of TB inci-
dent/100,000 population in each age group. As we have seen in the Figure, although the
population of people in the age group of 45-65+ is not very high (from Figure 4.3), the TB
cases reported in this age group is still very high. Thus it results to a higher TB incidence in
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Fig. 4.3 Gombe state gender and age group of the population in the year 2017
the aforementioned age group as seen in Figure 4.5. This particular dynamics in TB trend is
very unfamiliar and contrary to what was found in most literature. TB incidence in the age
group of 25-34 reveals similar to TB incidence in the age group of 55-65 and 65+ in Gombe
state according to notified cases.
22% of the reported cases are living with TB/HIV co-infection in Gombe state. The
World Health Organization (WHO)[25] estimated that 27% of Nigeria’s TB patients are
HIV-positive; this gives an insight on the dangers of increasing TB cases in the country since
the two diseases are opportunistically related. It is evidently clear that although Gombe
state has an estimated very low HIV prevalence of about 3.9% [72] yet the percentage of
TB/HIV co-infection is very alarming especially in female patient. Even though we saw
in the previous figures, males contribute higher percentage of TB cases in the state, but
Figure 4.6 indicates that female are at more risk due to their higher percentage of TB/HIV
co infection. Figure 4.7 gives a more detailed description of TB cases and TB incidences in
Gombe state
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Fig. 4.4 The mean reported TB case by gender and age group from 2007 to 2016 in Gombe
state Nigeria.
The mean incidence per 105 population in each district is given in Figure 4.7. It is clear
that Gombe city alone contributed about 50% of all the TB cases reported in Gombe state
with mean TB incidence of 202/105. This can be attributed to the very high population
density (7,409Km−2 of the city compare to the other district and the fact that medical care
is more available. The second highest incidence is Kaltungo with average TB incidence
of 80/105 and a population density of 244Km−2. Although there are other districts with a
higher population density than Kaltungo, the high HIV prevalence in Kaltungo area could be
one of many explanations that makes it possible for the district to have a higher TB incidence
than other districts.
4.3.2 Analysis of data from field’s work
It is evident from the summary of various interviews conducted in Gombe state that almost
0% of the patients are aware of TB symptoms and signs before they were sick with the
disease. These implies that a great percentage of the public does not know how active TB
looks like and would not take any precaution to protect themselves from TB. Hence, the
greater percentage or even majority of the public are at a very high risk of being infected
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Fig. 4.5 The mean reported TB incidence by age group from 2007 to 2016 in Gombe state
Nigeria.
with TB. Also, from the interviews held, only about 2% of the patient have an absolute
understanding of TB transmission and spread, about 20% have some level of understanding
of TB transmission and 78% have no idea or what so ever on TB transmission and spread.
This is a very serious and alarming situation, there is an army of TB sick people in the mixed
of the people and more than 78% of them have no idea about the disease transmission talk
less of how to prevent others from being infected with the disease. These was illustrated in
Figure 4.8.
It was also evident from the interviews that only a few health care workers have a full
understanding of TB and its transmission; this is evident in the way little or no information
on how one can protect others from being infected was given, only 37% of the patient were
informed by the health care workers on TB transmission pattern as shown in Figure 4.8.
Moreover, from some of the sessions held with the health workers during our visit to Gombe
state, it is clear that most of these health workers does not know about Bovine TB, which
some of the patient may be suffering from due to their interactions with herd of cattle and
livestock (Many are herders). There is very little percentage (14%) of smokers amongst the
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Fig. 4.6 HIV/TB Co-infection: The mean reported cases of HIV/TB co-infection from 2007
to 2016 in Gombe state Nigeria.
patient interviewed, and about 26% of the interviewed patient are HIV+. 20.4% are MDR
and about 29% of them suffered from some kind of chronic disease. It was also deduce that
the excessive long delay before going to the hospital in the average of 26 weeks is due to
many factors that could be associated with the following:
• Lack of nearby health care facility
• Alternative medicine which most of the patient admit on trying before going to hospital
• Miss diagnosis in both hospitals and smaller clinics visited by the patient
• Poverty and lack of resources to access health care
• Constant visit by the patient to untrained health workers that have smaller rooms in the
society operating as alternative to hospitals
• Ignorance and unawareness of the disease
• Ignorance and unawareness of free treatment for the disease
84 Socioeconomic factors that facilitate low notification rate in Gombe State
Fig. 4.7 TB incidence:The mean TB incidence/105 reported of each district from 2007 to
2016 in Gombe state Nigeria.
To get a clear insight of how some of the above mentioned items affect the TB dynamics in
Gombe state, we carried out a statistical analysis on the result of the interviews conducted
(IDI). The results of the analysis is also used in parameter estimation for the development
of an Agent-Based Model for tuberculosis spreading in Gombe state that is presented in the
next Chapter.
4.3.3 Inferential Statistical Analysis of interviews
The determination of the exact proportion of TB infected and sick people of Gombe state
population would require a complete study that would involve monitoring a large part
of the population. A study of this magnitude would be very expensive and at the same
time Herculean task. Nonetheless, we use the understanding of inferential statistics to
make important estimates and conclusions about TB in the population, using the interviews
conducted as our representative sample of TB patients in the population.
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Fig. 4.8 Field work: Some of the result from the interview conducted. Awareness: 2% are
fully aware, 20% are partially aware, 78% are un aware. Chronic disease: 29.6% of patient
have some type of chronic disease. HIV/TB co-infection: 26% of patient are living with HIV.
MDR: 20% of patient have MDR. Smoking: 15% of patient smokes. Informed by health
worker(informed by HW): 37% of patient were informed by health workers
Analysis of surface area and population density of districts in Gombe state
As previously mentioned, we have obtained all the reported TB cases from 2007 to 2016,
and we have calculated the mean TB incidence for each district per 105 populations. We start
by identifying the districts with the highest TB incidence.
In an effort to explain and quantify the TB incidence in different districts of Gombe, we
carried out an Anova analysis of the mean TB incidence by surface area of each district.
Figure 4.9 presents the result of the analysis, with mean TB incidence as a function of surface
area between the districts. As it can be observed, while most of the mean incidence base on
the reported cases happens to be less than 50 cases per 105 populations, 3 district stands out
namely Gombe city with 202 cases per 105, followed by Kaltungo with 80 cases per 105 and
lastly Y/deba with 54 cases 105. Table 4.1 below summarizes the statistical analysis of the
relationship between the mean TB cases and the surface area of each district. As seen in the
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Fig. 4.9 Anova analysis of surface area: Relation between surface area and mean TB incidence
of reported cases between 2007 and 2016 in each district.
Table 4.1 Summary result of Anova analysis of TB incidence in relation to surface area
Variable No of Sample Mean Std Minimum Maximum
Mean TB Incidence/105 11 47.27 55.41 11 202
Surface area (Km2) 11 1584.5 1014.5 52 3815
table, TB reported incidence seems to decrease with an increase in surface area, with every
increase of 1km, the mean TB incidence seems to decrease by 0.03109 per 105. With 95%
confidence, the decrease in mean TB incidence will remain between (-0.065 0.0028) per 105
populations. It is also clear that the 32.4% variability in the meant TB incidence is due to the
increase in the surface area, we could say that the surface area is quasi significant statistically
with a P-Value of 0.0676. The larger the surface area, the less reported cases.
Furthermore, we investigate the relationship between mean TB incidence and population
density (because figure 4.9 demonstrates a clear relation between TB incidence and the
surface area of the inhabitant). We define population density as the number of inhabitant per
Km2 of the area. Results are shown in figure 4.10.
Table 4.2 Summary result of Anova analysis of TB incidence in relation to population
R-sq Equation with 95% Confidence interval for the slope as (-0.064978 0.002773)
32.40% Mean TB/105 = 96.5303−0.0310880∗Sur f aceArea
P-Value 0.0676
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Fig. 4.10 Anova analysis of population density: Relation between population density and
mean TB incidence in each district base on reported cases from 2007 to 2016 in Gombe state.
Table 4.3 Summary result of Anova analysis of population density
Variable No of Sample Mean Std Min Max
Mean TB Incidence/105 11 47.27 55.41 11 202
Population density (Km−2) 11 585.3 2174.1 78 7409
Analysis of Variance
Source DF Adj SS Adj MS F-Value P-Value
Between groups 1 26583.0 26583.0 58.14 ≤ 0.0001
Within groups 9 4115.2 457.2
Total 10 30698.2
Figure 4.10 shows the relationship between mean TB incidence and the density per unit
Km−2 of the inhabitant of each district. Table 4.3 is associated with the figure and gives a
summary of the statistical implication of the density of the population in relation to the mean
TB incidence in each district. From Figure 4.10, we can say that 3 districts with the highest
TB incidence seem to have higher population density as well. With every increase in 1 unit
of population density, the mean TB incidence also increases by 0.02372 per 105, this number
is huge when converted to actual number of TB cases. Given a 0.05% confident level, we
are 95% sure that the increase in the mean TB incidence will remain between (0.016679
and 0.0308) per 105 populations if all parameters remain the same. It is also clear from the
results above that 86.6% of the variability in TB incidence in the respective district is due to
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Table 4.4 Summary result of Anova analysis of TB incidence in relation to population density
R-sq Equation with 95% Confidence interval for the slope as (0.016679 0.0308)
86.59% Mean TB/105 = 26.9191+0.0237146∗ populationdensity
population density. The Anova analysis of variance with a P-Value of 0.0133 indicates that
the test between mean TB incidence and the population density is statistically significant.
4.3.4 Estimate of some of the most relevant parameters extracted from
the interview
Age
One of the most important parameters when investigating tuberculosis in any given population
is the age distribution and the distribution of the TB patients across the age groups. We
extracted the ages of all patience interviewed and estimated the mean age of TB patients in
Gombe state.
Fig. 4.11 Normality Test:. Normal probability distribution test of age of patient interviewed
in Gombe state (Nigeria).
From Figure 4.11, the mean age of patient interviewed is 33 with a standard deviation of
12.5, this is very consistent with data analyzes from NTBLCP in Section 4.3.4, which implies
the sample is a good representation of the TB population in Gombe. The Anderson Darling
test shows that the age of TB patient in the population is not normally distributed, this is
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Table 4.5 Age distribution Normality test of patients interviewed
No of Sample Mean Std Mini Max
52 33.4 12.478 2 62
Anderson’s test
Null hypothesis H0: Data follow Normal Distr.
Alternative hypothesis H1: Data do not follow Normal Distr.
AD Value P-Value
0.97 0.0133
expected as in most cases, the productive age of 25 to 40 are always the age groups with
highest number of TB cases just as seen in section 4.3.4 of the data analyzes from NTBLCP.
We estimate that, with a 95% confidence, the age group with the highest TB burden in Gombe
state are between 29 to 37 years of age.
Number of dependent
Number of dependents is also considered to be a good marker for understanding the TB
dynamics in the population. The type of healthcare policy practice in these areas is called
over the counter payment policy where a patient has to pay for his medical expenses over the
counter not by insurance policies, these system raise a significant concern as to how much an
individual earns and the type of expenses and dependent attached to the income earn.
Fig. 4.12 Normality test of number of dependent per patient: Normality probability distribu-
tion test for number of dependent per TB patient interviewed in Gombe State Nigeria
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Table 4.6 Estimated income distribution of patient interviewed (C)
No of Sample Mean Std Mini Max
52 66.591 57.012 7.229 289
Anderson’s test
Null hypothesis H0: Data follow Normal Distr.
Alternative hypothesis H1: Data do not follow Normal Distr.
AD Value P-Value
0.97 < 0.005
From Figure 4.12, the number of dependent is somehow normally distributed. the P-Value
for the test is 0.0630 which show quasi significant of the number of dependent. Another
look at the data in relation to district shows that people in urban areas has less number of
dependent compared with people in rural areas, the analysis is statistically significant with
a P-Value of 0.0495 and 11.9% of increase in number of dependent could be explained
by whether an individual reside in urban area or rural area. We predicted that, the mean
number of dependent will remain between (5 8) with a 95% confidence level, with a standard
deviation of 4.5 and mean value of 7.
Estimated income of patient
The estimated income of the patient was also analyzed, the result of this analysis is given in
Table 4.6.
We predicted the mean estimated income to be between is (48 85)C per month with a
standard deviation of 57 and mean of 67C with a 95% confidence level. Anderson’s Darling
test shows that the estimated income of the population is not normally distributed.
Ratio of patients to hospital in each district of Gombe state
We estimated the ratio of patient to secondary hospitals in each district of Gombe state by
dividing the population of that district with the number of secondary facilities in the district.
This will give us an idea of overcrowding and efficiency of TB control in each district.
The mean ratio of patients to hospital facility in Gombe State is 183,685:1, with a standard
deviation of 99,990. The hospitals are normally distributed across the respective district,
so we can assume a fairly similar type of behavior and facilities in the hospitals across all
districts except for health workers.
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Fig. 4.13 Normality test: Normal distribution test for number of patients to hospital in each
district of Gombe state Nigeria
Table 4.7 Ratio of patients to hospital facilities in the districts of Gombe
No of Sample Mean Std Mini Max
11 183685 99990 0 339407
Anderson’s test
Null hypothesis H0: Data follow Normal Distr.




The issue of diagnosis delay is one of the most fundamental focal point of these research, the
longer the patient remain undiagnosed, the more he/she is likely to transmit the disease to rest
of the population. To have a clear picture of what is causing delay in diagnosis of we divide
this phenomena into two sub categories. The first is diagnosis delay before going to hospital,
also known as Patient Delay ("time interval between onset of symptoms suggestive of TB
and the patient’s first contact with a health care point") [86] . This delay could be related
to so many different factors ranging from lack of access to hospital, inadequate knowledge
about tuberculosis and its symptoms, poverty due to many dependent of the patient, lack of
education and understanding of the hospital system, traditional or religious beliefs, etc, as it
has been summarizes from the interviews conducted. The second type of delay is what we
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termed as diagnosis delay at the hospital, also known as Diagnostic Delay ("time interval
between the first consultation with a health care point and diagnosis")[86]. This could be
attributed to lack of expert and or training of the hospital staffs, lack or inadequate facilities
at the hospital, over crowding of patient, expenses incurred due to treatment etc. There is a
third category of delay that is not considered in this study, which is the delay on starting the
treatment, also known as Treatment Delay ("time interval between diagnosis and initiation of
anti-TB treatment"). Diagnostic Delay and Treatment Delay, together, conform the Health
System Delay[86]. Finally, we can define Total Delay as the sum of the different delays.
Diagnosis delay before hospital (Patient Delay, PD)
The diagnosis delay before hospital of the patient interviewed was recorded and analyzed
and summarized in table 4.8.
Fig. 4.14 Anova test: One way Anova analysis of PD of patients interviewed in Gombe state
(Nigeria).
Figure 4.14 presents the one way Anova analysis for the diagnosis delay before going to
the hospital of the patients interviewed, and table 4.8 presents the summary of the analysis.
The PD was found to be 9.6 weeks with a standard deviation of 4.8, the Andersons test
shows that the delay is not normally distributed, the P-Value of ≤ 0.005 shows a very strong
significant of the diagnosis delay is statistically in relation to the TB dynamics. Later, we
will analyze how the delay before going to hospital is related with several other factors such
as poverty, location or district and Age using multiple Anova regression Analysis.
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Table 4.8 Diagnosis delay before going to hospital of patient interviewed in the districts of
Gombe, in weeks.
No of Sample Mean Std Mini Max
52 9.6364 4.8994 2 21
Anderson’s test
Null hypothesis H0: Data follow Normal Distr.
Alternative hypothesis H1: Data do not follow Normal Distr.
AD Value P-Value
1.33 < 0.005
Diagnosis delay at the hospital (Diagnostic Delay, DD)
The delay at the hospital for all the patients interviewed was also recorded and analyzed.
Fig. 4.15 Anova test: One way Anova analysis on diagnosis delay at the hospital of patient
interviewed in Gombe Nigeria.
Figure 4.15 and table 4.9 describe and summarize the statistics of diagnosis delay at the
hospital for the patient interviewed. The mean DD is 6 days with a standard deviation of 2.
The Andersons test shows that DD is not normally distributed across hospitals of the different
district in Gombe state. With 95% confidence, we can also infer that the mean delay at the
hospital for diagnosis of TB in Gombe state is between 5 and 7 days for a TB patient across
all districts.
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Table 4.9 Diagnosis delay at the hospital of patient interviewed in the districts of Gombe, in
days.
No of Sample Mean Std Min(days) Max()
52 5.7073 2.0401 2 10
Anderson’s test
Null hypothesis H0: Data follow Normal Distr.
Alternative hypothesis H1: Data do not follow Normal Distr.
AD Value P-Value
3.0 < 0.005
Table 4.10 Diagnosis delay before hospital in weeks of patient interviewed in the districts of
Gombe
No of Sample Mean Std Min(weeks) Max(weeks)
52 13.7 11.9 2 68
Regression Equation
Diagnosis delay = 7.891 + 0.005525Area
R-sq P-Value
24.07% < 0.0002
4.3.5 Significance and important relationships between some of the
most relevant parameters extracted from the interviews
The next important questions to face is if the relationships between some of the parameters in
section ?? are significant and important statistically. To answer such an endearing question,
we employ the use of different types of statistical analysis such as Machine learning for
regression and Decision trees, Anova for analysis of variance between variables and Correla-
tion analysis. Our input variables are both numeric and categorical in nature (age of patient,
population density, surface area of each district, number of dependent, estimated income per
month of patient, ratio of patients to hospital, level of education, previous contact with TB
patient, knowledge about TB symptoms and transmission, smoking, etc.) and we consider
our response variables to be the diagnosis delay before going to hospital (PD) and at the
hospital (DD).
A one way Anova analysis of the input variables to the response variables reveals that the
most important variable that affects the diagnosis delay before hospital is the surface area of
the districts. We have already seen that the diagnosis delay before hospital is not normally
distributed, it varies from district to district. We hypothesize that the diagnosis delay before
hospital depends on the size of the district. Patients from districts with large surface area are
more likely to have a longer time before they visit hospital.
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Fig. 4.16 Anova Analysis: One way Anova analysis on diagnosis delay before hospital and
surface area of district in Gombe Nigeria.
Figure 4.18 and table 4.10 give evidence to support our hypothesis. 24.1% of the variation
in diagnosis delay before hospital is due to an increase in surface area of the district. The
P-value from the Anova analysis of variance supports the hypothesis that there is strong
evidence that diagnosis delay before hospital is related with an increase in surface area of
the district. For every 1Km2 increase in surface area, the delay before hospital also increase
by 1:08 hours (0.006 weeks). Table 4.11 gives both the Pearson correlation summary of all
the variables involved in the model and there corresponding statistical significance based on
their P-Values.
Figure 4.17(a) shows that patients with previous knowledge of infection have a lower
diagnosis delay of about 6 weeks than patients without previous knowledge on TB infection,
with a mean delay of about 25 weeks. Also, patients who have a previous contact with
other TB patient seems to have higher delay time. A closer look on the interaction between
previous knowledge of TB infection, previous contact with TB patient and diagnosis delay
before Hospital (in Figure 4.17(b)) reveals that patients who are not knowledgeable about TB
and have previous contact with other TB patient have the highest delay time, while patients
with previous knowledge of TB and have no previous contact with TB patient have the lowest
of delay time of 5 weeks.
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Table 4.11 Pearson correlation coefficient for model variables (P-values are given under the
respective correlation values in red)
Age No of Estimated Patient: Population Surface Delay





Patient: -0.0217 0.0539 0.0999
hospital 0.8788 0.7039 0.4811
Population 0.0157 -0.2361 0.2005 0.0527
density 0.9122 0.0920 0.1542 0.7108
Surface 0.1255 0.2324 -0.2138 0.0395 -0.7575
area 0.3752 0.0973 0.1281 0.7809 < 0.0001
Delay -0.1476 0.0827 0.0135 -0.0231 0.1223 -0.1011
at hospital 0.2964 0.5600 0.9244 0.8711 0.3877 0.4755
Delay before 0.1420 0.2105 0.03518 0.15416 -0.1589 0.4906 0.3077




Fig. 4.17 Multiple regression Tree: Interaction plots (a) Interaction plot that signifies the
individual effect of previous knowledge on TB and previous contact with TB patient on
diagnosis delay before hospital. (b) Multiple interaction plot that shows the mutual effect of
both previous knowledge on TB and previous contact with TB patient.
Distinction in diagnosis delay before hospital (PD) and diagnosis delay at hospital (DD)
for high burden areas vs low burden areas in Gombe state
We have established in section 4.3.5 that diagnosis delay both at the hospital and before the
hospital are the two most relevant and important parameters when it comes to TB dynamics
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Table 4.12 Test for difference in diagnosis delay at hospital between areas with high reported
incidence and areas low reported incidence in Gombe state
Null hypothesis H0: µ1 −µ2 = 0
Alternative hypothesis H1: µ1 −µ2 ̸= 0
T Value DF-Value P-Vlaues
1.51 50 0.1375
Table 4.13 Test for difference in diagnosis delay before hospital between areas with high
incidence and areas low incidence in Gombe stated
Null hypothesis H0: µ1 −µ2 = 0
Alternative hypothesis H1: µ1 −µ2 ̸= 0
T Value DF-Value P-Values
-1.39 52 0.1728
in Gombe state. It is also clear that the most important factor that facilitates such delay is the
surface area of the respective district and the population density. To this end, a distinction
between districts can be made according to the reported incidence: those with a high mean
TB incidence (reported cases) namely Gombe city, Kaltungo and Y/deba, with incidence
between 54-202/105, and those districts with low mean TB reported incidence between
0-49/105s. In order to understand the cause of this distinction, we divided the data of the
interviewed patient into two categories according to reported incidence, the high burden
districts (HBD) and low burden districts (LBD). We first start by checking the diagnosis
delay at the hospital between the LBD and the HBD, and we carry out a two way sample
Anova test for equal mean.
First we had to test for equal variances between the high incidence and low incidence
areas using Leven test, and equal variance was adopted for the result shown in table 4.12.
The table shows that there is no statistically significant difference in diagnosis delay at the
hospital for both HBD and LBD. This implies that the quality of service at the hospital across
the district is the same. We might say that the delay at the hospital might not necessarily be
associated to the quality of service at the different hospitals.
Now we look at the diagnosis delay before hospital in both high burden districts and low
burden districts.
We also start by testing for equal variance in both high incidence and low incidence
areas, where equal variance was also assumed for the result of the test in table 4.13. The
table shows no statistically significant differences between the mean diagnosis delay before
hospital of high incidence and low incidence areas. It is clear from this summary that delay
before going to the hospital does not depend on the TB incidence but rather on the surface
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area of the district. The result is also showing that both areas with high reported incidence
and areas with low reported incidence seem to have similar type of delay before hospital.
We can also infer from this result that low incidence areas (namely Akko, Balanga, Billiri,
Dukku, Funakaye, Kwami, Nafada, Shongom) does not necessarily have low TB incidence
but rather lower reported cases than the high incidence areas (namely Gombe, Kaltungo and
Y/deba).
4.3.6 Multiple regression analysis
Still on the quest to identify the parameters that lead to TB diagnosis delay both at the hospital
and before going to the hospital in Gombe State, we did a multiple regression analysis with
all the parameters mentioned in section 4.3.4, considering only diagnosis delay at hospital
and diagnosis delay before hospital as our response variables.
(a) (b)
Fig. 4.18 Multiple regression tree: (a) Result of multiple regression analysis of results from
the interview with diagnosis delay before hospital as a response variable. (b) Result of
multiple regression analysis of results from the interview with diagnosis delay at the hospital
as a response variable.
Figure 4.18(a) present the result for diagnosis delay before going to hospital as a response
variable, while Figure 4.18(b) presents the result of the multiple regression analysis for the
diagnosis delay at the hospital as a response variable. The diagnosis delay before hospital
(Figure 4.18(a)) seems to be mostly associated with surface area of the district, estimated
income of patient and population density, more than the rest of the parameters from the
interview. From the regression tree, the most important of the 3 parameters mentioned is
the surface area of the district. For patients that live in district with surface area bigger than
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1707 Km2, their mean delay time before going to the hospital is 25 weeks. Patients that live
a in district with surface area less than 1707 km2 with estimated income of less than 43C per
month have a mean delay time of 9 weeks before going to the hospital, while patients that
live above 43C per month in the area with a population density higher than 3902 Km−2 have
a mean delay time of 17 weeks. Otherwise, the mean PD of patients is 12 weeks.
The results also show that there are 3 important variables from the interviews that are
mostly related with the diagnosis delay at the hospital. Starting from the root of the tree in
Figure 4.18(b), HIV status is the most important variable; HIV positive individuals average
diagnosis delay at the hospital is 0.791 weeks which is approximately 5 days. For HIV
negative individuals, the next important parameter is the number of dependent of the patient,
patient with more than 5 dependent seems to have an approximate DD of 14 days, while
patient with less than 5 dependents and either married, divorce or widow have an approximate
delay time of 6 days. Single patients have an approximate DD of 12 days.
4.4 Discussion
[63] Two types of data sets have been analyzed statistically: data from NTBLCP, and data
from in-depth interview of TB patients in Gombe state. The analysis of data from NTBLCP
highlighted information about some of the major characteristics of TB such as distribution of
the disease amongst gender and age group of the inhabitants in the state. We have shown
that male are more vulnerable to TB and the age group of 25-44 contributed 48% of the
total reported TB cases. These data also indicate that the age group of 55+ has a similar TB
incidence/105 population to the most active age group of the society. HIV prevalence is high
amongst the TB patient, while smoking, alcoholism and other types of risk factors are low
with a total smear positive cases of about 32%. In the 11 district of Gombe state, reported
TB cases amongst the district is not uniform, Gombe city has the highest mean incidence
of 202/105 population, followed by Kaltungo with incidence of 80/105 and Y/deba with
incidence of 54/105. The data from the field work highlighted socioeconomic properties that
allowed the propagation of TB in Gombe state. We found that 0% of the patient interviewed
understand TB symptoms before they were sick, only 2% of the patient understand TB
control and little or no information is communicated to the patient by the healthcare workers.
Evidence of Bovine TB is on the high side which most of the healthcare workers does not
know about, a very high percentage of HIV+ (26%) amongst the patient, and 20.4 % are
MDR. Some of the obvious challenges facing these communities include but not limited to
• Lack of access to the health care facilities
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• Present of alternative medicine which most of the patient admit trying before going to
hospital
• Inaccurate diagnosis at the smaller clinics
• Poverty and lack of resources to access health care
• Constant visit by the patient to untrained health workers that have smaller rooms in the
society operating as alternative to hospitals
• Ignorance and unawareness about the disease
The analysis also indicates that one of the major problems that facilitate the spread of TB is
longer delay time before going to the hospital, which is related to the size of the respective
district. The larger the district, the less likely for the patient to go to hospital on time. The
population density of the respective district plays a role, in particular in relation to the delay
time and inaccurate diagnosis in the district with a large population density. Number of
dependent also happens to be another factor that contributed to the delay time which varies
from urban areas to rural areas. Hospitals in all of the district are normally distributed with
similar facilities except for Gombe city. The discrepancies in the mean TB incidence of each
district may not be as a result of lower TB cases but as a result lower reported TB cases
(lower notification in some areas lower than the others). Furthermore, a multiple regression
analysis shows that the most important factor that affects the diagnosis delay of the patient
before going to hospital is the surface area of the district, followed by the estimated income
of the patient and the population density of the respective district.
Chapter 5
Using Agent-based simulations to test
interventions in Gombe
5.1 Introduction
Some of the main findings from the previous chapter include the relationship between the
diagnosis delay time and surface area of the district, the delay time and population density,
and the distribution of the delay time among the interviewed patient. The very low notification
of TB in this community makes it necessary to incorporate changes in the TB control program
and hence the re-evaluation of the intervention strategies. An ABM is appropriate in this task
due to to its discrete nature and possibility to take individual diversity into consideration,
whereas SEIR approaches can model the mean dynamics of the TB at higher level. Hence, in
this chapter, we tackle the problem of TB propagation from an ABM approach. We adapt
and implement an ABM for the dynamics of TB in the population of Gombe state, and we
test its outcomes by means of virtual experiments.
The complex nature and particular characteristics of ABMs makes it difficult to provide
a comprehensible description of the model that allows it to be replicated, which is a key to
science. These prompt some experienced ABM modellers like [32] and [33] to develop a
standard ODD protocol for ABMs. The ODD stands for Overview, Design concepts, and
Details. This methodology is used in this chapter for describing the implemented model. The
parameters used in the simulations are a combination of data extracted from NTBLCP, the
field work in Gombe and literature. The simulator is created using C programming language,
we simulated TB dynamics in the population of Gombe and data from WHO is used to
validate the simulation. The results and conclusions of the simulations are used to further
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design intervention strategies that could be adopted or tested in containing TB epidemics in
Gombe state.
5.2 ODD description of the model
5.2.1 Overview
The objective of this ABM is to analyze the evolution of pulmonary TB incidence in a
community and test interventions. It is fitted to Gombe state area of north east Nigeria,
considering the population to be constant (this is because the available data from WHO used
for fitting the model could only support the simulation in a constant population), and the
possible effects of epidemiology control strategies and public health decisions are checked
through virtual experiments.
5.2.2 Entities, state variables, and scales
The fundamental entities of the model are persons. They are considered to undergo through
five infection states: healthy, infected, sick, under treatment, and recovered. Persons of any
infection state different from healthy are simulated as agents, while healthy population is a
property of the local space. Total population remains constant through out the simulation
time, as well as the characteristics of the healthy population such as age distribution, male
to female ratio and HIV+ percentage, among others. The healthy collective is much larger
than the sick, infected, under treatment or recovered collectives. Hence, it is not necessary to
control the healthy individuals one at a time, they are regarded to be property of the space.
Once a healthy person is infected, then he/she will acquire individuality. This strategy is an
integral and important optimization process to drastically reduce the computing time and the
cost of the model. The model was previously tested against those models that considered
healthy people as individuals [52].
The state variables of the agents mainly refer to their status in the TB infection cycle
as well as the time spent in such phases and individual diagnostic time when getting sick.
Other individual state variables and parameters are age, risk factors (e.g.,diabetes, possible
HIV infection, and other chronic diseases). Smear-positivity or negativity of infectious
agents is also considered. A state diagram of the model is presented in figure 5.1. The total
population of Gombe is about 3.4 million inhabitant in 2017, but the simulation is carried
out per 100,000 population.
The model is partially spatially explicit, space is considered but it is not explicit, i.e., it
does not mimic the exact real space of Gombe State. Simulation occurs in a discrete area of
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Fig. 5.1 State diagram of the model, where the five states of individuals and their possible
transitions are shown. Output whit dotted arrows refer to deaths; input dotted arrows are
the corresponding entrances of randomly selected individuals in order to keep population
constant.
501 × 501 spatial cells. Each spatial cell represents a local abstract space where persons can
interact and transmission of the bacilli can occur with certain probability in a time step. The
time step is set to 1 day, and the simulation may cover up to a period of 1 year or more.
5.2.3 Process overview and scheduling
Our model was built in on C programming language, which is well suited for modeling
a broad range of agent-based systems. The simulation starts with the set-up of the initial
configuration, where the population is randomly generated according to the input distributions
of parameters and randomly distributed in the 501 × 501 grid. The model assumes discrete
time steps of 1 day, as mentioned. Each day, all individuals execute a series of actions, and
their variables are updated immediately.
The individual actions may be: to increase age, to move, to get infected, to get sick, to
be diagnosed and start a treatment, to abandon or finish the treatment, to recover, and to die.
Some of the actions take place daily for all the individuals in the system (e.g., aging and
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movement) and the other procedures are daily evaluated when necessary (e.g., the possibility
of a sick individual to be diagnosed is daily assessed). When an individual dies, a new person
is introduced with particular random characteristics according to the initial distribution of
individual parameters, since general population heterogeneity is assumed to remain constant
during the simulation. At the end of each time, step global variables are updated. figure 5.2
and 5.3 shows the flow diagram of the computational model.
Fig. 5.2 Flow diagram of the model, with all the involved processes and sub-processes. step
within the dotted box contained actions that required some certain conditions to be fullfilled,
some of these steps are further detailed in Figure 5.3
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The model is based on general knowledge and understanding of the natural history of TB
and TB transmission in a population. There are two essential characteristics of TB that must
be taken into account in any epidemiological model:
1. An infected individual does not necessarily develop an active disease; on average, only
10% of infected people develop active disease. A person can remain infected for a very
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long period of time and may develop active TB after several years, but the probability
of developing the disease decreases with time [29, 18]. Infected people are usually not
diagnosed, but they can be detected in a screening.
2. Only TB sick can spread the infection. The infection rate increases if the patient is
smear positive. Once a TB sick is diagnosed, it is assumed that after two weeks of
treatment, the patient could not be able to spread the disease.
The pharmaceutical treatment takes 6 months (World Health Organization [67]). Once
the treatment is finished, the possibility of getting sick again because of a TB reactivation
remains at 1% for 2 years. Moreover, in some experiments a treatment for detected infected
individuals can be included. This treatment is longer than the one given to persons with active
TB. It usually lasts 9 months and it is administered to infected individuals to prevent the
development of an active disease once they have been detected during a screening exercise
(World Health Organization [82]). There is also a probability of relapse for the infected state
that is calculated similar to the first treatment.
Emergence
Emerging phenomena are mainly related to long-term dynamics of the infection at the
population level. On one hand, only non-treated people with active TB can spread the disease
as explained by [? ]. Therefore, time before diagnosis is an essential component for the
prevalence of the disease. On the other hand, infected persons may develop active TB even
a few years after the infection. Therefore, global consequences of particular event at a
particular moment may be detected some years later.
Interaction
Local interactions between individuals are explicitly modeled and are one of the most crucial
component for the dynamics of the system. They refer to the contact of two persons favored
by the spatial proximity between them and the possibility that one of those individuals with
an active TB may infect the other person.
Stochasticity
Randomness is introduced at all levels of the simulation. The initial distribution of individual
properties is randomly executed according to input distributions from the experimental data
gathered. Movement is assumed to be random. Each action is associated with a certain
probability and thus executed according to a random probability.
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Observation
Output data shows the daily evolution of healthy people, infected people, sick people, people
under treatment, and persons already treated. We also record the total number of new sick
in a year, total diagnosed in a year and number of death due to TB in that year. Data are
recorded annually and exported to an external CSV data file, where they are further analyzed.
5.2.5 Details
Initialization
The user can change some initial conditions at the beginning of the simulation in order to
suit the purpose of the experiment. For this particular study, most of the input parameters are
taken from official reports. The initial population is fixed at 105 individuals. All percentages
shown in Table 5.1 are used for calculating the configuration of initial population: rates of
sick, under treatment and recovered individuals per 100,000 inhabitants; mean diagnosis
delay (from the fieldwork carried out); mean treatment abandon rate; notification rate; death
rate due to TB and death rate in children and general population; age distribution in the
population; age distribution in the initial population of the sick; gender distribution both
in general and sick population; smear positive; individuals with risk factors and with HIV
infection. Some other initial variables are assigned randomly: time spent in the infection
state-assigned; spontaneous recovery time of the unnotified sick; etc.
Submodels
• Age: All individuals increase their age by 1 day each time step.
• Move: All persons can move randomly through the surrounding local space, once a
day.
• Get infected: If there is a certain number of individuals susceptible to TB (healthy
and treated) different from zero in the proximity of a sick individual, meaning one of
the nine-neighboring spatial cells, including the one occupied by the sick person, this
sick agent can infect one of them with a certain probability. The total of susceptible
neighboring individuals is computed and then the infection process is repeated as
many times as healthy and treated people are found. The infection probability depends
on the type of TB disease that the sick person has, either smear positive or smear
negative. A smear positive is considered to double the infection probability. The value
of the infection probability is closely linked to the spatial and temporal scales, i.e.,
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Table 5.1 Official data of Gombe state (Nigeria). Values used in simulations of the model.
(*) Percentages with respect to the total number of TB sick people. (¶) Percentages with
respect to TB affected people.
Gombe state Value Unit Ref
Total population 3,257,000 persons [1]
Infected population ¶













Male 60.1 % NTBLCP data












0-5 years 3.69 ·10−4 % [96]
6-15 years 7.01 ·10−5 % [95]
16+ years 3.269 ·10−5 % [94]
Daily mortality (TB induced)
Notified cases 4.87 ·10−4 % [7]
Unnotified cases 1.82 ·10−3 % Calibrated
the probability of infection is inseparable from the spatiotemporal scale. A change in
any of these scales entails the revision of its value. Therefore, it is not a real infection
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Table 5.2 Continuation of table 5.1 Values used in simulations of the model.(*) Percentages
with respect to the total number of TB sick people.(¶) Percentages with respect to TB affected
people.
Gombe state Value Unit Ref











Smear positive ¶ 30 % [61]
Treatment abandon rate ¶ 15 % [6]
Notification rate ¶ 16 % [6]
HIV+ rate 4.9 % [92]
probability when a sick individual meets a healthy person, but an effective infection
probability given the particular spatio-temporal constraints. In this case (501 × 501
spatial cells and 100,000 individuals), the value of this probability was fixed at 0.76%
daily for the smear positive5.1. Once a person is infected, a newly infected individual
is created with characteristics randomly assigned according to the data from Table 5.1.
Assignment of gender, age group, HIV status, smear status and all other characteristics
entirely depend on the initial official data. The infection time of the new individual is
set at zero and starts increasing with each time step.
• Get reinfected: The process of reinfection is also considered, it is similar to the process
of infection, but the individuals that qualifies for reinfection are the infected and the
recovered. If there is a number of infected and or recovered different from zero in the
proximity of the sick individual, the sick person may infect one of them with a certain
probability. The details of this procedure are analogous to the Get infected ones.
• Get sick: Once infected, the individual may develop active TB according to a particular
annual probability that decreases with infection time during the 7 years post-infection
[29, 18, 84]. It is assumed that the infection lasts for a very long period of time, though
after the first seven years of infection, an individual is evaluated daily with a given
probability [7] for a spontaneous elimination of the disease. An immune factor of 0.1
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is introduced in the case of Gombe population, this is due to excessive exposure of
the population to the Mycobacterium tuberculosis obviously because of the very high
prevalence of the disease, hence allowing some of the susceptible population to develop
a spontaneous defense mechanism against the disease 5.3. For immunodeficient people,
such as HIV+, a certain factor is multiplied by this probability to increase the chances
of sickening. The same happens if there are other risk factors. The chance of becoming
a TB sick individual is evaluated at each time step for all infected persons. Globally,
the average of 10% of infected developing an active disease is satisfied. The possibility
of relapse (getting sick again) for recovered patients is also evaluated daily according
to the individual relapse probability (see below). Once a person gets sick, a notification
property will be assigned to him according to the input notification rate, and the disease
time counter starts running. After the first 19 days, the system will check if the person
is notified and then evaluate the chance of diagnosis based on the distribution in table
5.1. Otherwise, he will remain unnotified until after 3 years of sickness, when the
system will then check to see if he gets cured spontaneously.
• Get diagnosed and start treatment: if an individual has been assigned the chance to be
diagnosed (notification rate), this chance is daily evaluated according to the diagnosis
probabilities in table 5.1. Once diagnosed, medical treatment is assumed to start and to
stop TB spreading after the first fourteen days of treatment. Individual’s time under
treatment is initially set to zero and then updated at each time step.
• Abandon treatment: There is a certain probability that an individual abandons the
treatment before finishing it. This possibility is evaluated daily for each patient under
treatment, according to the input abandonment probability. If a person leaves treatment
during the initial 15 days post-diagnosis, he/she becomes ill again. If he/she abandons
the treatment after 15–180 days post-diagnosis, the model will consider him/her to be
recovered but with a certain probability of relapse during the following 2 years. This
probability is assumed to decrease linearly from the 100% of a 15-day abandonment to
the 1% of the 180-day treatment period.
• Recover: When a sick individual is diagnosed and treated for 180 days, he/she becomes
recovered and a relapse probability of 1% is assigned (the chance of getting sick again
during the following 2 years). After 2 years, the individual is considered to be healthy
again.
• Die: Each individual has a certain probability of dying according to his/her age. These
probabilities are fixed using demographic data from Gombe [2–4]. Accordingly, the
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daily dying probabilities are considered to be 3.69 ·10−4 % for individuals under 5,
7.019 · 10−5% for individuals between 6 and 15, and 3.269 · 10−5% for individuals
over 15, which is a simplification of the real mortality distribution. Furthermore, TB
induced death probability for notified sick persons is given as 4.87 ·10−4 [7] while for
unnotified sick persons is calibrated to be 1.82 ·10−3. This probability is evaluated
daily for each sick individual, taking into account that 40% of non-treated TB sick may
die in 5 years. Each time an individual dies, a new individual is introduced into the
simulation world with the aim of maintaining a constant population. The individual’s
characteristics are fixed according to the distribution of the initial population as in table
5.1.
5.3 Model implementation and results
5.3.1 C implementation of the model
In this section, the features of the C implementation will be described. The reader is assumed
to be familiar with the C language. For further information, refer to the source code.
Details
• Space: The space is considered be a 2D grid represented by a 2D array. Although each
individual can be in one of the points of the grid, only the healthy ones are considered
as values in the array (i.e. a 3 in the array means that 3 healthy individual are at that
particular point). For the rest of the states, the position is a property of the individual
(explained further in the following items).
• Individuals: All individuals but healthy are considered separately. That is, the indi-
viduals of each state are represented by different structures which contain different
properties. This structures are implemented with struct’s. Some common characteris-
tics for the non healthy individuals are age (in days), gender, and position on the grid
(i.e. an x and a y value). The particular properties of each state are as follow:
– Characteristics of infected individuals: time infected (in days), HIV status, im-
mune factor, and reinfection factor.
– Characteristics of Sick individuals: time sick (in days), diagnosis time (in days),
smear status, notification factor.
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– Characteristics of individuals under treatment: time under treatment (in days)
and smear status.
– Characteristics of treated individuals: time spent under treatment (in days), time
since finishing the treatment (in days), smear status, probability of relapse before
being considered healthy.
File configuration
For easier comprehension of the simulator, the source code was split into different files. This
allows to classify these files based on their respective functions and thus makes it easier to
debug, test and maintain the code. We give a detailed description of the different files:
• IBMheader.h: this is the header file that contains all declarations of functions and
global variables of the simulator.
• IBMparams.c: the file contains all the global variables and parameters used in the
simulator. This file is particularly important because it allows the change of any
parameter easily without modifying the source code. Some of the parameters have
been introduced in table 5.1, the rest of the parameters can be found in this file.
• IBMsetup.c: the file contains the definition of the functions needed for the initialization
of the simulation, i.e., the functions that generate the individuals in each state according
to the initial setup. It also initializes and generates the structure where the individuals
are embedded in.
• IBMdynamics.c: the file contains the definition of the functions needed for the evolu-
tion of the simulation, i.e., the functions that represent the dynamics of the model such
as infection, movement, diagnosis, etc.
• main.c: the main file of the program. This contains the function main and the flow of
the simulation, it is where the functions in the two previous files are called.
• random functions.c: this contains the functions related with (pseudo)random numbers,
from the generation of a pseudorandom number according to a certain distribution to
the choice of an element between a collection with different probabilities.
• list.h: header file that contains the declaration of functions of the file list.c.
• list.c: file that contains the definition of the functions of the doubly linked lists used.
This implementation is independent of the IBM model and could be used in other
programs.
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Assuming that one wishes to compiles with gcc compiler (a commonly used C com-
piler), the line needed to compile the program from these files is: gcc main.c IBM-
params.c IBMsetup.c IBMdynamics.c random functions.c list.c..
5.3.2 Model validation
Once the simulator was ready, it was tested to see if it presents the same dynamics as
the previous simulator [79] and mimics the real behavior of the system as well as which
improvements, if any, are present with respect to the previous version [79].
In order to evaluate the dynamics of the system, 10 years simulation was performed
starting with the parameters shown in table 5.1. Figure 5.4, 5.5 and 5.6 present the results of
these test simulations with a common set of parameters. The mean of the simulations in each
case was fitted to the official data as the case may be.
Fig. 5.4 Model validation prevalence: Result of 10 simulation compared to WHO official
data of estimated prevalence between 2007 to 2016, and also the SEIR model estimates [7]
for Gombe state. Light lines correspond to single ABM simulations, while red line shows the
mean of 10 independent simulations.
The initial conditions 5.3 were estimated from the official data of NTBLCP of Gombe
state and then adjusted until it fits the model, while the parameters used are described in table
5.1 (more details about the parameters are found in the source code file IMBparams).
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Fig. 5.5 Model validation of incidence rate: Result of 10 simulation compared to official
data from WHO between 2007 to 2016. Light lines correspond to single ABM simulations,
while red line shows the mean of 10 independent simulations.








In Figure 5.4, 10 different simulations of prevalence in Gombe are presented. The mean
of all the simulation is the red curve fitted between the official data of Nigeria’s prevalence
from WHO in a black curve, and the estimated prevalence of Gombe state in the blue curve
(using techniques adopted from section 3 [7]).
Observation shows that simulation presents some noise level which is expected since
we are dealing with stochasticity. The mean prevalence is between the real data and the
SEIR-estimated data, and also follow the same behavioral tendency as the real data. In
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Fig. 5.6 Model validation diagnosed patient: Result of 10 simulation compared with diag-
nosed cases of Gombe state from official data of NTBLCP Gombe state between 2007 to
2016. Light lines correspond to single ABM simulations, while red line shows the mean of
10 independent simulations.
conclusion, it can be said that the implementation of the model in the C simulator was a
success in term of the prevalence of TB observed.
Similar to the prevalence, the incidence in Figure 5.5 also present 10 simulations of TB
incidence in Gombe, the mean of the simulation was also compared to the incidence of TB
in Nigeria from official data of WHO (in a black curve) between 2007 to 2016. Observation
also shows that the mean TB incidence tends to flow the behavior of the real data as in the
case of the prevalence.
Figure 5.6 also presents 10 simulation of the diagnosed. The mean of the simulation
tends to follow the behaviour of the diagnosed cases in Gombe state from 2007 to 2016. In
conclusion, we can assert that the model is well posed and well behave and the implementation
was successful.
5.3.3 Experiments testing different types of intervention in Gombe state
We have designed 3 different experiments to test different types of intervention in Gombe
state. We start by testing the increase in notification alone which is the direct consequences of
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educating the general public about TB and improving AAAQ of health facilities (intervention
I); then, we test a decrease in diagnosis delay time alone (also consequence of higher
awareness of population and increase in AAAQ of health system) and in combination with
the increase in notification (intervention II); finally, we test the effect of a lower transmission
due to a through education of the TB patients during diagnosis consultation with the health
workers, also in combination with the previous interventions (intervention III).
Increasing notification rate is essential to reduce prevalence of TB in Gombe (Interven-
tion I)
In the context of Nigeria, the country adopted passive case finding policies when it comes to
TB [7]. For instance, in the case of Gombe state, an individual must go to the hospital by
him or herself in order to become a reported TB case. Then, there is no follow up from the
hospital to the patient domiciliary in order to fish out TB sick or infected people and also to
check for treatment compliance. We use the simulator to test the effect of this policy on the
TB dynamics. We assume the low notification of TB cases in Gombe and Nigeria at large as
the direct consequences of this policy. We design an experiment to investigate the effect of
increasing the notification parameter gradually from 16% to 20%, 25%, 30%, 60%, and 85%
as shown in Figure 5.7.
(a) (b)
Fig. 5.7 Test for increase in notification: (a) Result of multiple simulations with a gradual in-
crease in notification in the TB prevalence of Gombe state. (b) Result of multiple simulations
showing the corresponding diagnosed persons with each increase in notification.
The experiment proves that the lack of active case finding or low notification explains the
high prevalence of TB in the area. We carried out multiple simulations with a gradual increase
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in the notification parameter from 16% up to 85%, while all other associated parameters
remain the same (5.7).
The notification rate of TB in Nigeria is about 16% [7]. Therefore, the notification
parameter in the baseline simulation was 16% as seen in table 5.1. Simulation results show
that a 10% increase in the notification would decrease the prevalence by almost 35% in
10 years. Furthermore, simulation also shows that 44% increase in the notification will
decrease the prevalence by 60%. It would be of interest to do a rough economic evaluation
of the consequences of the increase in the notification. According to research carried out by
[103], the cost-effectiveness analysis estimated that in the case where there is a reduction in
mortality from 14% to 2%, the result in a cost per daily adjusted life year averted of $330.
35,000 household were screened at the cost of $363,275, which bring the cost to $10.378 per
household. The yearly cost of TB treatment under full DOT 80% coverage smear-positive
cases is $845.4 per patient [12] in Sub Sahara Africa. The difference in the accumulated
number of TB cases in 10 years between the baseline simulation in Figure 5.7(a) and the
increment of 10% in notification in Figure 5.7(a) is over 422. The total cost of treatment
for these number will be $356,590 while the cost of active case finding is $4,379.5 thus a
difference of $352,211 [12]. The sum presented is only a rough estimate per 105 population.
The cost of TB burden clearly outweighs the cost of investment in an increasing notification
or active case finding. A full economic evaluation of the consequences of an increase in the
notification would be explored in future research.
The role of the diagnosis delay combined with an increase in notification rate(Intervention
II)
We carried out another experiment where we started by testing the effect of reducing the
diagnosis delay alone and then combining with an increase in the notification rate. The result
of the experiment is given in Figure 5.8
We can consider the increase in the notification rate as a consequence of educating the
general public about TB. Besides, a decrease in diagnosis delay can be favoured from such
education, although it also requires an improvement on the AAAQ of the health system.
As explained in Section 4, the diagnosis delay distribution among sick that is used in the
model is a direct representation of the diagnosis delay time distribution obtained from the
fieldwork in Gombe state. The corresponding mean delay time is about 169 days. In Figure
5.8, the green curve is the result of the decrease in the diagnosis delay time alone, using the
baseline notification rate (16 %). We use a diagnosis delay distribution which is similar to
the original data but reducing the length of period for diagnosis with 23% of the sick been
diagnosed in the first 49 days and 77% of the patient been diagnosed within the next 30 days.
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Fig. 5.8 Model test for increasing notification and decreasing diagnosis delay: Multiple
simulation indicating the effect of a decrease in the diagnosis delay without and with an
increase in notification rate. The Notation Not mean notification and Delay means diagnosis
delay time
Then, the mean diagnosis delay time is 26 days. The simulation shows that after 10 years of
this strategy there is only about 8% decrease in prevalence. A combined strategy of educating
the general public thereby increasing the notification by 10% and reducing the diagnosis
delay time shows a 42% decrease in prevalence after 10 years. Similarly, if we adopt the
combined strategy of educating the public where the notification is increased by 44% and
reducing the diagnosis delay as we did, prevalence shows a 65% decrease after 10 years.
The 3 ways intervention strategy (Intervention III)
We carried out another experiment where we combine: (1) education of the general public
as a means of increasing the notification rate; (2) education of the general population and
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improvement of the AAAQ of the health system to reduce the diagnosis delay; and (3)
education of the patients during diagnosis consultation with the health worker as a means of
reducing the time of infectiousness after starting treatment. The results of the experiment are
given in Figure 5.8
Fig. 5.9 Model Test for 3 ways intervention strategy in TB control: Multiple simulation
indicating different type of education both for the general population and the patient with a
reduced diagnosis delay.
As above-mentioned, we consider that the increase in the notification rate may be partially
achieved with an increasing in education of the general public about TB. The control of
TB spreading by the sick persons during the first 2 weeks after diagnosis is considered to
be the consequence of educating the patient by the health workers; in addition, a decrease
in diagnosis delay also contributes in controlling the spreading of the disease, since the
infectious pre-diagnosis period of patients is reduced. The decrease in diagnosis delay may
be achieved by a necessary combination of educating general population about the need
for being diagnosed together with the improvement of the AAAQ of the health system and
120 Using Agent-based simulations to test interventions in Gombe
facilities. In Figure 5.9, the red curve is the result of achieving an increase in notification rate
only after 10 years of simulation, starting with from the baseline 16% to 20%, 25%...85%.
The blue curve is a combination of reducing diagnosis delay and an increase in the notification
rate. Finally, the green curve is the combination of both with a reduction in diagnosis delay.
It is clear from the simulation that, once the highest notification is achieved (80%), the other
two strategies are not necessary. Nevertheless, for intermediate notification rates they reveal
to generate a significant decrease in prevalence. Adopting the first strategy by increasing
notification by 10% will reduce prevalence by 35% in 10 years, while adopting the 3-way
strategy will reduce prevalence by almost 50%. Thus, we can say that optimal strategy that
will yield the fastest results is when we combine the 3 strategies. Table 5.4 shows a respective
decrease in prevalence with respect to each of the strategies mentioned above.
Table 5.4 Comparison between interventions: Associated decrease in prevalence with respect
to each intervention implemented after a period of 10 years.
Notification increase 4% 10% 15% 44% 69%
Intervention I 17% 33% 38% 59% 76%
Intervention II 38% 40% 54% 64% 77%
Intervention III 40% 49% 61% 73% 79%
5.4 Discussion
The current simulator is a step by step towards a heterogeneous, integrated and sophisticated
platform for the simulation of tuberculosis spread in high burden areas. The simulator was
built from a mechanistic perspective that accounts for the existing knowledge on the disease
natural history and on the socioeconomic context taking environmental factors into account
from the community of Gombe state. Factors such as immunological capacity, age and
gender distribution, the delay time for diagnosis and its distribution were all deduced from
the statistical analysis of data collected from Gombe state. The infected population and death
due to TB were estimated using the SEIR model from section 2.1, while the probability of
progression to active TB, natural death and other parameters were taken from literature.
All parameters have been calibrated to fit tuberculosis situation in Gombe state, the model
is robust enough to fit any given situation with the implementation of few changes.
The simulator was implemented on the C program, and it is evident that it is a big
improvement on the Netlogo counterpart version in term of computing time. The simulator
in C does present a lower computational cost. It can simulate populations 100 times bigger in
a reasonable time and perform smaller simulations more than 30 times faster than in Netlogo.
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We have shown the capability of the simulator in reproducing both TB prevalence, incidence
and notified cases in the population of Gombe with very high accuracy.
With model perfectly calibrated, we performed an experiment to show some interven-
tion strategies. 3 types of intervention were proposed, an increase in the notification rate
(Intervention I), an additional decrease in diagnosis delay (Intervention II) and an additional
decrease in the infectiousness of diagnosed sick patients (Intervention III). All of them are
expected results of interventions at the educational level, both of general population and of
patients, as well as of an improvement of the AAAQ of the health system. For intermediate
levels of notification rates, Interventions II and III provide significant improvements, while




Conclusions and further work
In this chapter, the conclusions and further work are presented. Conclusions are organized
as follows: first, specific conclusions to each specific objective of the thesis are detailed;
afterwards, main conclusions that respond to the general aim of the thesis are presented.
6.1 Specific conclusions
Specific conclusions are detailed as individual response to each of the objectives from section
1.5.1.
Research objectives and conclusions
R1: To understand the main features of TB dynamics in low burden countries and high burden
countries.
The features of both high burden and low burden context were studied, and differences in
epidemiological behaviours were identified.
• Population as limiting factor: Models with population as a limiting factor tends to
behave better in high burden setting while models with population as a non-limiting
factor behave better in a low burden setting. This bring us to the role of the susceptible
population in understanding TB dynamics in a given population.
• Model complexity: It appears that simple models could actually explain a lot about TB
in both high burden and low burden setting, but to understand some specific features of
these setting, the models have to be complex enough.
• Diagnosis delay: Diagnosis delay is one key parameter that is common to both high
burden and low burden context. We observe that most low burden contexts with a good
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public health system tend to have low diagnosis delay time while high burden contexts
usually have a very high diagnosis delay time
• Latent infected population: Although stated by WHO that the 30% of the world
population is infected with latent TB, we confirm this hypothesis in both low and high
burden contexts. In the case of low burden contexts, about 20-25% of the population
are latently infected with TB, while in the high burden contexts, about 37-60% of the
population are latently infected with TB.
• Reinfection: Reinfection is an integral part of understanding TB dynamics, but it is
only relevant in high burden contexts.
R2: To determine the cause of high incidence and its persistence in Nigeria
TB in Nigeria was extensively and rigorously studied, 4 major conclusions arise from the
study.
• TB in Nigeria still remains a major health challenge due to poor notification and case
detection, the notification of TB cases is estimated to 16% only.
• Current strategies focusing on treatment’s adherence and efficiency will not yield to a
positive results unless the notification of TB cases are drastically improved.
• The persistence of non-decreasing prevalence is also associated with a very large
number of latent infected population.
• There is a lot of unreported death due to TB that is associated with low notification
rate.
R3: To analyse the behavioural and socioeconomic reasons of TB persistence in Gombe
(Nigeria)
To understand the reason behind the low or poor notification detected in chapter 3, we
studied the behavioural and socioeconomic factors in one of the communities in Nigeria,
namely Gombe state, by analysing data from National TB and Leprosy Control Program and
from a field work study where 52 patients were randomly selected and interviewed.
• TB notification in Gombe state is averagely found to be similar to TB notification in
Nigeria, which is around 16%. TB prevalence is also estimated to be similar to that
one in Nigeria, which is around 330/105 inhabitants.
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• Looking at the particular characteristics of TB diagnosed cases in Gombe, we find
that HIV/TV co-infection is about 26%, 20% of interviewed patient are MDR, male
population are more vulnerable to TB (around 61%), 48% of TB cases occurs in the
age group between 25-44 years and TB incidence/105 in the age group 60+ is as high
as TB incidence in the most productive age group.
• The population density is a key component in determining the high incidence of TB in
different districts.
• Mean diagnosis delay of interviewed patients is 26 weeks on average. One of the main
reasons associated with longer diagnosis delay before going to the hospital is the large
surface area of the district in the state. Income level is partially associated with delay
time at the hospital, which is 1 week on average.
R4: To propose interventions to improve TB control in Gombe (Nigeria)
• 3 main types of interventions have been proposed, aimed at increasing the notification
rate, decreasing diagnosis delay time and decreasing the infectiousness of TB patients.
• Education of general population, education of patients and increasing the AAAQ of
health system are three ways that can improve the three stated problems.
• Amongst the strategies proposed, the most effective at intermediate notification rates
was identified to be the combination of the 3 strategies. Among them, the most
important one that should be firstly implemented is the increase in notification rate.
Methodological objectives and conclusions
Different types of mathematical models have been developed and adapted to different contexts
and levels of observation.
M1: To develop several compartmental models with increasing complexity adapted to
study different context and address specific questions.
• We have developed several compartmental models with different levels of complexity.
With each of them, we proposed specific questions that can be addressed such as those
related with population structure of the susceptible, time since infection, diagnosis
delay time or reinfection process, among others.
• A method for estimating parameters taking advantage of the successive increase in
degrees of complexity of SEIR models was successfully developed.
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M2: To adapt a general Agent-Based Model for the study of the specific situation in
Gombe
• An Agent-Based Model was designed specifically to Gombe state demography, where
information from the previous compartmental models and from interviews’ statistical
analysis was used for its development and fitting.
• The model provides results that are very consistent with the dynamics of TB in Gombe
state, and has been used as a virtual experiments platform to help on the design of
control interventions.
Public health objective and conclusion
PH: To look for possible in near future, real and feasible interventions to improve TB control
in Gombe (Nigeria)
The proposed actions are focused on increasing the AAAQ (Accessibility, Availability,
Acceptability and Quality) of local health system.
• The most feasible solution for improving TB notification and reduce the time before
hospital in near future in Gombe sate is educating the general public, which will also
increase Acceptability of the health system. This can be achieved by educating the
general public about the importance of visiting the hospital once a person is sick
through social media campaigns, posters at the hospitals and public places like schools,
programs on TB in radio and TV stations, among others.
• A necessary action is the raising awareness of health workers so that they educate the
patients about the main features of TB clinical symptoms and ways of infection. This
should be accompanied with the design of graphic material that can be shown and/or
distributed among patients.
• Other interventions should be focused on facilitating the diagnosis in remote areas
with actions like active case finding (increasing Accessibility and Availability) and
new cheap and portable diagnostics tools (increasing Accessibility, Availability and
Quality).
6.2 General conclusions
The general aim of this thesis was to improve the control of TB in high incidence contexts.
This aim has been pursued through the study of TB situation in Nigeria and, in particular, in
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Gombe state. In fact, improving TB control in high burden contexts is necessarily associated
with understanding the underlined problem of TB control programs in a specific area under
investigation. There are no universal solutions for a global TB problem; conversely, particular
solutions to specific contexts will provide the necessary ways towards the global TB problem.
Some of the major challenges of TB control in Nigeria have been tackled in this thesis.
Among the main identified problems that prevent TB incidence to decrease in high burden
contexts like Nigeria, we can highlight the following conclusions:
• Notification rate: Notification rate or un-notified cases of TB is one of the major
problems of high burden contexts countries in terms of TB control. The methods and
procedures of identifying and tackling the issue of un-notified TB cases were explored.
It has been shown that the low notification rate is the bottleneck for the efficacy of
other control measures.
• Diagnosis delay: Delay in diagnosis has also found to be another major area of concern
in high burden contexts like Gombe state.
• TB treatment adherence: This was also found to be a problem in the context of high
burden countries, but it has been shown that an increase in treatment adherence requires
a previous drastic increase in notification rate in order to contribute to the TB control.
Among the main socioeconomic factors that are behind the stated problems in Gombe
state, we have concluded that:
• Education of patients and of general population is essential in order to make progress
on the notification rate and diagnosis delay, as well as to prevent sick patients of
generating new cases. The education of patients requires a previous specific formation
of health workers on this sense.
• The improvement of AAAQ of the health system is also essential in order to facilitate
the access and TB diagnosis to Nigerian population, and it will also benefit from a
powerful education program.
• An active case finding strategy may help on increasing the diagnosis but also on
educating general population.
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6.3 Perspectives and further work
The results gathered in this thesis have answered many questions, but they have also suggested
new ones and opened new avenues to explore. Below are a few of the many possibilities for
further developments on this field.
In the research presented, the TB situation in Nigeria has been investigated. The ABM
simulator has done a good job in mimicking the TB dynamics in some areas of the country, but
the parameter space for the model was not explored. The simulator could also be improved
by introducing allowing the population to be an open population, introducing birth rate as
well as death in stead of a constant population. Another twist into the model could also be
the consideration of intensity of contact during the transmission of the disease, environment
could also play a vital role since the disease is an air bone disease. We can improve the
simulator by considering places where the transmission occurs such as school, house holds
recreational centers etc. We can improve the result from chapter 5 by carrying out statistical
analysis on the result from the virtual experiment. This could add to our understanding of
which intervention strategy would be optimal use in containing TB in this area. Additionally,
a cost analysis for carrying out such intervention should be consider, this will allow the stake
holders an insight into the types of resources needed in containing the epidemic.
Finally, we hope to carry out a pilot program, to implement some of the interventions
mentioned in chapter 5 in one of the district of Gombe state, and monitor the outcome.
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Appendix A
Mathematical analysis
Analysis of the model
The model analysis is based on the SE8IR described in section 2.2. The general or total
population N(t) is given by,
N(t) = S(t)+E1(t)+E2(t)+E3(t)+E4(t)+E5(t)+E6(t)+E7(t)+E>7(t)+ I(t)+R(t).




= Π− (Λ−µ)x1, (A.1)
dx2
dt
= Λ(x1 + x11)+Λ1 ∑xi − (ν1 + p1 + k)x2, i = 3,4,5...9. (A.2)
dx3
dt
= kx2 − (ν2 + p2 + k)x3 −Λ1x3, (A.3)
dx4
dt
= kx3 − (ν3 + p3 + k)x4 −Λ1x4, (A.4)
dx5
dt
= kx4 − (ν4 + p4 + k)x5 −Λ1x5, (A.5)
dx6
dt
= kx5 − (ν5 + p5 + k)x6 −Λ1x6, (A.6)
dx7
dt
= kx6 − (ν6 + p6 + k)x7 −Λ1x7, (A.7)
dx8
dt
= kx7 − (ν7 + p7 + k)x8 −Λ1x8, (A.8)
dx9
dt
= kx8 − (ν8 + p8 + k3)x9 −Λ1x9, (A.9)
dx10
dt
= ∑(pixi)− (µ + k)x10, (A.10)
dx11
dt
= k3x9 + k1x10 − (µ +Λ)x11. (A.11)
Consider the model (A.1 - A.11) with death as natural death in all of the compartment.
Proposition 1.0:
The following biologically feasible region of model (A.1 - A.11)
Ω = {(xiεR11 : ∑xi ≤
Π
µ
, i = 1,2,3...11)} is positively invariant and any solution of the
model with initial condition in Ω will remain in the region for t ≥ 0
Proof. Adding the equations in model (A.1 - A.11) gives
dN(t)
dt
= Π−µN(t)⇒ N(t)≤ Π
µ
(A.12)
by (A.12) and Gronwall [36, 11], Ω is positively invariant and it is enough to consider the
dynamics of the model (A.1 - A.11) in Ω epidemiologically and biologically well posed.
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Positivity of Solution
i f xi(0) > 0, f or i = 1,2,3, ...,11 then the solutions xi(t) of the model (A.1 - A.11) are
positive for all t ≥ 0.











Using a similar approach, it can be shown that xi(t)≥ 0 for all i and hence the proof.
Disease-Free Equilibrium (DFE)

























this type of equilibria occurs when there is no infection. At disease free equilibrium, we set
the reinfection Λ1 to zero, we have x2 = x3 = x4 = ...= x11, ⇒ N = x1.The linear stability
of E0 can be established using the next generation operator method on the model (A.1 -
A.11). The only occurrence of the variable x1 in equation 2 to 11 of model (A.1 - A.11)
is (αx10x1)/N in equation 2 which becomes αx10 at equilibrium, therefore linearization of
equation 2 to 10 is close because it doesn’t involve the deviation of x1 from its steady state.
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for small xi, i = 2,3, ...,11[36].
dx1
dt
= π − (λ −µ)x1, (A.17)
dx2
dt
= αx10 − (ν1 + p1 + k)x2,
dx3
dt
= kx2 − (ν2 + p2 + k)x3,
dx4
dt
= kx3 − (ν3 + p3 + k)x4,
dx5
dt
= kx4 − (ν4 + p4 + k)x5,
dx6
dt
= kx5 − (ν5 + p5 + k)x6,
dx7
dt
= kx6 − (ν6 + p6 + k)x7,
dx8
dt
= kx7 − (ν7 + p7 + k)x8,
dx9
dt
= kx8 − (ν8 + p8 + k3)x9,
dx10
dt
= ∑(pi−1xi)− (µ + k2)x10, i = 2,3,4...9 (A.18)
this we can call a linearized infection subsystem, it only describe the production of new
infection.
let X̃ = (x2,x3, ...x10)t , we can rewrite the linearization system as Ẋ = (T+B)X̃ , where T, B
are matrix associated with transmission and transition respectively, given as
T=

0 0 0 0 0 0 0 0 α
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0






−w1 0 0 0 0 0 0 0 0
k −w2 0 0 0 0 0 0 0
0 k −w3 0 0 0 0 0 0
0 0 k −w4 0 0 0 0 0
0 0 0 k −w5 0 0 0 0
0 0 0 0 k −w6 0 0 0
0 0 0 0 0 k −w7 0 0
0 0 0 0 0 0 k −w8 0
p1 p2 p3 p4 p5 p6 p7 p8 −(k2 +µ)

, (A.20)
where wi = pi + v1 + k. This mean all event that lead to the new infection are integrated via
T and all other event via B. Let ℸ=−TB−1, then the dominant eigenvalue of ℸ is our basic





where η = p8k7+w8 p7k6+w8w7 p6k5+w8w7w6 p5k4+w8w7w6w5 p4k3+w8w7...w4 p3k2+
w8w7...w3 p2k+w8w7...w2 p1. and ζ =(µ+k2)w8w7...w1, wi =(vi+k+ pi), i= 1,2,3...7, w8 =
(v8 + k3 + p8)
Definitions of terms in the R0: the threshold quantity , R0 , represents the average number
of Mtb secondary cases in the population that one Mtb-sick can generate if introduced into a
completely susceptible population [11, 36]
Lemma 1.
The DFE E0 of the model (A.1 - A.11) is locally asymptotically stable (LAS) if R0 < 1 and
unstable if R0 > 1 [11, 36].
Global Stability analysis
Consider the model A.18 without reinfection Λ1, the DFE E0 is globally asymptotically
stable(GSA) in Ω.
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Proof. Consider the linear Lyapunov function Ḟ = a0x2 where a0 = (αℜ0−α), with deriva-
tive given as Ḟ = a0(
αx10x1
N
−w1x2)≤ a0αx10 ≤ 0 i f ℜ0 ≤ 1 for all t > 0 in Ω.
Since all the parameters and variables of model (A.1 - A.11) are non-negative (Theorem
2), it follows that Ḟ ≤ 0 f or R0 ≤ 1 with Ḟ = 0 if and only if x10 = 0 Thus, it follows, by
LaSalle’s Invariance Principle [36], that x10(t) → 0 as t → ∞. Therefore limsup x10(t) =
0, t → ∞, it follows that, given a small ω > 0, there exist M > 0, such that limsup x10(t)≤ ω
for all t > M. Hence using the second equation of the model (A.1 - A.11), for t > M, ẋ2 ≤
αω −w1x2. Thus, by comparison theorem [36, 11], limsup x2 ≤ (αω)/w1, so that, if we let
ω → 0,
limsup x2 ≤ 0, t → ∞. (A.22)
Similarly it can be shown that
limin f x2 ≥ 0, t → ∞. (A.23)
Hence it is obvious to see that
lim x2 = 0, t → ∞. (A.24)
and following similar argument we can show that the result hold for all xi, i = 3,4,5...11,




, t → ∞. (A.25)




. Hence the proof.
Appendix B
Table of interviews from fieldwork
Fig. B.1 Summary of in-depth interview conducted in Gombe State Nigeria
LC TS GD AG MS NS NK LW EM (C) OC P/R A1 A2 HW DH DD HIV MDR CD SMK Stg
Gombe UB F 25 MR 1 1 None 0 Wife 6/2 1 2 0 5 7 0 0 0 0 1
Gombe UB M 42 MR 1 5 NCE 119 Trike 22/4 1 3 0 2 6 0 0 0 0 0
Gombe R M 33 MR 1 5 SSCE 71 Trike 11/4 1 2 1 4 5 1 0 0 0 0
Gombe UB M 23 S 0 0 SSCE 47 Mason 11/5 1 2 1 8 2 1 0 0 0 0
Gombe UB M 22 S 0 0 SSCE 36 Mason 11/4 1 1 1 8 2 0 1 0 0 0
Gombe UB M 57 MR 1 11 SSCE 17 Trader 11/3 1 2 0 8 4 1 0 0 1 0
Gombe UB M 25 S 0 0 SSCE 24 Trader 11/5 1 2 1 8 14 1 1 0 0 0
Gombe UB M 40 MR 1 1 PS Cert 48 Iron bender 12/3 1 1 1 48 7 1 1 0 1 1
Gombe UB F 27 D 0 3 None 0 Tailoring 5/2 1 1 0 4 7 0 1 1 0 0
Gombe R M 32 MR 2 10 None 95 Labor 13/4 1 1 0 48 60 0 1 1 0 0
Gombe UB M 50 MR 1 11 None 120 Car wash 13/5 1 2 1 6 7 0 0 0 0 0
Gombe UB M 23 S 0 0 None 26 Pure water 10/4 1 2 1 4 2 1 1 0 1 1
Gombe UB M 38 S 0 0 SSCE 48 Car wash 3/1 1 2 0 24 7 0 0 0 0 0
Gombe R M 20 S 0 0 PS Cert 36 Trike 20/7 1 1 1 12 30 0 0 0 0 0
Gombe UB M 30 S 0 0 SSCE 95 Iron Bender 9/6 1 2 1 8 12 0 1 1 1 0
Gombe R M 25 S 0 0 None 60 Butcher 4/3 1 1 0 12 9 0 0 0 0 1
Gombe UB M 40 S 1 1 PS Cert 60 Iron Bender 12/3 1 1 0 8 12 0 1 1 1 0
Gombe UB F 27 D 0 3 None 0 Dependent 2/3 1 1 0 5 7 0 0 0 0 0
Gombe R M 39 MR 3 7 Diploma 286 Butcher 11/2 1 2 0 33 7 1 0 0 0 0
Gombe R M 70 W 0 2 None 12 Trader 4/3 1 1 1 3 4 0 0 0 0 0
Akko R M 58 MR 1 5 None 120 Groceries 7/2 1 1 0 20 7 1 0 1 0 0
Akko R M 62 MR 1 1 None 24 Famer 6/4 1 1 0 32 6 0 1 1 0 0
Akko R M 40 S 0 0 Diploma 83 Civil servant 8/4 1 1 1 6 3 0 0 0 0 0
Kaltungo R M 48 MR 1 8 JSS3 75 Mason 11/5 1 1 0 8 2 1 0 0 0 0
Akko R M 26 S 0 0 SSCE 36 Mason 11/4 1 1 1 154 2 1 0 1 0 0
Kaltungo R F 50 W 0 5 None 18 Trader 6/3 1 1 0 9 4 0 0 0 0 0
Kaltungo R M 25 S 0 0 None 24 Driver 11/3 1 1 0 10 14 0 0 0 0 0
Y/Deba R M 15 S 0 0 SSCE NA None 15/3 1 1 0 20 7 0 0 0 0 0
Y/Deba R F 19 S 0 0 PS Cert 10 Tailor 7/4 1 1 0 12 7 1 0 1 0 0
Kwami R F 41 MR 8 25 None 0 Wife 25/5 1 1 0 48 14 0 0 1 0 0
Dukku R F 48 W 9 10 None 0 Wife 35/5 1 1 0 68 7 0 1 1 0 0
Fig. B.2 Summary of in-depth interview conducted in Gombe State Nigeria
LC TS GD AG MS NS NK LW EM (C) OC P/R A1 A2 HW DH DD HIV MDR CD SMK Stg
Dukku R M 2 S 0 0 None 0 NA 60/15 1 1 0 30 7 0 0 0 0 0
Shomgom UB M 23 S 0 0 None 7 Pure water 40/4 1 1 0 25 5 0 0 0 0 0
Shomgom R F 29 MR 1 1 None NA Wife 5/2 1 1 0 8 7 0 0 1 0 0
Y/Deba R M 33 MR 1 7 SSCE 71 Trader 20/3 1 1 0 14 5 0 0 1 0 0
Nafada R M 22 MR 0 0 SSCE 36 Mason 10/2 1 1 0 11 7 0 0 0 0 1
Balanga UB M 42 MR 1 11 None 72 Trader 22/4 1 1 0 9 6 0 0 0 0 0
Balanga R M 33 MR 2 15 None 72 Trike 20/3 1 1 0 14 5 0 0 1 0 0
Kaltungo R M 25 S 0 0 Diploma 54 Restaurant 11/3 1 1 1 8 2 1 0 0 0 0
Billiri R M 25 S 0 0 SSCE 0 Student 40/5 1 2 1 8 5 0 0 0 0 0
Billiri R M 33 MR 1 2 MSC 238 Civil Servant 4/3 1 1 0 5 4 0 0 1 0 0
Billiri UB M 30 MR 0 17 SSCE 54 Trader 11/5 1 1 1 8 6 1 0 0 0 0
Y/Deba UB M 25 MR 1 1 PS cert 48 Plumber 12/3 1 1 1 18 7 0 0 0 0 0
Somgom R F 27 D 0 3 None 8 Trader 5/2 1 1 0 4 7 0 0 0 0 0
Dukku R F 60 W 0 9 0 None Dependent 25/5 1 1 0 28 7 0 0 1 0 0
Nafada R M 42 MR 2 12 None 95 Labourer 16/4 1 1 0 6 7 0 0 1 0 0
Balanga UB M 53 MR 1 14 None 46 Farmer 17/5 1 1 1 18 7 1 0 0 0 0
Funakaye UB M 28 MR 2 2 None 71 Plumber 10/4 1 1 1 14 2 0 0 0 1 1
Funakaye UB M 38 MR 3 11 SSCE 90 Car wash 15/3 1 1 0 24 7 0 0 0 0 0
Kaltungo R M 20 S 0 0 None 24 Vendor 20/2 1 1 1 12 30 0 0 0 0 0
Funakaye UB F 30 MR 1 7 PS Cert 0 Wife 15/6 1 1 1 8 12 0 0 1 0 0
Kaltungo R M 25 S 0 0 None NA NA 10/4 1 1 0 11 10 0 0 0 0 0
Kwami R F 35 MR 1 6 None NA Wife 10/3 1 1 0 6 13 0 0 0 0 0
Key
LC: Location
TS: Type of Settlement (UB = Urban, R = Rural)
GD: Gender (M = Male, F = Female)
AG: Age
MS: Marital Status (MR = Married, S = Single, W = Widow, D = Divorce)
NS: Number of spouse
NK: Number of Children
LW: Level of Western education
EM: Estimated monthly income
OC: Occupation
P/R: Person per room
A1:Awareness on TB signs, symptoms and treatment (on a scale of 1-3)
A2:Awareness on TB transmission and spread (at a scale of 1-3)
HW:Health Care Worker
DH: Delay before hospital
DD: Delay at hospital
HIV: HIV status
MDR: Multi-drug resistance TB
CD: Chronic disease
SMK: Smoking
Stg: Stigma
